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Summary
Humans have been affected by tuberculosis (TB) for millennia. Today, TB remains a
global health problem and the leading cause of mortality due to a single infectious agent.
TB in humans is primarily caused by seven human-adapted phylogenetic lineages of My-
cobacterium tuberculosis (Mtb) complex. Mtb lineages differ in their geographical distri-
bution, partly reflecting human demographic histories. Importantly, variation in Mtb is
known to impact TB infection and clinical disease.
In recent years, advances in sequence-based molecular markers i.e. single nucleotide poly-
morphisms (SNPs) and whole genome sequencing (WGS) technologies have enabled robust
classification of Mtb strains which ultimately have allowed researchers to address impor-
tant questions regarding Mtb phenotypes, transmission patterns and the evolutionary
history of TB. Remarkably, such investigations remain underexplored in high-endemic
TB settings of sub-Saharan Africa.
By applying phylogenetically robust methods such as SNP-based typing complemented
with WGS we can gradually disentangle the role of Mtb variation on TB epidemic in high
burden clinical settings. On the other hand, with recent large-scale WGS, it is becoming
clear that Mtb strains are heterogeneous at the lineage level. Several studies have explored
the phylogenetic substructure of Lineage 2 and Lineage 4; the two most geographically
widespread and more successful Mtb lineages. However, Lineage 1 and 3 are still important
drivers of TB epidemics along the Indian Ocean rim, which includes parts of Africa. Yet
to date, the phylogeographies of these two lineages have not been fully explored. By
contrast, Lineage 2–Beijing seems to have emerged only recently in Africa. Among the
seven Mtb lineages, Lineage 2–Beijing is highly virulent and associated with antibiotic
resistance; thus, this calls for investigation of its origin on the African continent.
In this thesis, we aimed to gain countrywide insights into the genetic diversity of Mtb in
Tanzania based on SNP-typing. Secondly, using a combination of SNP-typing and WGS
techniques we describe the local diversity of Mtb and assessed for clinical phenotypes in
urban and rural settings of Tanzania. We then studied the global phylogeographies of
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Mtb Lineage 1 and 3 to infer their evolutionary histories and global spread. Finally, we
analyzed the origin of Mtb Lineage 2–Beijing in Africa using WGS.
This thesis contains 7 chapters. The first two chapters provide the background on TB,
Mtb lineages, and the objectives of the thesis. The remaining four chapters cover the
conducted research performed during this PhD thesis. In the final chapter, we summarize
the key findings, limitations and discuss the general implications of our work.
In Chapter 1, we highlight the global burden and control of TB, the outcome of TB infec-
tion and disease, the overview on the Mtb genetic diversity, different molecular markers
and genotyping techniques, and the consequences of Mtb diversity.
In Chapter 2 we state the objectives of the thesis.
In Chapter 3, we studied a countrywide population structure of Mtb in Tanzania based on
SNP-typing and assessed relationships between Mtb lineages with patients’ clinical and
sociodemographic characteristics.
In Chapter 4, we zoomed into the local urban and rural settings of Temeke, Dar es
Salaam and Ifakara, Morogoro in Tanzania, to identify clinically relevant Mtb phenotypes.
In addition, we describe the local diversity and performed an exploratory analysis on
transmission patterns in the urban setting.
In Chapter 5, we studied the phylogeography and the spread of Lineage 1 and 3 us-
ing global representative genomes from places where strains of the two lineages are fre-
quent.
In Chapter 6, we used whole genome sequences of Mtb Lineage 2–Beijing to investigate
the evolutionary history of this lineage in Africa. We reveal multiple introductions of Mtb
Lineage 2–Beijing into Africa originating from Asia. We further show that these intro-
ductions occurred over the last 300 years, with most pre-dating the antibiotic era.
In Chapter 7, we summarize the key findings from this PhD thesis, discuss the implications
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1. Introduction
1.1. Global burden and control of tuberculosis
For millennia, human beings have suffered from tuberculosis (TB), with a billion human
deaths caused by TB during the last 200 years (Daniel, 2006). In 2017, TB claimed an
estimated 1.6 million lives (including in 300’000 immunodeficiency virus [HIV] infected
individuals), and an estimated 10 million people newly contracted the disease (WHO,
2018). Most of the global TB burden lies in the 30 high-burden countries, many of which
are in sub-Saharan African (Figure 1.1). Africa, the second largest home to the world’s
population, carries one-quarter of the global burden of TB cases and has the highest TB
related deaths (WHO, 2018). The most alarming challenges facing the control of TB are
the HIV pandemic and the emergence of drug resistant (DR)–TB. The two aggravate the
TB epidemics, which prior to these events had begun to decrease, at least in the developed
world (Dye et al., 2010). Figure 1.2 highlights the three high-burden lists for TB, TB/HIV
and multidrug resistance (MDR)–TB with each category accounting for 90% of the global
burden (WHO, 2018).
Individuals infected with HIV are immune-compromised and therefore unable to mount
efficient immune responses against TB (Kwan et al., 2011), putting them at up to a 37-
fold risk of developing active TB disease compared to HIV-negative individuals (Getahun
et al., 2010). In addition, TB is the leading cause of mortality among people living with
HIV. The WHO African region bears the largest TB/HIV burden where approximately
72% of HIV–associated TB in 2017 occurred in the region (WHO, 2018). Moreover, MDR
and extensively-drug resistant (XDR) TB are two almost incurable forms of TB disease.
Over 450,000 people were estimated to develop MDR–TB in 2017, of which 8.5% had
XDR–TB (WHO, 2018). However, these figures could be underestimated as high-burden
TB settings still lack appropriate tools to diagnose DR–TB. By contrast, the highest
proportions of MDR–TB are in the former Soviet Union countries (Figure 1.2). Even
though treatment for MDR and XDR is possible, the regimen is costly, lengthy, linked to
many toxic side-effects, and associated with high rates of treatment failure and mortality
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(Nathanson et al., 2006). Worse yet, DR–strains resistant to all first-line and second-
line drugs have emerged and they cause extremely drug-resistant (XXDR) or totally-drug
resistant (TDR) forms of TB (Migliori et al., 2007).
Despite the collective efforts, TB control still relies on out-dated diagnostic tools of
poor sensitivity (smear microscopy), old drugs (isoniazid, rifampicin, ethambutol, pyraz-
inamide, streptomycin) and vaccine (Bacille Calmette-Guérin [BCG]) of questionable ef-
ficacy (Young et al., 2008). Although BCG vaccination has an invaluable contribution in
protection against paediatric disseminated forms of TB (Colditz et al., 1995; Trunz et al.,
2006), its efficacy against adult pulmonary disease varies from absolute no efficacy to as
high as 80% protection (Fine, 1995). These tools remain in use in parts of the world where
TB is one of the most important public health concerns. Recently, new rapid molecu-
lar diagnostics such GeneXpert, line probe assays (LPA), nucleic acid amplification test
(NAAT) have come into play. The endorsement of GeneXpert and other rapid molecular
tests has enabled improved detection among TB/HIV co-infected individuals (who often
perform poorly with smear microscopy) and in parallel genotypic drug resistance test-
ing. However, the scale-up and cost-effectiveness of these tools under routine conditions
remain a challenge, especially for low-income settings (Weyer et al., 2011).
Figure 1.1.: Estimated TB incidence rates in 2017. Global Tuberculosis Report 2018, World
Health Organization (WHO) (WHO, 2018).
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Figure 1.2.: Countries in the three high burden lists for TB, TB/HIV and MDR-TB.
Modified from the Global Tuberculosis Report 2018 (WHO, 2018).
1.2. TB infection and disease outcome
TB is transmitted via air droplets from an infected individual with a pulmonary form
of disease to a health individual, primarily through coughing. Upon exposure to the
infectious droplets, a person could either clear the infection as a result of an efficient innate
immune response, progress to active disease or contain the infection in latent form. One-
quarter of the world’s population is latently infected with TB and a potential reservoir
for future active disease (Houben et al., 2016). About 5-10% of the latently infected
individuals have a life-time risk to progress to active TB disease where the risk is up to
50% in HIV co-infected individuals (Koul et al., 2011). Moreover, the features of active
TB disease can vary and include pulmonary and extra-pulmonary presentations.
The interplay of host, environmental factors, and the pathogen together influence both
TB infection and disease dynamics. Human factors include immunity on the one hand,
thus immune suppression i.e., due to HIV infection is a strong factor for TB progression to
active disease (Kwan et al., 2011), and genetic factors which influence TB susceptibility
on the other (Casanova et al., 2002). Environmental factors such as good ventilation
play a role by reducing the risk of exposure to infectious droplets. Pathogen diversity
is increasingly appreciated to have important phenotypic consequences (Coscolla et al.,
2014), further discussed in the next sections.
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1.3. Diversity in Mycobacterium tuberculosis
complex
Mycobacterium tuberculosis (Mtb) complex comprises bacterial species and sub-species
that cause TB in a wide range of mammalian hosts; both human and animals (Figure 1.3).
The animal-adapted Mtb include those infecting wild animals: M. microti (voles), M. ory-
gis (oryx, antelopes, gazelles, waterbucks and deers), chimpanzee bacillus (chimpanzee),
M. pinnipedii (sea lions and seals), M. mungi (mongoose), M. suricattae (meerkats), the
Dassie bacillus (hyrax) and those infecting domestic animals: M. caprae (goats and sheep)
and M. bovis (cattle) (Alexander et al., 2010; Brosch et al., 2002; Coscolla et al., 2013;
Cousins et al., 1994; Ingen et al., 2012; Parsons et al., 2013). However, M. bovis can also
cause bovine TB in humans. On the other hand, Mtb sensu stricto and M. africanum
are the typical human-adapted species. M. canettii is a peculiar and distantly related
member of the complex which belongs to the group of “smooth tubercle bacilli” (STB)
(Gutierrez et al., 2005). The STB are suggested to contain the putative ancestor of Mtb
(Gutierrez et al., 2005). So far, M. canettii has been isolated from the Horn of Africa and
differs from its counterparts Mtb and M. africanum in colony morphology, higher genetic
diversity and evidence of horizontal gene exchange (Supply et al., 2013). In addition, M.
canettii isolates show no evidence of human-to-human transmission, and epidemiological
data suggest that they are environmental organisms (Soolingen et al., 1997).
In general, strains of Mtb are genetically monomorphic compared to other bacteria (Acht-
man, 2008), and therefore had been considered “identical” in the past. It was not until
three decades ago that strains of Mtb were known to exhibit differences at the levels of
DNA sequence. Small insertions and deletions (indels), large duplications and insertion
sequences (Embden et al., 1993), large genomic deletions (Gagneux et al., 2006) and single
nucleotide polymorphisms (SNPs) (Stucki et al., 2012) for instance are important sources
of genetic diversity in Mtb and have been used as molecular markers to explore the Mtb
diversity.
Earlier phylogenetic analyses defined Mtb into evolutionary “ancient” and “modern” groups
based on the presence and absence, respectively, of a specific deletion, TbD1 (Brosch et
al., 2002). Presently, the human-adapted Mtb is classified into seven main phylogenetic
lineages (Comas et al., 2013). These include: Lineage 1 (Indo-Oceanic), Lineage 2 (East-
Asian), Lineage 3 (East-African-Indian), Lineage 4 (Euro-American), Lineage 7; and the
M. africanum lineages: Lineage 5 (West African 1), 6 (West African 2). Further, Lineage
1, 5 and 6 are considered evolutionary “ancient” lineages whilst Lineage 2, 3, and 4 are the
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evolutionary “modern” lineages. The phylogenetic lineages show a defined phylogeograph-
ical distribution consisting of broadly distributed lineages, Lineage 2 and 4 or “generalist”
and locally restricted lineages, Lineages 5, 6 and 7 or “specialist”, exclusively restricted
in Africa. Lineage 1 and 3 show an intermediate geographical distribution. It is pro-
posed that the diversity and distribution of Mtb lineages has been partly a consequence
of adaption to human populations and their demographic history and migration.
Figure 1.3.: Global phylogeny and geographical distribution of the human-adapted
Mtb complex. a.) Whole genome-based phylogeny of the Mtb complex rooted
on M. canettii. b.) Global distribution of the seven human-adapted Mtb lineages
(Gagneux, 2018)
1.4. Molecular markers and typing of Mtb diversity
Since Mtb harbors low DNA sequence diversity, the standard sequence-based methods like
multilocus sequence typing (MLST) only provide minimal phylogenetic resolution (Sree-
vatsan et al., 1997). The early genotyping tools in Mtb were therefore based on mobile
and repetitive genetic elements. Insertion Sequence (IS) 6110–restriction fragment length
polymorphism (RFLP) (McEvoy et al., 2007), was the first fingerprinting method used
to classify Mtb based on the analysis of variable copy number of a mobile element IS6110
(Embden et al., 1993). Polymerase chain reaction (PCR) based methods were devel-
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oped afterwards and included spacer oligonucleotide typing (spoligotyping) (Kamerbeek
et al., 1997) and mycobacterial interspersed repetitive units–variable number of tandem
repeats (MIRU–VNTR) (Supply et al., 2000). The two former techniques classify Mtb
based on repetitive elements; the clustered regularly interspaced short palindromic repeats
(CRISPR) found at the direct repeat (DR) locus and the VNTRs, found at different loci
in the Mtb genome.
The mobile and repetitive genetic elements are highly discriminatory markers given their
rapid change and thus have been applied in the molecular epidemiology field (Kato-
Maeda et al., 2011). However, this property of rapid change of the markers leads to
convergent evolution resulting into different Mtb strains independently acquiring similar
fingerprint patterns (Comas et al., 2009; Fenner et al., 2011). This phenomenon is referred
to as homoplasy and is a limitation for robust phylogenetic inferences (Comas et al.,
2009).
Ideally, phylogenetic markers should be stable and irreversible. In Mtb, large sequence
polymorphisms (LSPs) or genomic deletions and SNPs have been described as such (Co-
mas et al., 2009). In addition, the two markers possess low rates of homoplasy. LSPs are
robust phylogenetic markers because Mtb lack horizontal gene transfer (Gagneux et al.,
2006). However, genetic distances cannot be inferred from LSPs, and this hinders the pos-
sibility to explore evolutionary relationships among Mtb strains. The exponential increase
in whole genome sequences of Mtb strains in recent years has allowed for the discovery of
SNPs from which SNP-typing assays have been developed (Stucki et al., 2012) both for
lineage and within lineage i.e., sublineage typing (Stucki et al., 2016). SNP-typing is a
cost-effective approach to screen large collections of Mtb strains although WGS remains
the most ideal phylogenetic tool as it gives the most detailed insight into the Mtb genome
(Comas et al., 2009).
1.5. Consequences of Mtb diversity
In addition to host and environment, Mtb variation forms a triad in determining the extent
of TB infection and disease. Genetic variation in Mtb has been shown to translate to
relevant biological and epidemiological phenotypes (Coscolla, 2017). Indeed, Mtb strains
show different molecular and immunological phenotypes demonstrated in vitro or in vivo,
and “in clinico” phenotypes demonstrated in epidemiological settings.
For example, recent advances in Mtb “-omics” revealed lineage specific transcriptional pro-
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files and differences in mycolic acid biosynthesis. A well-established example of transcrip-
tional phenotype is one involving a dormancy regulator (DosR). Lineage 2–Beijing strains
have been shown to over express DosR, resulting to the accumulation of triglycerides,
which may be a source of energy upon nutrient scarcity for example during transmission
(Reed et al., 2007; Rose et al., 2013).
Lineage-specific patterns have also been observed in the biosynthesis of mycolic acids
(MAs). Portevin et al., 2014 reported significant variations in MAs profiles among Mtb
phylogenetic lineages. Specific variations in MAs have been shown to play role in in-
flammatory responses elicited by different Mtb clinical strains. Moreover, production of
other lipid classes such as a polyketide synthase-derived phenolic glycolipid, by strains of
Lineage 2–Beijing was shown to inhibit / reduce the pro-inflammatory responses (Reed
et al., 2004).
The ability of Mtb strains to induce reduced or delayed inflammatory responses is of-
ten associated with higher virulence in infection models. Phylogenetically modern Mtb
lineages have been demonstrated to elicit reduced or delayed immune responses in hu-
man monocyte-derived macrophages compared to ancient lineages: a property that could
improve their survival and proliferation during the early stages of infection in order to
achieve increased virulence at later stages (Portevin et al., 2011).
The reduced pro-inflammatory immune responses are also linked to more rapid progres-
sion of TB. In an epidemiological setting in the Gambia, contacts exposed to TB patients
infected with Lineage 2–Beijing were five times more likely to progress to active disease
than those exposed to M. africanum Lineage 6 (Jong et al., 2008). Studies conducted in
other epidemiological settings show that Mtb strains also vary in severity of disease and
their ability to transmit (Coscolla, 2017). Stavrum et al., 2014 showed that TB patients
in Tanzania infected with modern Lineage 4 had a lower body mass index and higher
induced levels of acute phase reactants than those infected with ancient Lineage 1. These
findings suggest enhanced virulence in modern strains. Reduced virulence and lower pro-
gression risk in ancient Lineage 6 for instance has been pinpointed to the presence of a
non-synonymous SNP in PhoP, which is a virulence regulator (Gonzalo-Asensio et al.,
2014). Further evidence from epidemiological settings advocate modern lineages to show
increased transmission compared to other lineages. Transmission potential is estimated
from parameters such as tuberculin skin test conversion of household contacts (Jong et al.,
2008), genetic clustering of Mtb strains (Spuy et al., 2003) and association with younger
age of TB patient (Borgdorff et al., 2013). Based on the afore mentioned transmission pa-
rameters, several studies have shown Lineage 2–Beijing strains to be highly transmissible
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(Buu et al., 2012; Holt et al., 2018). Lineage 2–Beijing strains have also been associated
with antibiotic resistance (Borrell et al., 2009).
Taken together, evidence suggests Mtb modern lineages to be more virulent, thus con-
sidered more successful over their ancient counterpart, a suggestion that is also reflected
by their wider geographical range. Linking Mtb genotype to phenotype is challenging as
variation in Mtb strains occurs in various forms, including repetitive and mobile elements,
deletions, duplications and SNPs, all of which have been shown to influence phenotypes
(Coscolla et al., 2014). Although for a long time, host genetics and the environment were
known to be crucial determinants of TB infection and disease, pathogen factors cannot be
excluded. Owing to their long-standing interactions, both the pathogen and host should
be explored for better understanding of infection and disease; ideally, with the integration
of socio-economic factors in a systems epidemiology manner (Comas et al., 2009).
2. Aims and Objectives
2.1. Aims of the thesis
The overall aims of this thesis were i) to characterize the diversity of Mtb isolates in
Tanzania at local and national level, ii) to study the epidemiological consequences of Mtb
diversity, iii) to infer the origin and evolutionary history of Mtb Lineage 1 and 3, and
African Lineage 2–Beijing.
2.2. Specific objectives
The following were the specific objectives of this PhD thesis:
Objective 1. To describe the countrywide diversity of Mtb in Tanzania (Chapter 3 )
Objective 2. To study the molecular epidemiology of Mtb in urban and rural Tan-
zania (Chapter 4 )
Objective 3. To study the evolutionary history of the Mtb Lineage 1 and Lineage 3
along the rim of the Indian Ocean (Chapter 5 )
Objective 4. To investigate the origins of the Lineage 2–Beijing in Africa (Chapter
6 )
2.3. Outline
In the next chapter (Chapter 3 ), we describe the genetic diversity of Mtb isolates from new
and retreatment TB cases in Tanzania and describe associations of the lineages identified
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with patients’ clinical and demographic characteristics.
To get deeper insights into Mtb epidemiological phenotypes and understand transmission
patterns, we focused on the urban and rural settings of Temeke district in Dar es Salaam
and Ifakara in Morogoro Tanzania, respectively. This molecular epidemiological study is
described in Chapter 4.
In Chapter 5, we studied the evolutionary history and global spread of Lineage 1 and 3.
To achieve this, we used whole-genome sequencing data from global representative clinical
strains to define their global phylogeography and infer their global dissemination.
In Chapter 6, we describe introductions of Lineage 2-Beijing into Africa followed by onward
spread on the African continent.
In the last chapter (Chapter 7 ), we discuss the key findings, general implications and
recommendations.
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3.1. Abstract
Background
Human tuberculosis (TB) is caused by seven phylogenetic lineages of the Mycobacterium
tuberculosis complex (MTBC), Lineage 1–7. Recent advances in rapid genotyping of
MTBC based on single nucleotide polymorphisms (SNP), allow for phylogenetically ro-
bust strain classification, paving the way for defining genotype-phenotype relationships in
clinical settings. Such studies have revealed that, in addition to host and environmental
factors, strain variation in the MTBC influences the outcome of TB infection and disease.
In Tanzania, such molecular epidemiological studies of TB however are scarce in spite of
a high TB burden.
Methods and findings
Here we used SNP-typing to characterize a nationwide collection of 2,039 MTBC clinical
isolates representative of 1.6% of all new and retreatment TB cases notified in Tanzania
during 2012 and 2013. Four lineages, namely Lineage 1–4 were identified within the study
population. The distribution and frequency of these lineages varied across regions but
overall, Lineage 4 was the most frequent (n = 866, 42.5%), followed by Lineage 3 (n =
681, 33.4%) and 1 (n = 336, 16.5%), with Lineage 2 being the least frequent (n = 92,
4.5%). We found Lineage 2 to be independently associated with female sex (adjusted
odds ratio [aOR] 2.14; 95% confidence interval [95% CI] 1.31 – 3.50, p = 0.002) and
retreatment cases (aOR 1.67; 95% CI 0.95 – 2.84, p = 0.065) in the study population.
We found no associations between MTBC lineage and patient age or HIV status. Our
sublineage typing based on spacer oligotyping on a subset of Lineage 1, 3 and 4 strains
revealed the presence of mainly EAI, CAS and LAM families. Finally, we detected low
levels of multidrug resistant isolates among a subset of 144 retreatment cases.
Conclusions
This study provides novel insights into the MTBC lineages and the possible influence of
pathogen–related factors on the TB epidemic in Tanzania.
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3.2. Introduction
Tuberculosis (TB) is the leading cause of mortality due to an infectious disease (WHO,
2017). In 2017, an estimated 10 million people developed TB globally, with 1.6 million
dying of the disease. Tanzania is among the 30 high burden countries, with a national
average TB notification rate of 129 cases per 100,000; however, some regions show higher
notification rates (NTLP, 2016). Like in most sub-Saharan African countries, the HIV
epidemic contributes substantially to the high TB incidence in Tanzania, where a-third
of the TB patients are co-infected with HIV (NTLP, 2016). Contrarily, drug-resistant
TB is still low in this setting (Nagu et al., 2015). Other risk factors such as poverty also
influence the epidemiology of TB in Tanzania (MoHSW, 2013).
Transmission of TB occurs via infectious aerosols, where upon exposure individuals can
either clear the infection, develop active disease or remain latently infected (Rieder, 1999).
The complex dynamics of TB infection and disease are determined by the environment,
the host and the pathogen (Comas et al., 2009). Seven main phylogenetic lineages of
the Mycobacterium tuberculosis complex (MTBC) (Lineage 1–7) cause TB in humans
(Gagneux, 2018). These lineages are phylogeographically distributed, partially reflect-
ing human migration histories (Gagneux et al., 2006; Fenner et al., 2013; Comas et al.,
2013). Genomic differences among the MTBC strains translate into relevant biological
and epidemiological phenotypes (Coscolla, 2017). Epidemiologically speaking, these phe-
notypes are demonstrated by indicators such as transmission potential, disease severity
and progression rates from infection to disease (Stavrum et al., 2014; Holt et al., 2018;
Hanekom et al., 2007; Cowley et al., 2008). In general, strains of the widely distributed
lineages, Lineage 2 and 4 or “generalists”, appear to be more virulent than those of the ge-
ographically restricted lineages, Lineage 5 and 6 or “specialists” (Coscolla, 2017; Gagneux,
2018).
Studying genotype-phenotype relationships requires understanding the genetic diversity
of MTBC clinical strains in a given clinical setting. In Tanzania, few studies have de-
scribed the genetic diversity of the MTBC (Mfinanga et al., 2014; Eldholm et al., 2006;
Kibiki et al., 2007; Mbugi et al., 2015). These previous works used conventional genotyp-
ing tools such as the spacer oligonucleotide typing (spoligotyping) technique and revealed
the presence of mainly the East African Indian (EAI), Central Asian (CAS) and Latin
American Mediterranean (LAM) spoligo families, and the Beijing family reported only at
the lowest frequencies. Based on phylogenetically robust techniques, which include single
nucleotide polymorphisms (SNPs), the spoligo families correspond to Lineage 1, 3, 4 and
2, respectively. These previous studies from Tanzania are limited as they only focused
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on few specific geographical locations on the country and only one study profiled MTBC
on a countrywide scale albeit with low sampling coverage (Mfinanga et al., 2014). More-
over, despite the invaluable contribution of techniques like spoligotyping in the molecular
epidemiology field, such techniques are suboptimal for phylogenetically robust strain clas-
sification due to high rates of convergent evolution (Comas et al., 2009; Fenner et al.,
2011).
In this study, we applied for the first time a robust SNP typing method to classify the
largest so far nationwide representative collection of clinical isolates to gain insights into
unknown patterns of MTBC diversity in different regions of Tanzania. Given that only
few studies have assessed and identified lineage-specific differences in clinical settings,
we then looked for potential associations between the MTBC lineages and the available
clinical and epidemiological characteristics of the patients in the study population.
3.3. Materials and Methods
3.3.1. Ethics statement
The study was approved by the National Tuberculosis and Leprosy Programme and the
ethical clearance was provided by the National Institute for Medical Research of Tanzania
(Dar es Salaam, Tanzania). The data in this study were analyzed anonymously.
3.3.2. The National Tuberculosis and Leprosy Program routine
drug surveillance system
Our study was based on a nationwide convenience sample of sputum smear positive new
and retreatment TB cases diagnosed between 2012 and 2013 in Tanzania. The collection
was obtained via a platform established for routine TB drug resistance surveillance by
the National Tuberculosis Leprosy Program (NTLP) of Tanzania, covering health facil-
ities in all geographical regions of the country. Briefly, smear positive sputa specimens
from approximately 25% of new TB cases and from all retreatment cases were obtained
for the drug resistance surveillance. To obtain 25% sputa from new cases each region
was allocated four months per annum, where the respective health facilities in the region
submitted sputa samples to zonal reference laboratories for culture. The zonal labora-
tories include the Central Tuberculosis Reference Laboratory (CTRL) in Dar es Salaam,
Bugando Medical Center (BMC) in Mwanza and Kilimanjaro Christian Medical Center
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(KCMC) in Kilimanjaro, which serve the Coastal and Southern zone, the Lake zone,
and the Northern zone, respectively. Isolates from the two zonal laboratories, BMC and
KCMC were then sent to the CTRL for drug susceptibility testing (DST). For this study
we included all the isolates we could retrieve from the culture archives at the CTRL.
3.3.3. Study population and data collection
We included a total of 2,039 unique (single patient) culture-confirmed TB cases, each of
whom we could retrieve the respective culture isolate from the CTRL culture archives.
This study population represents 1.6% of all the estimated TB notified cases in the country
between 2012 and 2013 (Figure A.1). We also obtained corresponding socio-demographic
and clinical information collected during patients’ consultation at the respective health
facilities. The demographic data collected included age, sex and geographical location of
the patients, whereas clinical data included HIV status and disease category (i.e., new
case and retreatment case).
3.3.4. Processing of culture isolates
The smear positive sputa samples were cultured on Loewenstein Jensen (LJ) growth
medium according to laboratory protocols. For this study, we included MTBC clinical
isolates retrieved from archived LJ media. We then prepared heat inactivated samples
for the retrieved clinical isolates by suspending MTBC colonies into 1ml sterile water and
heat inactivate at 95°C for one hour.
3.3.5. Molecular genotyping
We then classified the MTBC clinical isolates into main phylogenetic lineages by TaqMan
realtime PCR according to standard protocols (Applied Biosystems, Carlsbad, USA) and
as previously described (Stucki et al., 2012). Briefly, the TaqMan PCR uses fluorescently
labeled allele-specific probes for singleplex SNP-typing that are specific for each MTBC
lineage. For comparisons, we also performed 43-spacer spoligotyping on a membrane for a
subset of representative MTBC clinical strains following standard protocols (Kamerbeek
et al., 1997), since spoligotyping is still widely used as a gold standard for genotyping
in similar settings. We randomly selected 107 samples out of the 2,039 representative of
three lineages, Lineage 1, 3 and 4. We excluded Lineage 2 strains for this analysis given
that such strains almost exclusively belong to the Beijing family. The clinical strains were
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assigned to spoligotype families using the online database SITVITWEB (Demay et al.,
2012).
3.3.6. Drug resistance genotyping
We selected a subset of 144 clinical isolates from the 321 retreatment cases to perform
molecular drug resistance testing. We used a previously described multiplex polymerase
chain reaction (PCR) to target the rifampicin resistance determining region of rpoB gene
(Malla et al., 2012). The PCR assay targets both the tuberculous and non-tuberculous
Mycobacteria (MTBC and NTMs, respectively) rpoB gene, so we could also rule out the
presence of non-tuberculous isolates in our study sample using the assay. The amplified
rpoB gene product was confirmed by electrophoresis on a 2% agarose gel and sent for
Sanger sequencing. We analyzed the resulting sequences by Staden software package
(Staden, 1996) and using MTBC H37Rv rpoB gene as reference sequence.
3.3.7. Statistical analysis
For statistical analysis, we applied descriptive statistics to delineate patients’ character-
istics. We used Chi-square or Fisher’s exact tests for assessment of differences between
groups in categorical variables, whenever applicable. We used univariate and multivari-
ate logistic regression models to assess for the association between MTBC lineages and
patients’ clinical and demographic characteristics. The associations were assessed for Lin-
eage 2 compared to all other lineages (Lineages 1, 3 and 4), adjusting for age, sex, disease
category and HIV status. All statistical analyses were performed in R 3.5.0 (R Core
Team, 2018).
3.4. Results
3.4.1. Patients’ demographic and clinical characteristics
The patients’ demographic and clinical information in our study included age, sex, geo-
graphical location, HIV and disease category (new or retreatment case). Table 3.1 de-
scribes patients’ characteristics of the study population. The proportions of the observed
and missing data for the study population are summarized in Figure A.2.
Our study population consisted of TB patients ranging between the age of 2 and 89 years
with a median age of 28 years (interquartile range [IQR] 27–44). To further probe the age
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distribution in the study population, we categorized the TB patients into five different
age groups (Table 3.1). We detected approximately three-quarters of the TB cases to
occur among the “young age” and “early adult” age groups. Further, our findings show
that about 1.0% of the TB cases were pediatric cases (< 15 years).
Similar to other settings (WHO, 2017), we identified a higher proportion of male TB cases
compared to female TB cases. However, the male-to-female ratio observed in our study
population was higher than the national estimates for the two years of sampling (2.2:1 vs.,
1.4:1). The striking gender imbalance among TB cases seems to peak at adolescence on-
wards and is less pronounced among pediatric TB cases (Table A.1). Additionally, a-third
(32.2%, 517/1604) of the TB cases with available HIV status were HIV co-infected. In
contrast, TB/HIV co-infected cases were more likely to be female (44.5%, CI 38.3–50.7%
vs., 25.8%, 95% CI 20.6–31.0%) which is consistent with HIV being generally more preva-
lent in females than males in Tanzania (Hegdahl et al., 2016). We found that our study
population comprised 16.1% (321/2000) of TB retreatment cases, which was four-fold
higher than the overall countrywide notifications (NTLP, 2013).
Finally, more than half (51.6%, 1029/1996) of the TB patients in our study population
were diagnosed in the Coastal zone of Tanzania and about 40% were either diagnosed in
the Lake and Northern zones. In addition to higher TB notification rates, the three former
mentioned geographical zones contain the country’s zonal TB reference laboratories. The
remaining 10% of the patients were diagnosed in any of the remaining four geographical
zones of Tanzania.
3.4.2. Main MTBC lineages in Tanzania
Using SNP-typing, we detected four of the seven known MTBC lineages (Figure 3.1),
albeit at varying proportions. In our study population, Lineage 4 and Lineage 3 were
the most frequent (866, 42.5% and 681, 33.4%, respectively) followed by Lineage 1 (336,
16.5%). Lineage 2 was the least frequent (92, 4.5%). The remaining 64 clinical isolates
(3.1%) could not be assigned to any of the MTBC lineages possibly because there was
insufficient amount of DNA in the samples (below the detection limit). Of the seven
geographical zones, four (Coastal, Northern, Lake and Southern Highlands) were highly
represented with more than 100 clinical strains each (Table 3.2). The distribution of the
MTBC lineages varied within the geographical zones (Figure 3.1 and Figure A.3). Our
findings reveal that Lineage 1 strains were more frequent in the Lake zone compared to the
overall average frequency (20.9% vs. 16.8%), whereas the frequency of Lineage 3 in this
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Table 3.1.: Clinical and demographic characteristics of the TB cases.




Child age (<15) 9.9 20 (1.0)
Young age (15 - 24) 29.7 312 (15.3)
Early adult (25 - 44) 48.0 1,170 (57.4)
Late adult (45 - 64) 10.0 379 (18.6)
Old age (>65) 2.5 73 (3.6)
Not available 85 (4.2)
valid n = 1,954
Sex
Female 32.4 645 (31.6)
Male 67.6 1,346 (66.0)
Not available 48 (2.4)
valid n = 1,991
HIV status
Negative 67.7 1,086 (53.3)
Positive 32.2 517 (25.4)
Indeterminate 0.06 1 (0.1)
Not available 435 (21.3)
valid n = 1,604
Case
New case 84.0 1,679 (82.3)
Retreatment 16.1 321 (15.7)
Not available 39 (1.9)
valid n = 2,000
Zonal region
Central 1.1 22 (1.1)
Coastal 51.6 1,029 (50.5)
Lake 17.9 358 (17.6)
Northern 20.2 403 (19.8)
S. Highlands 8.1 162 (8.0)
Western 0.5 10 (0.5)
Zanzibar 0.6 12 (0.6)
Not available 43 (2.1)
valid n = 1,996
IQR, interquartile range; valid proportion, proportion excluding missing values; Total n, all values
including NA (not available).
zone was lower (27.6% vs. 34.3%) compared to other geographical zones. By contrast,
Lineage 4 was the most predominant in all geographical zones and showed relatively
similar frequencies across the zones.
3. Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania 19
Figure 3.1.: MTBC lineages in Tanzania. A. MTBC lineage classification of 2,039 nation-
wide clinical strains. B. MTBC lineage frequencies and geographical distribution in
Tanzania.
Table 3.2.: MTBC lineage distribution across geographical regions in Tanzania.
Geographical Zone Lineage Total
Lineage 1 (%) Lineage 2 (%) Lineage 3 (%) Lineage 4 (%)
Central 8 (38.1 ) 2 (9.5) 4 (19) 7 (33.3) 21
Coastal 168 (16.8) 50 (5) 350 (35) 432 (43.2) 1,000
Lake 72 (20.9) 12 (3.5) 95 (27.6) 165 (48) 344
Northern 52 (13.3) 22 (5.6) 145 (37) 173 (44.1) 392
S. Highlands 27 (16.9) 4 (2.5) 60 (37.5) 69 (43.1) 160
Western 0 (0) 1 (10) 4 (40) 5 (50) 10
Zanzibar 2 (18.2) 0 (0) 5 (45.5) 4 (36.4) 11
Total 329 (17) 91 (4.7) 663 (34.2) 855 (44.1) 1,938
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3.4.3. Sublineage classification
After we detected four main MTBC lineages, we next explored the respective subfam-
ilies on a subset of Lineage 1, 3 and 4 strains using spoligotyping. Lineage 2 strains
were excluded from this analysis since the global strains almost exclusively belong to one
spoligotype family, Beijing with almost identical fingerprint pattern. We identified 24
spoligotypes (SITs; Spoligotype International Type) among the 107 clinical strains ana-
lyzed (Figure A.6). Twenty six (24.3%) of the spoligo patterns had not been previously
reported in the SITVITWEB database and therefore we assigned them as orphan spolig-
otypes. Several spoligotypes were identified within each of the three lineages. EAI5 was
the common spoligotype among the Lineage 1 and CAS1_Kili spoligotype among the
Lineage 3 strains. Within Lineage 4 strains, LAM, T, and H families were detected and
the LAM subfamily, particularly LAM_ZWE was the most frequent.
3.4.4. Association between lineage and patients’
characteristics
Having described the circulating main lineages of the MTBC we then assessed the re-
lationship between these lineages and patients’ characteristics in the study population
(Table 3.3). We detected a higher proportion of female sex among TB patients infected
with Lineage 2 (52.1%) compared to those infected with the other three lineages (range
from 31% to 34.5%, p = 0.009). Moreover, we observed that retreatment cases were
frequently infected with Lineage 2 strains (26.8%), which was twofold higher compared
to Lineage 1 and 4 strains (p < 0.001). We found no evidence for association between
lineages and patients’ characteristics such as age and HIV status (Table 3.3).
Lineage 2 has previously been associated with retreatment cases, drug resistance and lately
also with female sex (Holt et al., 2018; Malla et al., 2012). We therefore investigated
if similar associations exist in our study population using a subset of TB cases with
complete clinical and demographic information (n = 1,535). To assess these associations
we performed logistic regression analyses comparing Lineage 2 to all other lineages pooled
together (Table 3.4). Our analyses revealed Lineage 2 to be independently associated with
female sex (adjusted odds ratio [aOR] 2.14; 95% confidence interval [95% CI] 1.31 – 3.50,
p = 0.002) and retreatment cases (aOR 1.67; 95% CI 0.95 – 2.84, p = 0.065). We did not
detect any association between the lineages and patients’ age and the HIV status.
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3.4.5. Mutations within rpoB gene in retreatment cases
To investigate whether drug resistance was linked to a particular lineage, we included
in total 144 out of 321 retreatment cases for drug resistance genotyping of the rpoB
gene that confers resistance to rifampicin. Out of these, 112 (77.8%) had no mutations
compared to the H37Rv reference gene and 15 (10.4%) contained at least one mutation,
either synonymous (3/15) or non-synonymous (12/15) (Figure A.4 and Table A.2). We
could not determine mutation status in the rpoB gene of 17 (11.8%) retreatment cases
due to PCR and sequencing failure. Among the 12 strains detected with non-synonymous
rpoB mutations, five belonged to Lineage 2, four to Lineage 4, and three to Lineage 3
(Table A.3). Table 3.5 summarizes the non-synonymous rpoB mutations detected.
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3.5. Discussion
In this study, we classified the countrywide collection of 2,039 MTBC isolates representing
1.6% of all smear positive new and retreatment TB cases notified during 2012 and 2013
in Tanzania. Our findings show that the MTBC strains among the study population are
diverse, comprising four main phylogenetic lineages (Lineage 1–4) which occur throughout
the country. Specifically, we found that Lineage 4 was the most frequent, followed by
Lineage 3 and 1. Despite Lineage 2’s recent global dissemination (Cowley et al., 2008), it
was the least frequent in our study population. Finally, our analysis on the relationship
between MTBC lineages and patients’ characteristics revealed associations of Lineage 2
with female sex and retreatment TB cases included in the study population.
Among the 7 human–adapted MTBC lineages, Lineage 4 is the most broadly distributed
and occurs at high frequencies in Europe, the Americas and Africa (Demay et al., 2012;
Stucki et al., 2016). In our study, we observe that TB epidemics in Tanzania are also
predominated by Lineage 4, which is regarded as the most successful of MTBC lineages
(Stucki et al., 2016). In general, the wide geographical range of Lineage 4 is postulated to
be driven by a combination of its enhanced virulence, high rates of human migration linked
to its spread and ultimately its ability to infect different human population backgrounds
(Coscolla et al., 2014; Stucki et al., 2016). In contrast, Lineage 1 and 3 are known to
be mainly confined to the rim of the Indian Ocean (Gagneux, 2018), which is consistent
with our observation that nearly 50% of the MTBC strains included in the study belong
to these two lineages. This high frequency of Lineage 1 and 3 likely reflects the long-term
migrations between Eastern Africa and the Indian subcontinent (O’Neill et al., 2019).
In addition, the distribution and frequency of Lineage 1 and 3 in the mainland subset
did not vary from that of the coastal region, suggesting spread via internal migrations.
Lineage 1 was proposed to have evolved in East Africa prior disseminating out of the
continent (Comas et al., 2013). Based on this, one might expect higher frequencies of
Lineage 1 in the region. Instead, the so called “modern” (TbD1–) lineages (4 and 3 in
this case) could be dominating in Tanzania despite presumably being introduced into
the African continent only after the first European contact (Stucki et al., 2016; Comas
et al., 2013). This perhaps illustrates the ability of “modern” lineages to thrive in co-
existence with the pre-existing “ancient” (TbD1+) lineages such as Lineage 1 in our case,
perhaps because of the comparably higher virulence (Portevin et al., 2011; Stavrum et al.,
2014). The neighboring countries of Tanzania on the other hand show comparable MTBC
lineage composition to our study (Mbugi et al., 2016; Chihota et al., 2018), suggesting
common demographic histories and ongoing exchanges that resulted into distinct MTBC
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populations. Our findings would suggest the frequency of Lineage 2–Beijing in Tanzania,
like in most parts of the continent except for South Africa (Mbugi et al., 2016; Chihota et
al., 2018) to be relatively low, despite the long-standing African-Asian contacts (Chihota
et al., 2018). Evidence from recent studies show that Lineage 2–Beijing was only recently
introduced into Africa (Cowley et al., 2008; Rutaihwa et al., 2019a).
The burden of TB disease is generally higher in males (Guerra-Silveira et al., 2013; WHO,
2017) rendering male sex as a potential risk factor for TB. Furthermore, the male bias
among TB patients is also observed in settings with no obvious sex-based differences in
health-seeking behavior (Rhines, 2013). Whilst we show similar trends in this study, our
findings reveal that the proportion of females was higher among TB patients infected
with Lineage 2. This finding is consistent with several other previous studies conducted
in different settings (Holt et al., 2018; Malla et al., 2012; Buu et al., 2009). Social
and physiological factors predisposing males to higher risk of TB have been indicated
(Nhamoyebonde et al., 2014). On the one hand, these include risk behaviors such as
substance abuse (alcoholism, tobacco smoking) and gender specific roles such as risk
occupations (e.g., mining) that are male dominated and known to increase the risk for TB.
On the other hand, genetic makeup and sex hormones might contribute to the differences
in TB susceptibility among females and males, as epidemiological and experimental studies
have suggested female sex hormones to be protective (Nhamoyebonde et al., 2014). These
observations would propose that the sex imbalance in TB emerges after the onset of
puberty. Of note, we observe less sex imbalance in “child” age group (< 15 years) which
also corroborates the national notification rates (NTLP, 2013). However, this observation
can be confounded by BCG vaccination which might be most effective in this age group.
Despite the high prevalence of HIV among young females in sub-Saharan Africa (Hegdahl
et al., 2016) and HIV being the strongest risk factor for TB, TB burden remains higher in
males. While social and physiological aspects play an important role, findings from this
study and others previously conducted in Nepal and Vietnam (Holt et al., 2018; Malla
et al., 2012) suggest that bacterial factors could disrupt the trends towards male bias in
TB, a finding which warrants further investigation. Our hypothesis is that because of
higher virulence, Lineage 2 strains are able to overcome the resistance poised by female
sex which could explain the less pronounced sex imbalanced.
In addition to its association with female sex, we found that retreatment TB cases were
more likely infected with Lineage 2. A retreatment case in our study population repre-
sented recurrent TB case either due to relapse or reinfection. We hypothesized that this
observation was possibly linked to drug resistance, given the previous reported association
3. Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania 27
between Lineage 2 and drug resistance (Borrell et al., 2009). However, we detected only
8.3% (12/144) of strains among the retreatment subset tested to contain mutations con-
ferring resistance to rifampicin, five of which belonged to Lineage 2. These findings would
suggest that retreatment cases included in this study are mainly driven by reinfection as
opposed to treatment failure or relapse. Finally, based on the age distribution of TB cases
in our study, recent or ongoing transmission in high burden countries is implicated as the
main contributor to the TB burden rather than disease reactivation (following longer la-
tency periods) (Yates et al., 2016). Additionally, an association with young age has been
used as an epidemiological proxy for highly transmissible strains and faster rates of disease
progression (Jong et al., 2008; Borgdorff et al., 2013). In this study, we did not detect any
differences in median age of TB patients infected with different lineages (Figure A.5), an
observation that could speak for high ongoing transmission rates in general, irrespective
of lineage.
Our study is limited by focusing on a convenient collection of MTBC clinical isolates
that could be retrieved from the culture archives, representing 1.6% of all TB cases no-
tified in 2012 and 2013. Given that our findings are based on a limited number of TB
cases, the results particularly those related to associations between lineages and patients’
characteristics should be taken with caution as the strength or lack of such associations
could likely be affected by the sampling. In addition, most of the geographical zones
were underrepresented which could in turn underestimate the respective regional lineage
composition and the overall countrywide distribution. Unfortunately, data on drug sus-
ceptibility based on other methods such as Xpert MTB/RIF, phenotypic DST and Line
Probe Assay (LPA) were unavailable, which could have complemented the drug resistance
genotyping performed on a limited subset of the retreatment cases. Systematic sampling
would allow for better resolution on the distribution patterns, the frequencies and on
epidemiological features of MTBC lineages, which might partially determine the regional
specific epidemics.
In conclusion, this study addresses for the first time the countrywide MTBC popula-
tion structure based on robust SNP-typing. We show that MTBC population in Tanzania
is diverse with four of the seven known lineages detected. This study sets the stage for
further in depth investigations on epidemiological impact of MTBC lineages in Tanza-
nia.
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3.6. Supporting information
Supplementary Figures and Tables are available online under https://doi.org/10.1371/
journal.pone.0206334 and on appendix A of the thesis.
Figure A.1. Flowchart illustrating estimated notified TB cases in 2012 and 2013 (dashed
lines) and the study population (solid line).
Figure A.2. Patients’ data included in the study. Proportion of observed and missing
data for the variables included in the study.
Figure A.3. MTBC lineage proportions. Distribution of MTBC lineages across different
regions of Tanzania. Size of the circle is proportional to the number of isolates analyzed
from the regions. MTBC lineage proportions.
Figure A.4. Flowchart of genotyped strains for rpoB mutations. A subset of MTBC
strains from retreatment cases included for rpoB drug resistance genotyping.
Figure A.5. Patients’ age distribution across MTBC lineages. The age distributions of
TB patients grouped by infecting MTBC lineage.
Figure A.6. Spoligotype patterns of a subset of MTBC clinical strains.
Table A.1. Sex distribution across different age groups of TB patients.
Table A.2. Mutations detected in the rpoB gene.
Table A.3. Distribution of rpoB mutations across the four MTBC lineages.
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4.1. Abstract
Human tuberculosis (TB) is primarily caused by seven human–adapted Mycobacterium
tuberculosis (Mtb) phylogenetic lineages. Together with host and environmental determi-
nants, factors related to Mtb genetic variation are known to modulate the outcome of TB
infection and disease. In this study, we assessed for clinical phenotypes associated with
Mtb lineages in urban and rural Tanzania, a country with a high TB burden.
We studied 900 pulmonary TB patients recruited at the urban setting of Temeke, Dar es
Salaam between November 2013 and June 2018, and 242 pulmonary TB patients recruited
at the rural setting of Ifakara, Morogoro between August 2015 and October 2018. We
used a combination of single nucleotide polymorphism (SNP)-typing and whole genome
sequencing (WGS) to characterize 764 (84.9%) Mtb isolates from the urban setting and 110
(45.5%) Mtb isolates from the rural setting. Sociodemographic and clinical information
obtained during patient enrolment was used to investigate the epidemiological relevance
of Mtb genetic variation in the two settings.
Our findings revealed four of the seven human-adapted Mtb lineages in the study sample,
with Lineage 3 and 4 predominating in both settings, accounting for 367 (48%) and 254
(33.3%) cases in the urban setting, and 55 (50%) and 40, (36.4%) in the rural setting.
Similar epidemiological features were observed between the urban and rural settings.
However, Lineage 2 was more frequent in patients of young age in the urban setting
(adjusted odds ratio [aOR] 0.96; 95% confidence interval [95% CI] 0.93–1, p = 0.03). No
evidence for Mtb lineage associations with any other patient characteristic was found in
either setting. Further analysis of 515 Mtb genomes from urban patients revealed that
ongoing transmission is disproportionally due to strains of the modern lineages, Lineage
2–4.
Our findings provide novel insights into the genetic diversity of Mtb and the influence of
pathogen–related factors on the TB epidemic in urban and rural Tanzania.
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4.2. Introduction
Approximately a quarter of the 10 million new tuberculosis (TB) cases estimated to
have occurred in 2017 were from Africa (WHO, 2018). The burden of TB is highest
in sub-Saharan African countries, which include Tanzania. Tanzania is also recognized
as one of the 30 high-burden TB countries, with a reported annual average incidence of
129 per 100,000 (NTLP, 2016). Prevalence of TB is particularly high amongst HIV co-
infected individuals. About one-third of TB cases is also HIV co-infected, making HIV
the most important risk factor for TB (NTLP, 2016). In addition, poor social economics,
population growth and urban overcrowding contribute to this high TB burden (Dye et
al., 2010; MoHSW, 2013). In Tanzania, prevalence of TB varies across regions, and
the TB burden is particularly high in dense populated regions (Figure 4.1). Of note,
Dar es Salaam, one of the fastest growing African cities and most densely populated in
Tanzania, is the largest contributor of all notified TB cases in the country. By contrast,
drug resistance (DR)–TB across the country is low; approximately 1% in new cases and
3% in retreatment cases (Nagu et al., 2015).
Human TB is primarily caused by seven human-adapted phylogenetic lineages (Lin-
eage 1–7) of the Mycobacterium tuberculosis (Mtb) complex. Evidence suggests that
genetic variation in strains of Mtb can lead to different biological and clinical phenotypes
(Coscolla, 2017). Epidemiological measures such as patient sociodemographic and clini-
cal characteristics, disease category (new cases, relapse), disease severity, site of disease
(pulmonary, extra pulmonary), treatment outcomes, drug resistance, and transmission
potential are used to make such inferences. On the one hand, the so-called “ancient”
lineages including those of the M. africanum lineages, Lineage 5 and 6, and Lineage 1 are
considered to be less virulent in average compared to the “modern” lineages, Lineage 2, 3
and 4 (Jong et al., 2008; Coscolla et al., 2014; Coscolla, 2017). Modern lineages on the
other hand, which include Mtb sensu stricto lineages, Lineage 2–4 contain more virulent
strains which are also more transmissible in average (Holt et al., 2018; Yang et al., 2012),
and exhibit enhanced disease progression and severity (Jong et al., 2008; Stavrum et al.,
2014).
Several studies have provided insights into the epidemiological consequences of Mtb lin-
eages in different clinical settings, including Africa (Jong et al., 2008; Guerra-Assunção
et al., 2015b; Holt et al., 2018). For instance, a study conducted in Malawi showed dif-
ferences by lineage in their contribution to recent transmission and disease recurrence
(Guerra-Assunção et al., 2015b). Based on previous studies, four of the seven known
Mtb lineages have been reported in Tanzania (Mfinanga et al., 2014; Mbugi et al., 2016;
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Figure 4.1.: Map of Tanzania illustrating (A) the regional tuberculosis (TB) notification rates
and (B) the locations of the study sites (triangles): study site 1 (urban), Temeke
District, Dar es Salaam Region; study site 2 (rural), Ifakara, Kilombero District,
Morogoro Region; and the TB laboratory (square) in Bagamoyo, Pwani Region
(Sikalengo et al., 2018).
Chihota et al., 2018) but only a few studies have assessed for lineage associations with
clinical phenotypes in Tanzania (Stavrum et al., 2014; Rutaihwa et al., 2019b).
In this study, we focused on urban setting of Temeke, Dar es Salaam to investigate the
epidemiological consequences of Mtb lineages. We collected the most comprehensive clin-
ical and socio–demographic data to date to infer in clinico phenotypes based on single
nucleotide polymorphisms (SNPs)-typing complemented with whole genome sequencing
(WGS). Further, we examined genetic clustering among the strains to discover potential
differential transmission by Mtb strains. Moreover, we searched for differences between
the molecular epidemiology of TB between rural and urban settings of Tanzania.
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4.3. Methods
4.3.1. Study setting
This study was conducted based on an ongoing prospective cohort that studies the epi-
demiology of TB (TB-DAR) in the urban setting of Temeke District in Dar es Salaam.
Dar es Salaam is the commercial capital of Tanzania and the most populated city (∼
5.5 million in 2016), with a third of its population residing in Temeke. Dar es Salaam
has the highest TB case notification rate in the country (Figure 4.1). In 2016, Dar es
Salaam had an estimated total of 13,257 TB cases, of which 4,495 (33.9%) cases were
notified in Temeke District alone. The TB-DAR cohort enrolls sputum smear positive
and Xpert MTB/RIF positive adult TB patients (≥ 18 years of age) who attend the TB
clinic at Temeke district hospital since November 2013. Temeke District Hospital is one
of three regional referral hospitals in Dar es Salaam and the largest health facility in the
district.
For the rural arm of the study, we included TB patients enrolled at the second recruitment
site located in Ifakara in the Kilombero District, Morogoro (Figure 4.1). The Kilombero
District is much less populated (∼ 448,000 in 2016) compared to Temeke. Recruitment of
TB patients for the rural site has been ongoing since August 2015 at the Chronic Disease
Clinic of Ifakara (CDCI) situated within the St. Francis Referral Hospital.
4.3.2. Study population and study procedures
In this study, we included a total of 900 out of 1,262 TB patients recruited at the urban
site (Temeke) between November 2013 and June 2018 (Figure 4.2), and a total of 242
out of 339 TB patients recruited at the rural site (Ifakara) between August 2015 and
October 2018 (Figure 4.3). Figures 4.4 and Figure 4.5 summarize the proportion of study
patients included by year of recruitment. During recruitment, confirmed TB patients
were interviewed and received physical examination as previously described (Mhimbira
et al., 2017; Said et al., 2017). Furthermore, clinical data and biological specimen i.e.
sputum samples were collected for downstream laboratory analyses. We also obtained
geographic coordinates (global positioning system [GPS]) from the patients’ residences
using Samsung Tab 4 android tablets (Samsung; Suwon, South Korea).
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Figure 4.2.: Study population flow chart for Temeke (urban) site. The chart shows total number
of TB patients recruited to the proportion that was included in this study.
4.3.3. Data collection and definitions
We collected socio-demographic, clinical and laboratory data (e.g. Ziehl Nielsen spu-
tum smear results and HIV status) from the enrolled TB patients. Data were cap-
tured in electronic case report forms via the OpenDataKit (ODK) application (www.
opendatakit.org) on Android PC tablets. The data were then uploaded and stored to a
password protected and a regularly backed-up server and monitored using the eManage-
ment “odk_planner” tool (Steiner et al., 2016).
To calculate clinical severity of TB, we applied the modified 12 points TB score parameters
system (Mhimbira et al., 2017) adopted from Wejse and colleagues (Wejse et al., 2008).
i) cough ii) hemoptysis iii) dyspnea iv) chest pain v) night sweating vi) observed anemia
vii) auscultation viii) high temperature 37.0 °C ix) mid upper arm circumference (MUAC)< 220 x) MUAC < 200 xi) body mass index (BMI) < 18 kg/m2 xii) BMI < 16 kg/m2. We
then grouped TB score into mild (0–5), moderate (6–7) and severe (≥ 8).
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Figure 4.3.: Study population flow chart for Ifakara (rural) site. The chart shows total number
of TB patients recruited to the proportion that was included in this study.
4.3.4. Mtb isolates and DNA extraction
Sputum samples collected from smear and Xpert MTB/RIF positive TB patients at the
Temeke District Hospital were sent to the biosafety level 2+ TB laboratory at Bagamoyo
Research and Training Centre (BRTC) and cultured on Löwenstein-Jensen solid media. In
the case of rural site, sputum samples were preserved in cetylpyridinium chloride (CPC)
and shipped to BRTC by post and processed for culture accordingly (Hiza et al., 2017).
Prior establishment of DNA extraction protocol at the BRTC (in 2017), Mtb isolates
stored in glycerol were shipped to Basel for processing in the biosafety level 3 TB labora-
tory at the Swiss Tropical and Public Health Institute (Swiss TPH). Before processing the
Mtb isolates we performed rpoB PCR to screen for potential MDR strains. The Mtb iso-
lates were then sub-cultured in 7H9 liquid medium and incubated at 37°C after excluding
those containing rpoB mutations (3/607). Pure genomic DNA was extracted from liquid
culture (in Basel) and solid culture (in Bagamoyo) using the CTAB extraction method























Figure 4.4.: Proportion of study population compared to total patients recruited in Temeke.
Study population in dark gray and total number of patients recruited in light gray.
(Embden et al., 1993). Since 2017, mycobacterial DNA is routinely being extracted at
BRTC using the same protocol.
4.3.5. Molecular genotyping
Classification of Mtb isolates into main phylogenetic lineages was done using TaqMan
real-time PCR protocol (Stucki et al., 2012) on heat inactivated samples (1 hour, 95 °C).
SNP-typing was only performed for Mtb isolates shipped to Basel.
4.3.6. Whole genome sequencing and phylogenetic inference
Whole genome sequencing was performed on prepared libraries from purified genomic
DNA using Illumina Nextera®XT library and NEBNext®UltraTM II FS DNA Library
Prep Kits (Illumina, San Diego, USA). Sequencing was done at the Department of Biosys-
tems Science and Engineering of ETH Zürich, Basel (D-BSSE) on the Illumina HiSeq
2500 or NextSeq 500 platforms (Illumina, San Diego, USA), generating paired-end 100 or
150 bp sequencing reads. For the whole genome analysis, first Illumina adaptors were

















Figure 4.5.: Proportion of study population compared to total number of patients recruited in
Ifakara. Study population in dark gray and total number of patients in recruited in
light gray.
clipped from raw sequencing reads and low quality reads were trimmed using Trim-
momatic 0.33 (SLIDINGWINDOW:5:20) (Bolger et al., 2014). Short reads (< 20 bp)
were excluded from the downstream analysis. Overlapping paired-end reads were merged
with SeqPrep 1.2 (overlap size = 15) (https://github.com/jstjohn/SeqPrep). Reads
were then mapped to a reconstructed Mtb complex ancestor sequence (Comas et al.,
2013) using BWA 0.7.13 (Li et al., 2009). We used Picard 2.9.1 module (Mark Dupli-
cates) to mark duplicated reads and excluded them afterwards. Pysam 0.9.0 (https:
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//github.com/pysam-developers/pysam) was used to exclude reads with alignment
score lower than (0.93*read_length)-(read_length*4*0.07), consistent with more than 7
miss-matches per 100 bp. SNPs were then extracted with Samtools 1.2 mpileup (Li, 2011)
and VarScan 2.4.1 (Koboldt et al., 2012) and only SNPs with minimum mapping quality
of 20, minimum base quality at a position of 20, minimum read depth at a position of 7X,
minimum percentage of reads supporting the call 90% and maximum strand bias for a
position 90% were kept. We excluded genomes with coverage < 20 X and those containing
phylogenetic SNPs belonging to different lineages (mixed strains). SNPs were annotated
using snpEff 4.11 according to the Mtb H37Rv reference annotation (NC_000962.3). We
excluded SNPs within regions such as PPE and PE-PGRS, phages, insertion sequences
repetitive regions (at least 50 bp identical to other regions in the genome) (Stucki et al.,
2016). SNPs known to confer drug resistance were also excluded for phylogenetic re-
construction. Finally, we inferred a maximum likelihood phylogeny with RAxML 8.3.2
using a general time reversible (GTR) model and 1,000 bootstrap inferences (Stamatakis,
2006).
4.3.7. Lineage assignment
We combined SNP-typing and WGS data to assign the Mtb strains to the corresponding
phylogenetic lineages (Figure 4.2). Out of 607 Mtb isolates received in Basel, 577; 95.1%
were classified into one of the main lineages (562 by SNP-typing and 15 by WGS). At the
time of this analysis, we obtained lineage information for an additional 187 (63.8%) out
of 293 Mtb DNA extracted in Bagamoyo and genome sequenced in Basel. We included
764 out of 900 (84.9%) total study population to describe the Mtb lineages in Temeke
and their relationship with patients’ socio-demographics and clinical variables.
We processed 117 Mtb isolates from the Ifakara site for SNP typing and 110 (94.0%) of
these were successfully classified into main lineages (Figure 4.3). We did not have WGS
data available from the rural site at the time of analysis. Hence, we used 45.5% (110/242)
of the rural study population to search for relationship between Mtb strain diversity
and patients’ characteristics. Figures 4.6 and 4.7 show the proportion of samples with
genotype information compared to the number of TB patients included in the study by
recruitment year.





























Figure 4.6.: Proportions of samples genotyped among those included in the study and the total
patients recruited at the Temeke site. Genotyped (green), study population (dark
gray), total patients recruited (light gray).
4.3.8. Statistical analyses
We used descriptive statistics to characterize TB patients in our study population. Kruskal
Wallis and Wilcoxon rank-sum tests were used for continuous variables and χ2 or Fisher’s
exact (when applicable) for comparison of categorical variables. With a focus on Lineage
1 and 3, we targeted a sample size of 720 TB patients, assuming a proportion of 22% TB
patients infected with Lineage 1 and 47% infected with Lineage 3, based on frequencies
described previously (Master thesis “Molecular Epidemiology of Mycobacterium tubercu-



















Figure 4.7.: Proportions of samples genotyped among those included in the study and the total
patients recruited at the Ifakara site. Genotyped (green), study population (dark
gray), total patients recruited (light gray).
4. Molecular epidemiology of Mycobacterium tuberculosis in urban and rural Tanzania 41
losis in Bagamoyo, Tanzania”, Jackson Thomas) and a power of 80% at 5% significance
level to detect clinical relevance difference of 10% between the two lineages. We used
univariate and multivariate logistic regression models to identify lineage associations with
patients’ demographics and clinical data adjusting for age, sex, HIV and risk factors for
TB i.e., smoking, alcohol abuse and recent household contact with TB case. Statistical
analyses were performed using R 3.5.0 (R Core Team, 2018).
4.3.9. Ethical approval
This study was approved by the institutional review board of the Ifakara Health Institute
(IHI; reference no. IHI/IRB/No 04-2015), the Medical Research Coordinating Committee
of the National Institute of Medical Research (NIMR; reference no. NIMR/HQ/R.8c/Vol.I
/357) in Tanzania and the ethics committee of Northwestern and Central Switzerland
(EKNZ; reference no. UBE-15/42). All patients signed a written informed consent prior
enrollment.
4.4. Results
4.4.1. Patients’ demographics and clinical characteristics in urban
Temeke
We studied a total of 900 TB patients recruited between November 2013 and June 2018
at the urban site of Temeke. Table 4.1 summarizes the socio-demographic and clinical
characteristics of the TB patients. The median age of TB patients in the study population
was 33 years (interquartile range [IQR]: 27–40 years) and 640 (71.1%) were male patients.
The TB patients had a median body mass index (BMI) of 18.2 kg/m2 (IQR: 16.7–20.0)
and 55.3% (498/900) of the patients were underweight (< 18.5 kg/m2). HIV co-infection
was detected in 187/900 (20.8%) of TB patients. More than half of TB patients had mild
TB severity score, and only 9.3% showed a severe TB score.
4.4.2. Risk factors in urban Temeke
In addition to HIV, we determined the prevalence of nine other known risk factors for
TB including recent contact with a TB case, diabetes, alcohol abuse (defined as regular
alcohol drinking–at least three bottles of beer daily), use of steroids, smoking (defined as
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Table 4.1.: Socio-demographic and clinical characteristics of TB patients in Temeke
Characteristics Total (n = 900) Proportion %
Age (years), medium (IQR)
33 (27-40)
Age groups (years)
Child age (<15) 0 0.00
Young age (15-24) 158 17.6
Early adult (25-44) 606 67.3
Late adult (45-64) 123 13.7








Underweight <18.5 498 55.3
Normal 18.5–24.9 366 40.7
Overweight 25.0–29.9 29 3.2






Mild 0–5 557 61.9
Moderate 6–7 259 28.8
Severe ≥ 8 84 9.3
n, Number; IQR, Interquartile range; BMI, Body mass index; HIV, Human immunodeficiency virus.
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current smoking), intravenous drug use, incarceration, silicosis and tumor necrosis factor
therapy (Figure 4.8). Among the nine risk factors, smoking was the most prevalent among
TB patients (23%) followed by alcohol abuse (19.8%) and recent contact with a TB case
via household (10.9%). More than one-third of TB patients lacked diabetes status, and
only 1.1% of those who did had diabetes. Less than 1% of TB patients had history of
silicosis, steroids and intravenous drug use. None of the TB patients were recorded to
have had tumor necrotic factor therapy.
4.4.3. Spatial distribution of TB patients in Temeke
We measured geographical locations of patients’ residences using geographical coordinates
(longitude and latitude) collected by trained field workers. Figure 4.9 shows the spatial
distribution of TB patients included in the study area of Temeke. Temeke is one of three
districts in Dar es Salaam located in the southern part and bordered by the Indian Ocean
to the east. Temeke District Hospital is situated on the western part of the district and
it is intersected with regional and interregional highways. Most of the TB patients were
densely distributed in close proximity to the district hospital.














































Figure 4.8.: Proportion of risk factors quantified among TB patients in the study population from
urban site (Temeke). recenthousetb, recent contact with a TB case; alcoholabuse,
alcohol abuse; ivdruguse, intravenous drug use; prison, incarceration; and tnftreat,
tumor necrosis factor therapy.
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Lineage 1 : 12.4%  (95)
Lineage 2 : 6.3%  (48)
Lineage 3 : 48.0%  (367)
Lineage 4 : 33.3%  (254)
Figure 4.10.: Frequency distribution of Mtb lineages detected in Temeke. Mtb lineage classifica-
tion of 764 clinical strains.
4.4.4. Mtb lineages in Temeke
We classified Mtb strains isolated from 764 (84.9%) out of 900 TB patients included in the
study into the main phylogenetic lineages. Four Mtb lineages were detected (Figure 4.10).
Lineage 3 was the most frequent (48%), with the other Mtb strains belonging to Lineage
4 (33.3%), Lineage 1 (12.4%) and Lineage 2 (6.3%). The overall Mtb lineage distribution
was fairly constant during the 2014 to 2016 collection years (p = 0.10) (Figure 4.11).
4.4.5. Mtb lineages and patients’ demographics and clinical
characteristics in Temeke
We assessed the relationship of Mtb lineages with the patients’ socio-demographics and
clinical characteristics using 764 genotypes available (Table 4.2). We observed TB patients
infected with Lineage 2 to be younger in average (30 years, IQR: 25–35.3 years) compared
to patients infected with other lineages (Table 4.2 and Figure 4.12). This observation
was also reflected in a higher proportion of Lineage 2 strains among the “young age” TB
patients (22.9%) and a lower proportion in “late adult” TB patients (8.3%) than those
of Lineage 1, 3, and 4 (13.7%, 14.7% and 13.8%, respectively). We did not observe any
difference between sex distribution, median BMI, HIV status and TB severity scores across
the four infecting Mtb lineages (Table 4.2 and Figure 4.13).

















Figure 4.11.: Frequency distribution of the four Mtb lineages circulating in Temeke by recruit-
ment year.

































































































































































































































































































































































































































































































































































































































































Figure 4.12.: Distribution of age of TB patients by the respective infecting Mtb lineage in Temeke.
4.4.6. Associations between Mtb lineages with patients’
sociodemographic and clinical characteristics in
Temeke
Given that TB patients infected with Lineage 2 showed a lower median age, we next
performed logistic regression analyses to assess for a possible association by comparing
Lineage 2 against all other lineages. The multivariate analysis revealed that for every year
increase in age there is a 4% decrease chance for being infected with Lineage 2 (adjusted
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Figure 4.13.: Mean severity TB scores for each of the 12 TB score parameters among the four
Mtb lineages.













































































































































Figure 4.14.: Spatial distribution of TB patients mapped by the infecting Mtb lineage and HIV
status.
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4.4.7. Local diversity of Mtb strains circulating in Temeke
To further characterize the Mtb diversity in Temeke, we analyzed a total of 515 whole
genome sequences that were available at the time of analysis. Figure 4.16 shows the
phylogenetic tree reconstructed from 23,306 variable single nucleotide positions. The
whole genome sequence dataset reflected similar lineage frequencies (Lineage 1, 65; 12.6%,
Lineage 2, 38; 7.4%, Lineage 3, 256; 49.7% and Lineage 4 156; 30.3%) to those determined










Figure 4.16.: Maximum likelihood phylogeny of 515 Mtb strains from TB patients in Temeke.
The backgrounds on the phylogeny are shaded by lineage specific color code (Lin-
eage 1; pink, Lineage 2; blue, Lineage 3; purple and Lineage 4; red). The first outer
ring indicates the HIV status of the patients. The second and third outer rings
show the presence of drug resistance associated mutations detected in the strains
(these are colored by drugs they confer resistance to as indicated on the legend).
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4.4.8. Drug resistance
From the whole genome sequences, we further detected mutations conferring resistance
to ethambutol (EMB), fluoroquinolone (FQ), isoniazid (INH), pyrazinamide (PZA) and
streptomycin (SM). These drug resistance conferring mutations occurred in all Mtb lin-
eages with varying frequencies, except in Lineage 2 (Table 4.3 and Table 4.4). Overall,
13.2% of the Mtb strains contained at least one drug resistance mutation. We found
that drug resistance mutations were more frequent in Lineage 4 (12.2%). Despite being
the most frequent, only 3.9% of Lineage 3 strains harbored drug resistance mutations.
Furthermore, we detected mutations conferring resistance to more drugs among Lineage
4 strains compared to Lineage 1 and 3. We did not detect any mutation conferring re-
sistance to rifampicin (RIF). Of note, we assigned fabG1 C-15T mutation as conferring
resistance to Ethionamide(ETH) as well since the fabG1 -inhA promoter mutations are
known to confer cross resistance to both INH and ETH drugs (Rueda et al., 2015; Cirillo
et al., 2017).
Although ethA mutations S266R and N345K were previously reported in MDR strains
as conferring resistance to ETH (Boonaiam et al., 2010; Brossier et al., 2011), we detect
both mutations to be phylogenetic markers. The two mutations were identified among
Lineage 2 and Lineage 1 strains corresponding to sublineages Lineage 2–Beijing (L2.2.1)
and L1.2.2, respectively (Coll et al., 2014; Coll et al., 2015). These mutations were
excluded in the frequency analysis of drug resistance mutations.
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Table 4.5.: Proportion of clustered and non-clustered strains within the Mtb lineages
Lineage Cluster number Cluster members Total
No, n (%) Yes, n (%)
Lineage 1 0 65 (100) 0 (0) 65
Lineage 2 4 14 (36.8) 24 (63.2) 38
Lineage 3 7 203 (79.3) 53 (20.7) 256
Lineage 4 6 134 (85.9) 22 (14.1) 156
Total 17 416 (80.8) 99 (19.2) 515
4.4.9. Transmission clusters of Mtb strains in Temeke
From clustering analysis we identified a total of 28 clusters containing two or more strain
members using a 5 SNPs threshold (Figure 4.17). Overall, we found 23.5% (121/515)
of TB patients were in clusters. Of note, these clusters contained TB patients infected
with Mtb modern lineages (Lineage 2–4) whereby, 17, 7 and 4 clusters belonged to TB
patients infected with Lineage 3, 4 and 2, respectively. No clusters were identified among
TB patients infected with Lineage 1 (Figure 4.18). We detected 11 clusters out of the 28
comprising of two patients, 10 belonging to Lineage 3 and one to Lineage 4.
For further analysis we kept clusters with at least three members that resulted into 17
clusters where: 4 clusters belonged to Lineage 2, 7 clusters to Lineage 3 and 6 clusters to
Lineage 4. Considering cluster size of three and more, 19.2% (99/515) of the TB patients
were found in clusters. The cluster sizes ranged between 3 and 15 patients. Patients
infected with Lineage 3 had the largest cluster sizes (maximum 15 members) followed
by those infected with Lineage 2 (maximum 8 members) and Lineage 4 had the smallest
cluster sizes (maximum 5 members). On quantifying the proportion of strains in clusters
within each lineage, we discovered that Lineage 2 strains were more frequently found in
clusters compared to Lineage 3 and 4 (p = <0.0001). These results were consistent when
considering strains in two-member clusters also.
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4.4.10. 4.4.11 Patients characteristics and risk factors in rural
Ifakara
We studied 242 TB patients recruited at the rural Ifakara site from August 2015 and
October 2018. TB patients from the rural site had a median age of 36 years (IQR: 28–43)
and two-thirds of the patients were males (161; 66.5%). Out of the 242 TB patients
recruited in the rural setting, 58 (24.0%) were HIV co-infected. Table 4.6 summarizes the
sociodemographic and clinical characteristics of patients in the rural site.
In addition to sociodemographic and clinical information, we quantified known risk factors
for TB in the study population (Figure 4.19). Noteworthy, 20.7% of TB patients enrolled
in Ifakara were recorded to have had recent contact with a TB case within a house-
hold. Other predominant risk factors detected were alcohol abuse (28.5%) and smoking
(22.3%).
Table 4.6.: Socio-demographic and clinical characteristics of TB patients in the Ifakara site
Characteristics
Total
(n = 242) Proportion %
Age (years), median (IQR)
36 (28-43)
Age groups (years)
Child age (<15) 0 0.00
Young age (15-24) 39 16.1
Early adult (25-44) 146 60.3
Late adult (45-64) 47 19.4




BMI (kg/m2), median (IQR)
17.8 (16.2-19.9)
BMI categories, (kg/m2)
Underweight <18.5 146 60.3
Normal 18.5-24.9 92 38.0
Overweight 25.0-29.9 3 1.2





n, Number; IQR, Interquartile range; BMI, Body mass index; HIV, Human immunodeficiency virus.
















































Figure 4.19.: Proportion of risk factors evaluated among TB patients in the study population
from the rural site (Ifakara).recenthousetb, recent contact with a TB case; alcoho-
labuse, alcohol abuse; ivdruguse, intravenous drug use; prison, incarceration; and
tnftreat, tumor necrosis factor therapy.
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Lineage 1 : 11.8%  (13)
Lineage 2 : 1.8%  (2)
Lineage 3 : 50.0%  (55)
Lineage 4 : 36.4%  (40)
Figure 4.20.: Frequency distribution of Mtb lineages detected in Ifakara. Mtb lineage classifica-
tion of 110 clinical strains.
4.4.11. Mtb lineages in Ifakara
We classified 110 Mtb strains representing 45.5% of TB patients included in the study
from the rural site. Our SNP-typing results revealed the presence of four Mtb lineages
(Lineage 1 –4). The most frequent lineages were Lineage 3 with 55 strains (50%) and
Lineage 4 with 40 strains (36.4%). Thirteen strains (11.8%) belonged to Lineage 1 and
only two (1.8%) to Lineage 2 (Figure 4.20).
4.4.12. Mtb lineages and patients’ characteristics in Ifakara
Using lineage information available for the 110 TB patients, we described patients’ charac-
teristics by infecting Mtb lineage, excluding Lineage 2 due to the small number of patients
infected with this lineage (Table 4.7). We observed a similar median age and median BMI
in patients infected with Lineage 1, 3 and 4. Furthermore, sex distribution and HIV status
did not differ among the lineages.
4.4.13. Rural and urban comparison
We analyzed 900 patients enrolled at the urban setting in Temeke and 242 patients enrolled
at the rural setting in Ifakara. Patients in the urban setting were younger than those from
the rural setting (median age of 33 years (IQR: 27–40) compared to 36 years (IQR: 28–43],
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p = 0.007). Both patient populations from the urban and rural site had similar median
BMI (18.2 [IQR: 16.7–20.0] vs., 17.8 [IQR: 16.2–19.9], p = 0.05). HIV prevalence was
higher in the rural setting compared to the urban setting (24% vs., 20.8%) however this
difference was not statistically significant. The majority of the patients in both settings
were new cases, although the proportion of recurrent TB was higher in rural cases (5.8%;
14/242 vs., 1.8%; 16/900, p = 0.001). In addition, the recurrent TB cases were distributed
among Lineage 3 and 4 (data not shown). There were no differences in sex distribution
between the two sites. The two sites shared comparable risk factors for TB for instance,
smoking, alcohol abuse and recent household contact with a TB case. In the rural setting
however, the frequency of patients who had contact history with a TB case within a
household was two-fold higher than those reported in the urban site (20.7% vs., 10.9%, p
= 0.0003). In both sites, we detected the same four Mtb lineages (Lineage 1–4) occurring
in comparable frequencies although Lineage 2 was less frequent in the rural setting.
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4.5. Discussion
We studied 900 urban and 242 rural pulmonary TB patients in Tanzania to test for
associations between Mtb lineage and patient characteristics. We found that in both
settings, TB was more frequent in young adults, males, and comprised mainly new TB
cases. These results corroborate previous findings (Rutaihwa et al., 2019b; Sikalengo et
al., 2018). Our findings further showed Lineage 3 and 4 to be the dominant lineages in
both the urban and rural locales. Finally, we demonstrate Lineage 2 strains to be highly
transmissible in the urban setting, despite being the least frequent.
TB was most prevalent among the “early adult” age group (25-44) both in the urban
and rural sites, an observation that is consistent with national estimates (NTLP, 2016;
Rutaihwa et al., 2019b). This finding highly speaks for on-going transmissions in the
two settings, which was irrespective of infecting Mtb lineage. Furthermore, we found that
younger TB patients in the urban setting were more likely to be infected with Mtb Lineage
2 strains. We did not detect additional correlations between genetic characteristics of the
infecting Mtb strains with patients’ sociodemographic and clinical information.
The emergence of HIV in Tanzania was linked to the rise of TB incidence (Egwaga et
al., 2006). More than 20% of TB patients in both study populations were also HIV co-
infected. These findings indicate that HIV is still an important risk factor for TB and a
major contributor to TB burden, particularly in settings of high TB transmission. HIV
has been suggested to have minor overall contribution to TB transmission for reasons such
as minimal social contact due to morbidity, short infectious periods due to increased mor-
tality, smear negative and extrapulmonary forms of disease (Corbett et al., 2004; Yates
et al., 2015). However, these outcomes could vary depending on the HIV immunosuppres-
sion levels of the TB patients and TB/HIV co-infected patients with high CD4 counts
are shown to transmit as well as HIV negative individuals. We found Mtb strains from
TB/HIV patients were as likely to be found in transmission clusters as strains from HIV
negative TB patients. Unfortunately, we did not have CD4 counts for such patients. How-
ever, this observation could be driven by the fact that our study populations consisted
of TB patients who were smear positive which is the most transmissible form of disease.
Overall, HIV individuals could contribute to TB transmission given the scale up of an-
tiretroviral therapy in HIV endemic countries, which restores immunosuppression.
Based on the proportions of TB patients with recent household contact to TB case,
our findings suggest that household transmission occurred more frequently in the rural
setting than the urban setting. However, given these proportions, still more than 80%
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of TB transmission appears to occur in the communities. Moreover, sharing a household
with an index case does not necessarily reflect within-household transmission as previous
evidence shows multiple TB cases in one household to be infected with dissimilar Mtb
strains (Lalor et al., 2017).
Our genetic clustering results indicated that Lineage 2 and 3 strains are likely to transmit
more than Lineage 4 strains in the urban setting. One would expect this to be the case
for Lineage 3 since it is the predominant lineage, which in general had a higher number
of clusters and also formed large cluster sizes. Lineage 2 on the other hand, is the least
frequent but showed remarkable propensity to transmit, where more than 50% of its
strains were found in clusters. In line with findings from other settings, recent and higher
magnitude of transmission in Lineage 2, hence increased virulence is unrelated to drug
resistance. Despite being one of the two major lineages, Lineage 4 strains formed the
smallest cluster sizes and had the least proportions of strains found in clusters. We found
that Lineage 1 formed no transmission clusters in the urban setting. Patients infected
with Lineage 1 strains have been shown elsewhere to be less likely due recent transmission
and also less likely to cause secondary cases (Guerra-Assunção et al., 2015a; Holt et al.,
2018). Our results support the notion that ancient lineages, in this case Lineage 1 is less
virulent compared to modern lineages. However, this does neither seem to be related to
HIV co-infections nor old age.
We observed 80.5% of the TB patients to have taken at least one type of antibiotic prior
to TB diagnosis. The most common antibiotics consumed include amoxicillin, cloxacillin,
amplicox, and ampicillin. Although 6% of the patients from the urban site were recorded
to have taken ciprofloxacin, which is a quinolone, this proportion did not include the
patient identified with a FQ resistant strain. We mostly found mutations conferring resis-
tance to first line drugs where INH resistance was more prominent. Mutations conferring
resistance to rifampicin were not detected and this might also be due to excluding such
strains prior processing in the BSL3 laboratory in Basel. Drug resistance levels are low
in Tanzania particularly among new TB cases (Nagu et al., 2015). Part of the reason
could be because Tanzania was the first country in the world to implement the directly
observed treatment, short course strategy more than four decades ago. In addition, TB
drugs are administered by the national control program. However, in addition to fac-
tors like traditional healers, over-counter availability of other antibiotics could contribute
to delays in TB diagnosis and treatment which ultimately could have consequences on
disease transmission (Said et al., 2017).
Our study has several limitations. First, TB-DAR cohort enrolls smear-positive TB pa-
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tients. Therefore, we were unable to assess associations of Mtb strains from smear-negative
patients, which are a relevant clinical presentation of TB disease, especially in TB/HIV
patients. Hence the proportion of HIV/TB might have been underestimated. Another
limitation could be due to convenience sampling as only patients visiting Temeke District
Hospital and CDCI hospitals in the respective study sites were recruited. However, pa-
tient enrolment was random. Hence we would expect representative study populations.
Since the study used a subset of the total patients recruited during the study duration,
findings from this study are preliminary and incomplete. For instance, x-ray scores were
unavailable at the time of analysis which hindered us from assessing correlations of cav-
itary disease with Mtb strains and genetic clustering. Cavitary disease is a proxy for
enhanced transmission and virulence to reflect more successful Mtb strains (Wampande
et al., 2013). Finally, WGS data of Mtb strains from the rural setting were not available
at the time of analysis. Therefore, genetic clustering (and drug resistance) among rural
Mtb strains could not be evaluated and transmission pattern disparities between urban
and rural addressed.
Although several studies have defined Mtb clinical phenotypes with respect to host pop-
ulation in question, the implications of Mtb genetic variation in clinical settings are not
entirely clear. The existing inconsistent results or lack of correlations between infect-
ing lineage and patients’ characteristics in our case might be contributed by sampling
in addition to other factors such as host genetics and the environment. Perhaps future
studies should consider addressing the interplay between the “triad” and its influence on
TB infection and disease preferably in a population based setting for over a period of
time. This could inform us on relevant epidemiological features particularly those related
to transmission and help improve control strategies.
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5.1. Abstract
There are 7 human-adapted phylogenetic lineages of Mycobacterium tuberculosis (Mtb)
complex. With the increasing number of whole genome sequenced strains, it is clear that
Mtb strains are also heterogeneous within individual lineages. Whilst several studies have
investigated the phylogenetic substructures of Lineage 2 and Lineage 4, Lineage 1 and 3
remain unexplored. Unlike Lineage 2 and 4 which are globally distributed, Lineage 1 and
3 show an intermediate geographical range that mainly rims the Indian Ocean, making
the two lineages important drivers of tuberculosis (TB) epidemics in that part of the
world.
In this study, we refined the phylogenies and geographical distribution of Lineage 1 and
3 by using the most comprehensive whole genome dataset to date, covering a wide ge-
ographical range of clinical strains belonging to these two lineages. We confirmed our
previous classifications for describing the global population structure of Lineage 1, which
however was not the case for Lineage 3. We also identified Lineage 1 strains in Brazil
that were likely introduced multiple times from Africa. Further, our results suggest mul-
tiple transfers of Lineage 3 across the endemic geographic regions, indicating the ability
of these strains to establish in various locales of different host backgrounds. Finally, the
prevalence of Lineage 1 and 3 in the African region are likely reflecting back-to-Africa
migrations from South Asia.
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5.2. Introduction
Human tuberculosis is predominantly caused by seven human-adapted phylogenetic lin-
eages of Mycobacterium tuberculosis (Mtb) complex, Lineage 1–7 (Gagneux, 2018). These
lineages are distributed in a phylogeographic manner, a pattern that partly reflects human
demographic history and local adaptation of the pathogen to particular human popula-
tion (Wirth et al., 2008; Gagneux, 2012; Comas et al., 2013). The most likely origin of
the Mtb complex overall is in Africa, from where it dispersed around the world following
human migrations out of Africa (Wirth et al., 2008; Comas et al., 2013). The present
phylogeography of the Mtb complex shows human-adapted lineages to exhibit any of three
geographical ranges, where the “generalist” Lineages 2 and 4 are globally distributed, the
“specialist” Lineages 5, 6 and 7 are geographically restricted, and Lineage 1 and 3 showing
an intermediate geographic range (Coscolla et al., 2014; Stucki et al., 2016).
Lineage 1 has been hypothesized to have originally emerged in Africa, after a first split
from the most recent common ancestor (MRCA) of Mtb complex (Comas et al., 2013).
Of the three “ancient” lineages, Lineage 1 is the only phylogenetic lineage observed in
Eastern Africa and outside of Africa, mainly in regions along the rim of the Indian Ocean,
and has thus previously been referred to as the Indo-Oceanic lineage (Gagneux et al.,
2006). Lineage 3 on the other hand, emerged after the second split from the MRCA
among the three evolutionary modern lineages, Lineage 2–4 (collectively also referred to
as “Eurasian” lineages) around the Eastern Mediterranean region. The Eurasian lineages
have previously been hypothesized to have expanded together with their respective human
host populations in Europa, India and China, respectively, and to have later been re-
introduced into Africa (Hershberg et al., 2008). Today, Lineage 3 strains are mainly
distributed in the Indian sub-continent, Eastern and Northern Africa and Central Asia
(O’Neill et al., 2019).
The recent increases in whole genome data from Mtb clinical strains reveal that strains are
heterogeneous within individual lineages. The global diversity and evolutionary histories
of lineages 2 and 4 have been extensively studied (Luo et al., 2015; Merker et al., 2015;
Stucki et al., 2016; Brynildsrud et al., 2018), and these studies revealed substantial within
lineage heterogeneity in phylogenetic structure and geographical distribution. However,
similar studies are largely lacking for Lineage 1 and 3, and their substructures remain
poorly characterized. These two lineages remain important drivers of TB epidemics,
particularly in Southern Asia and the high TB burden settings of Africa.
The currently known phylogenetic substructures of Lineage 1 and 3 were primarily defined
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based on spoligotyping where the two lineages are referred to East African Indian (EAI)
and Central Asian (CAS), respectively. The spoligotyping subfamilies of Lineage 1 include
EAI2-Manila, EAI1-SOM, EAI8-Madagascar, EAI3-INDIA, EAI4-VNM and EAI (6 and
7) - BGD1, reflecting regions they are commonly isolated from (Brudey et al., 2006).
Similarly, the CAS1-Delhi and CAS1-Kili are the two common subfamilies within Lineage
3 mainly isolated in the Indian subcontinent (Bhanu et al., 2002; Singh et al., 2004) and
in Tanzania (Eldholm et al., 2006; Mbugi et al., 2016), respectively.
Furthermore, the geographic distribution of Lineage1 and 3 might have been underes-
timated. Until recently, the two lineages were known to be confined to the rim of the
Indian Ocean. However, recently, Lineage 1 strains have been reported in Acapulco,
Mexico (Nava-Aguilera et al., 2011). These strains were of the EAI2-Manila subtype (a
predominant Lineage 1 family in the Philippines), possibly reflecting the historical con-
tacts between Mexico and Philippines during Spanish colonization. Lineage 3 on the other
hand was reported in New Zealand and found to be associated with the indigenous Ma¯ori
ethnic group (Yen et al., 2013). These findings suggest Lineage 1 and 3 distributions that
are uncharacteristic, which require further investigation.
We recently used WGS data of 420 Mtb clinical strains (Coscolla, unpublished) and ex-
tracted phylogenetically informative SNPs to define sublineages of Lineage 1 and Lineage
3 (Rutaihwa, master’s thesis, 2014). These definitions were based on WGS data from 50
and 42 strains, respectively (Figure 5.2 and 5.3), and overlapped with previous classifica-
tions (Coll et al., 2014). Our findings showed substantial substructure within Lineage 1
and 3. In the present study, we aimed to revisit the global phylogenies and geographical
distributions of Lineage 1 and 3 using the most comprehensive global WGS datasets to
date and to infer their evolutionary histories.
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Figure 5.1.: Geographical distribution of Lineage 1 and 3. An intermediate geographical
range Lineage 1 and 3 (Coscolla et al., 2014).
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5.3. Methods
5.3.1. Study sample collection
To refine the global phylogenies and geographical distribution of Lineage 1 and 3, we
obtained globally representative strain collections of the two lineages focusing on the ge-
ographical locations where these strains are commonly reported. In addition, we actively
explored geographical locations where these strains are uncharacteristic, for example Lin-
eage 1 strains from Brazil. The geographical locations mostly included Eastern Africa,
Southern Asia for both lineages; South-eastern Asia, Australia, Southern America and
Melanesia for Lineage 1; and Central Asia for Lineage 3. In addition, we obtained whole
genome sequencing data of Lineage 1 and 3 from previously published studies. In total,
we included 1,667 genome sequences of Lineage 1 and 2,104 genome sequences of Lineage
3.
5.3.2. Mtb isolates and DNA extraction
Mtb isolates previously identified as Lineage 1 and 3 either by SNP-typing or spolig-
otyping, were grown in Middlebrook 7H9 liquid medium supplemented with ADC and
incubated at 37°C. Purified genomic DNA was obtained from cultures using the CTAB
extraction method (Embden et al., 1993).
5.3.3. Whole genome sequencing, variant calling and
phylogenetic inference
For the Lineage 1 and 3 strains that we sequenced in house, whole genome sequencing was
performed on prepared libraries from purified genomic DNA using Illumina Nextera®XT
library and NEBNext®UltraTM II FS DNA Library Prep Kits (Illumina, San Diego,
USA). Sequencing was performed using the Illumina HiSeq 2500 or NextSeq 500 paired-
end technology (Illumina, San Diego, USA). For the whole genome analysis, we first
clipped the Illumina adapters from the raw sequencing reads and then trimmed low qual-
ity sequencing reads using Trimmomatic 0.33 (SLIDINGWINDOW:5:20) (Bolger et al.,
2014). We excluded short reads (< 20 bp) from the downstream analysis and the over-
lapping paired-end reads were merged with SeqPrep 1.2 (overlap size = 15) (https:
//github.com/jstjohn/SeqPrep). The reads were mapped to a reconstructed Mtb com-
plex ancestor sequence (Comas et al., 2013) using BWA 0.7.13 (Li et al., 2009). Picard
2.9.1 module (Mark Duplicates) was used to mark duplicated reads, which we excluded
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afterwards. Pysam 0.9.0 (https://github.com/pysam-developers/pysam) was used to
exclude reads with alignment score lower than (0.93*read_length)-(read_length*4*0.07),
consistent with more than 7 miss-matches per 100 bp. We then extracted SNPs with
Samtools 1.2 mpileup (Li et al., 2009) and VarScan 2.4.1 (Koboldt et al., 2012) and kept
SNPs with minimum mapping quality of 20, minimum base quality at a position of 20,
minimum read depth at a position of 7X, minimum percentage of reads supporting the
call 90% and maximum strand bias for a position 90%. Genomes with coverage < 20 X
and those containing phylogenetic SNPs belonging to different lineages (mixed strains)
were excluded. We annotated the SNPs using snpEff 4.11 according to the Mtb H37Rv
reference annotation (NC_000962.3). We excluded SNPs within regions such as PPE and
PE-PGRS, phages, insertion sequences repetitive regions (at least 50 bp identical to other
regions in the genome) (Stucki et al., 2016). We excluded SNPs known to confer drug re-
sistance from phylogenetic reconstruction. We inferred a maximum likelihood phylogeny
with RAxML 8.3.2 using a general time reversible (GTR) model and 1,000 bootstrap
inferences (Stamatakis, 2006).
5.3.4. Lineage 1 anad 3 substructures and distribution
Having reconstructed the phylogenies of Lineage 1 and 3, we next examined their geo-
graphical distribution by mapping the patients’ place of birth as a proxy for origin of the
strains. Further, we used the previous sublineage definitions to describe the substructure
of Lineage 1.
5.4. Results
5.4.1. Lineage 1 global phylogeny and geographical
distribution
To characterize the global diversity of Lineage 1, we analyzed 1,667 whole genome se-
quences from at least 49 countries, including Africa (Eastern, Southern Central and
Western), Asia (Southern, South-eastern, Eastern and Western), America (Southern and
Northern), Melanesia, Australia and Europe. We next reconstructed ML phylogeny for
Lineage 1 based on 107,703 variable positions (Figure 5.4). As previously demonstrated,
our Lineage 1 phylogeny displayed a defined substructure with discrete monophyletic
sublineages. We found our previous definitions for the Lineage 1 substructure to be com-
prehensive and covering the entire diversity of the globally representative strains. That
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is to say, most of the Lineage 1 strains were classified into any of the six sublineages we
had defined previously (L1.1 – L1.6). However, we detected an additional clade branching
off between the L1.1 (EAI2-Manila) and L1.2 sublineages, and the three together formed
the L1.2.1 clade previously defined by (Coll et al., 2014). Overall, L1.2.1 is the deepest
branching clade of Lineage 1 comprising on the one hand strains from Eastern Africa
(i.e. Ethiopia, Djibouti, Somalia and Tanzania), Melanesia (i.e. Papua New Guinea), and
Southeastern Asia (i.e. East Timor) in the L1.2 sub clade. On the other hand, L1.1 also
embedded within L1.2.1 clade, comprised strains mainly from Southeastern Asia (e.g. the
Philippines). The majority of Lineage 1 strains in our dataset came from Eastern African
and Southern Asia (i.e. the Indian subcontinent), and these were scattered throughout
on the phylogeny into several sublineages. Of note, strains from the Indian subcontinent
occupied basal positions in most sublineages (i.e. L1.3, L.4 and L1.6). Our Lineage 1
dataset also included strains from Brazil. We observed such strains to fall into three of
the six Lineage 1 sublineages (L1.3, L1.4 and L1.6). These Lineage 1 strains from Brazil
clustered with those from African countries including Malawi and Madagascar, indicat-
ing multiple introductions from Africa into Brazil, perhaps linked to the European slave
trade. Strains belonging to sublineage L1.5 were mostly from Vietnam, which clustered
in a monophyletic sub group L1.1.1.1 (Figure 5.2). These strains were reported from a re-
cent study in Vietnam, where little transfer was detected with strains of non-Vietnamese
origin (Holt et al., 2018). Of note, the basal clade of L1.5 comprised strains from West
Africa.
5.4.2. Lineage 3 global phylogeny and geographical
distribution
We used 2,104 whole genome sequences from at least 42 countries including Africa (East-
ern, Southern Central and Western), Asia (Southern, South-eastern, Eastern and West-
ern), Northern America and Europe to characterize the global diversity of Lineage 3. We
inferred a ML phylogeny of the Lineage 3 strains from 76,319 variable nucleotide positions
(Figure 5.5). In contrast to Lineage 1, Lineage 3 showed a less structured phylogeny and as
a result the previously established sublineage classifications were not optimal to describe
its true phylogenetic substructure. In general, the deep branching clade on the phylogeny
encompassed a previously defined L3.1 sublineage, which includes the previously described
“pseudo-Beijing” strains (Fenner et al., 2011), with the rest of the strains belonging to the
monophyletic “L3Basal” clade (Figure 5.3). Most of the Lineage 3 strains originated from
Lineage 3 endemic areas of Eastern Africa and Southern Asia. Although the phylogeny
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depicts clustering of strains by geography to a certain degree, these strains still appear
to intersperse irrespective of their geographical origin. For instance in Figure 5.5, we
highlighted (in red) strains isolated from a clinical setting in Dar es Salaam, Tanzania,
which are intermingled with strains from several other locations (in black).
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5.5. Discussion
We studied the global phylogenies and geographical distribution of Mtb Lineage 1 and 3,
using the most comprehensive whole genome datasets available to date. We confirmed the
previously described geographical ranges for Lineage 1 and 3, where both lineages span
from Eastern Africa and along the Indian Ocean regions to Southern Asia, with Lineage
1 extending further east into South-East Asia and Melanesia. Furthermore, we show that
our previously established Lineage 1 sublineage definitions are robust, covering most of
the global diversity of Lineage 1 strains. By contrast, Lineage 3 presented a less distinct
phylogenetic substructure. Our novel findings revealed the presence of Lineage 1 in the
Para state, North of Brazil that likely resulted from multiple introductions. We observed
Lineage 3 strains to intermingle geographically, suggesting frequent exchange among the
endemic regions. Finally, our study proposes a common evolutionary history regarding
the introductions of Lineage 1 and 3 back to Africa.
We characterized Lineage 1 strains in our study using the previously defined six sublin-
eages, L1.1 – L1.6. Based on the phylogenetic positions and geographical distribution of
the strains, we hypothesize possible evolutionary scenarios (some previously put forward)
to explain the present phylogeography of Lineage 1. We found that the most basal branch
of the Lineage 1 phylogeny (L1.2) consisted mainly of strains from Eastern Africa and
Melanesia, an observation which supports the emergence of Lineage 1 in Eastern Africa
followed by its early dispersal into Melanesia (Hershberg et al., 2008). This dispersal
corresponds to human migrations out of Africa that mostly likely arrived to Melanesia for
example in Papua New Guinea and Australia then as part of the former Sahul. Although
L1.1/EAI2-Manila is commonly isolated in patients of Filipino origin (Douglas et al.,
2003) also as evidenced in this study, our results reveal this clade contains strains from
other patients’ origins such Papua New Guinea and some Southeastern Asian countries.
This distribution of L1.1/EAI2-Manila could reflect the Austronesian migration wave into
such regions via the Philippines.
In general, we observe strains from Eastern Africa and Southern Asia (i.e. India subcon-
tinent) to be the most diverse. The fact that strains from Southern Asia are spread out
and occasionally occupy basal positions on the phylogeny indicates further diversification
of Lineage 1 strains in Southern Asia post introductions from Eastern Africa. Therefore,
suggesting the current Lineage 1 geographical distribution to partly reflect migrations out
of Southern Asia (O’Neill et al., 2019). Throughout history, the Indian Ocean has been
vital to interactions between East and West for instance via several trade routes. Such
historical and present interactions could have facilitated the spread of Mtb strains along
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the Indian Ocean region (Gilbert, 2002).
The presence of Lineage 1 strains in Brazil suggest historical contacts with Eastern Africa
as these strains clustered with those from Malawi and Madagascar. One possible scenario
to have led to the introduction of Lineage 1 into Brazil is the Trans-Atlantic Ocean slave
trade between the 16th and 19th centuries (Vos, 2012). In addition to Western Africa
and Mozambique, African slaves were also shipped from Eastern Africa (UNESCO, 1992)
which is part of geographical range for Lineage 1. Of note, strains from Brazil were
grouped into three different Lineage 1 sublineages, indicating multiple introductions of
Lineage 1 into Brazil.
In line with previous observations, Lineage 3 presented less phylogenetic structure. Thus,
the previous definitions of Lineage 3 sublineages were inappropriate to describe the current
substructure. Similar to Lineage 2, it was proposed that Lineage 3 experienced sudden
expansion as a result of human population expansions, albeit with lower rates of migration
compared to e.g. Lineage 2 (Comas et al., 2013; Luo et al., 2015; O’Neill et al., 2019).
By contrast, Lineage 3 emerged in Southern Asia from where it has solely disseminated
to other geographical locations mainly into Eastern and North Africa. Based on our
Lineage 3 phylogeny, it appears that there is constant exchange of strains across the
Lineage 3 endemic regions. As an illustration, we mapped Lineage 3 strains isolated
from TB patients in Dar es Salaam, Tanzania (studied in Chapter 4 of this thesis).
We found these strains to intersperse with others from neighboring countries such as
Malawi. This observation would suggest multiple transfers of Lineage 3 between the
regions. Again, Lineage 3 strains from India were seen to be scattered throughout the
phylogeny, indicating a similar scenario to Lineage 1 strains in the subcontinent. In both
phylogenies, we observe further intracontinental spread.
Due to logistical and time constrains, our analysis of this chapter is preliminary and
only included partial datasets for the two respective lineages. Therefore, we are aware
that our research might have a number of limitations at this stage. To begin with, both
Lineage 1 and 3 global phylogenies were still missing important geographical links that
was contributed by either difficulty in the accessibility of data or availability of the data at
the time of analysis. For instance, at the time of analysis, Lineage 1 genomes from Taiwan,
which included strains isolated from Aboriginal population were not yet available. Given
that our Lineage 1 collection included strains from other Austronesian-speaking regions
such as Madagascar and others from Southeastern Asia, we might have explored dispersal
of Lineage 1 linked to the Austronesian expansion (Ko et al., 2014). Unfortunately, we
so far were also unsuccessful in obtaining Lineage 1 strains from Australian Aborigine
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population. Such strains would have perhaps allowed us to disentangle introductions of
Lineage 1 linked to early migration waves from Africa from those related to Austronesian
migrations (Main et al., 2001; Reich et al., 2011). An additional setback in our Lineage
1 dataset was the unavailability of L1.1/EAI2-Manila strains from Acapulco, Mexico
previously reported (Nava-Aguilera et al., 2011), which hinder us from revisiting the
evolutionary spread most likely as result of historical Spanish contacts. Similarly, our
Lineage 3 dataset lacked representatives from important geographical zones such as the
Eastern Mediterranean and North Africa where the strains are known to be diverse and
frequent (Comas et al., 2015; O’Neill et al., 2019). In addition, information on place of
origin was missing for several strains of both lineages. This put a setback when inferring
the phylogeographies and evolutionary histories of the two lineages. For instance, in
the current analysis, most of Lineage 3 strains on the deepest rooted branches lacked
information on geographical origin.
Unfortunately even for the data available, due to time constraints, we were unable to
perform more extensive downstream analyses following the phylogenetic inferences. First,
we were unable to validate the existing sublineage definitions using alternative methods.
We propose to validate / confirm the existing sublineage definitions using approaches such
as principle component analysis (PCA), pairwise distances, genetic diversity comparison
i.e. nucleotide diversity to determine the within lineage separation for robust classifica-
tions and revisiting the Lineage 3 substructure all together. Given the historical scenarios
put forward, we would also perform coalescent analyses to reconstruct the evolutionary
history and spread of the two lineages.
Based on the phylogenetic and geographic distribution, our results suggest initial spread
of Lineage 1 out of Africa to Southern Asia, extending further east. These introductions
were likely followed by diversification of Lineage 1 mainly in the Indian subcontinent prior
to dissemination out of Southern Asia (O’Neill et al., 2019). This is in contrast to Lineage
3, which is proposed to have emerged in Southern Asia. With regard to out-of-India /
Southern Asian migration, both Lineage 1 and Lineage 3 were likely distributed via simi-
lar human migrations particularly those that link Eastern Africa to Southern Asia before
spreading within the African continent and beyond Eastern Africa to Southern America
in the case of Lineage 1. Our study highlights the importance of globally representative
datasets when studying population structure and geographical distribution of Mtb lin-
eages. This contributes to our understanding of the evolutionary history and spread of
Lineage 1 and 3, which are currently underexplored.
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6.1. Abstract
The Lineage 2–Beijing (L2–Beijing) sub-lineage of Mycobacterium tuberculosis has re-
ceived much attention due to its high virulence, fast disease progression, and association
with antibiotic resistance. Despite several reports of the recent emergence of L2–Beijing in
Africa, no study has investigated the evolutionary history of this sub-lineage on the con-
tinent. In this study, we used whole genome sequences of 781 L2 clinical strains from 14
geographical regions globally distributed to investigate the origins and onward spread of
this lineage in Africa. Our results reveal multiple introductions of L2–Beijing into Africa
linked to independent bacterial populations from East- and Southeast Asia. Bayesian
analyses further indicate that these introductions occurred during the past 300 years,
with most of these events pre-dating the antibiotic era. Hence, the success of L2–Beijing
in Africa is most likely due to its hypervirulence and high transmissibility rather than
drug resistance.
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6.2. Introduction
Tuberculosis (TB) is mainly caused by a group of closely related bacteria referred to as
the Mycobacterium tuberculosis Complex (MTBC). The MTBC comprises seven phylo-
genetic lineages adapted to humans and several lineages adapted to different wild and
domestic animal species (Gagneux, 2018). The human-adapted lineages of the MTBC
show a distinct geographic distribution, with some “generalist” lineages such as Lineage
(L)2 and L4 occurring all around the world and others being geographically restricted
“specialist” that include L5, L6, and L7 (Coscolla et al., 2014; Stucki et al., 2016). Africa
is the only continent which is home to all seven human-adapted lineages, including the
three “specialist” lineages exclusively found on the continent. Current evidence suggests
that the MTBC overall originated in Africa (Gagneux, 2018) and subsequently spread
around the globe following human migratory events (Wirth et al., 2008; Comas et al.,
2013). The broad distribution of some of the “generalist” lineages and their presence
in Africa has been attributed to past exploration, trade, and conquest. For instance,
an important part of the TB epidemics in sub-Saharan Africa is driven by the general-
ist Latin–American–Mediterranean (LAM) sublineage of L4, which is postulated to have
been introduced to the continent post-European contact (Stucki et al., 2016; Brynildsrud
et al., 2018).
Among the different human-adapted MTBC lineages, the L2–Beijing sublineage has been
of particular interest (Merker et al., 2015). L2–Beijing has expanded and emerged world-
wide from East Asia; its most likely geographical origin (Luo et al., 2015; Merker et
al., 2015). In some parts of the world, the recent emergence of L2–Beijing has been
linked to increased transmission (Yang et al., 2012; Holt et al., 2018) high prevalence
of multidrug–resistant TB (MDR–TB) (Borrell et al., 2009), and to social and political
instability, resulting into displacement of people and poor health systems (Eldholm et al.,
2016). Increasingly, L2–Beijing is also being reported in Africa (Affolabi et al., 2009;
Gehre et al., 2016; Mbugi et al., 2016; Bifani et al., 2002), and evidence suggests that
L2–Beijing in African regions is becoming more prevalent over time (Cowley et al., 2008;
Spuy et al., 2009; Glynn et al., 2010; Bifani et al., 2002). Some authors have hypothesized
that the introduction of L2–Beijing into South Africa resulted from the importation of
slaves from Southeast Asia during the 17th and 18th centuries and/or the Chinese labor
forces arriving in the 1900s (Helden et al., 2002). Alternatively, in West Africa, the pres-
ence of L2–Beijing was proposed to reflect more recent immigration from Asia (Affolabi
et al., 2009; Gehre et al., 2016). To a certain extent, the recent expansion of L2–Beijing
in parts of Africa has been associated with drug resistance (Githui et al., 2004; Klopper
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et al., 2013) and higher transmissibility (Guerra-Assunção et al., 2015a). In addition,
a study in the Gambia showed a faster progression from latent infection to active TB
disease in patient house-hold contacts exposed to L2–Beijing (Jong et al., 2008).
Whilst L2–Beijing seems to be expanding in several regions of Africa, no study has for-
mally investigated the evolutionary history of L2–Beijing on the continent. In this study,
we used whole genome sequencing data from a global collection of L2 clinical strains to
determine the most likely geographical origin of L2–Beijing in Africa and its spread across
the continent.
6.3. Materials and Methods
6.3.1. Identification of Lineage 2 Strains and Whole-Genome
Sequencing
We obtained whole-genome sequencing data of L2 strains from the two previously largest
studies focusing on the evolutionary history and global spread of L2–Beijing strains (Luo
et al., 2015; Merker et al., 2015). We then identified additional published genomes as
African and non-African representatives of L2– Beijing strains from other studies (Comas
et al., 2010; Comas et al., 2013; Casali et al., 2012; Casali et al., 2014; Kato-Maeda et al.,
2012; Zhang et al., 2013; Portevin et al., 2014; Guerra-Assunção et al., 2015a; Koch et
al., 2017; Manson et al., 2017). Moreover, we newly sequenced 116 additional L2–Beijing
strains using Illumina HiSeq 2000/2500 paired end technology PRJNA488343. In total,
we included 781 L2 genome sequences (Figure B.1 and Supplementary Table 1).
6.3.2. Whole Genome Sequence Analysis and Phylogenetic
Inference
We used a customized pipeline previously described to map short sequencing reads with
BWA 0.6.2 to a reconstructed hypothetical MTBC ancestor used as reference (Comas
et al., 2013). SAMtools 0.1.19 was used to call single nucleotide polymorphisms (SNPs),
and these SNPs were annotated using ANNOVAR and customized scripts based on the
M. tuberculosis H37Rv reference annotation (AL123456.2). For downstream analyses,
we excluded SNPs in repetitive regions, those annotated in problematic regions such as
“PE/PPE/PGRS” and SNPs in drug-resistance associated genes. Small insertions and
deletions were also excluded from the analyses. Only SNPs with minimum coverage of
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20x and minimum mapping quality of 30 were kept. All SNPs classified by Samtools as
having frequencies of the major non-reference allele lower than 100%(AF1 < 1) within
each genome were considered to be heterogeneous and were treated as ambiguities and
excluded, and were otherwise considered fixed (AF1 = 1). Mixed infections or contamina-
tions were discarded by excluding genomes with more than 1,000 heterogeneous positions
and genomes for which the number of heterogeneous SNPs was higher than the number of
fixed SNPs. In addition we excluded genomes for which the number of fixed SNPs would
fall below Q1–1.5 IQR of all fixed SNPs considering all L2 genomes (Q1 being the first
quantile and IQR the inner quantile range as calculated in R 3.5.0). All genomes were
typed for lineage and sub-lineage using SNP markers as defined in (Steiner et al., 2016)
plus (Coll et al., 2014) and those showing simultaneously more than one marker were ex-
cluded. We concatenated fixed SNPs from the variable positions obtained, which yielded
a 32,269 bp alignment. The alignment was then used to infer a maximum likelihood
phylogeny using RAxML 8.3.2 with a general time reversible (GTR) model in RAxML
and 1,000 rapid bootstrap inferences, followed by a thorough maximum-likelihood search
(Stamatakis, 2006). The topology was rooted using the reference strain, H37Rv which
belongs to Lineage 4.
6.3.3. Phylogeographic Analyses
Reconstruction of the Ancestral Geographic Range
To investigate the likely geographic origin of L2–Beijing strains in Africa, we inferred
the historical biogeography of L2 using the RASP software (Yu et al., 2015) on a repre-
sentative subset of 422 genomes due to software’s sample limitation.We achieved this by
randomly removing clustered genomes (i.e., those with 12 or less SNP distances) from the
same country of origin, using hierarchical clustering implemented in pvclust package in R
(Suzuki et al., 2006) on a distance matrix of the 781 genome sequences. We then applied
a Bayesian binary based method (BBM) in RASP to reconstruct geographical states at
the ancestral nodes on the best-scoring ML tree inferred with RAxML using the 422 L2
genomes. We used geographical regions (according to United Nations geoscheme) as proxy
for origins of the L2 strains. In total 14 regions were loaded as geographic distributions
(indicated in Supplementary Table 1). The ancestral reconstruction was performed with
the Proto-Beijing clade as outgroup. We finally ran Bayesian analysis with 10 chains and
50,000 generations.
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Stochastic Character Mapping
To determine the number of introduction events of L2–Beijing into African regions, we
applied stochastic character mapping as implemented in SIMMAP (Bollback, 2006) on
the 781 L2 phylogeny inferred from the best-scoring ML tree rooted on the Proto-Beijing
clade, using the make.simmap function in phytools package 0.6.60 in R 3.5.0 (Revell, 2012;
R Core Team, 2018). Geographical origin of the L2 strains was treated as a discrete trait
and modeled onto the phylogeny using ARD model with 100 replicates. This model al-
lows unequal rates of state transition permiting independent region-to-region transfers.We
summarized the results of the 100 replicates using the function summary in phytools pack-
age 0.6.60 in R (Revell, 2012). We referred to the resulting introductions as migration
events “M,” and discuss only those introductions with 5 or more genomes.
Population Genetic Analyses
Nucleotide diversity (pi)
We calculated the mean pair-wise nucleotide diversity per site (Pi) measured by geographic
region. We excluded geographic regions represented by < 20 genomes. Confidence intervals
were obtained by bootstrapping through resampling using the sample function in R with
replacement and the respective lower and upper confidence levels by calculating 2.5th
and 97.5th quartiles. Resampling was additionally done using the smallest size of the
geographical regions to account for the effect of different sample sizes.
Pairwise SNP distances
We used dist.dna function of ape package implemented in R (Paradis et al., 2004) to
calculate pairwise SNP distances with raw mutation counts and pairwise deletions for
gaps. Mean pairwise SNP distance to all strains of the same geographic population was
calculated per strain and the distribution of the mean SNP pairwise distance for all strains
plotted. The mean pairwise SNP distances were assumed not to be normally distributed
and we therefore used Wilcoxon rank-sum test to test the differences among geographic
regions. Additionally, we calculated pairwise SNP distances within African L2– Beijing
populations for migration events with more than 10 genomes each.
Drug Resistance
To distinguish between drug-susceptible and drug-resistant strains, we used genotypic
drug resistance molecular markers previously described (Steiner et al., 2014). We catego-
rized strains into: susceptible as having no drug resistance specific mutations; monoresis-
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tant as having mutations conferring resistance to a single drug; MDR as having mutations
conferring resistance to isoniazid and rifampicin; and extensively drug-resistant (XDR)
as having mutations conferring resistance to fluoroquinolones and aminoglycosides in ad-
dition to being MDR (Table B.1).
Bayesian Molecular Dating
Data preparation and preliminary analysis
To estimate the historical period in which L2–Beijing was introduced to Africa, we per-
formed a set of Bayesian phylogenetic analyses using tip-calibration (Rieux et al., 2017).
Among the 781 studied L2 strains, we had information on the year of sampling for 308. We
performed all further analysis on this subset of 308 strains. We excluded all genomic posi-
tions that were invariable in this subset and all positions that were undetermined (missing
data or deletions) in more than 25% of the strains, and obtained an alignment of 10,769
polymorphic positions. In tip dating analysis it is important to test whether the dataset
contains strong enough temporal signal (Rieux et al., 2016). To do this, we performed
a tip randomization test (Ramsden et al., 2008) as follows. We used BEAST2 v. 2.4.8
(Bouckaert et al., 2014) to run a phylogenetic analysis with a HKY + GAMMA model
(Hasegawa et al., 1985), a constant population size prior on the tree and a strict molecular
clock. Additionally, we used the years in which the strains were sampled to time-calibrate
the tree, and we modified the extensiblemarkup language (xml) file to specify the num-
ber of invariant sites as indicated by the developers of BEAST2 here: https://groups.
google.com/forum/#!topic/beast-users/QfBHMOqImFE (strict_preliminary.xml). We
ran three independent runs (245 million generations in total), and we used Tracer 1.7
(Rambaut et al., 2018) to identify the burn-in (8 million generations), to assess that the
different runs converged, and to estimate the effective sample size (ESS) for all param-
eters, the posterior and the likelihood (ESS >110 for all parameters). We then used
TipDatingBeast (Rieux et al., 2017) to generate 20 replicates of the xml file in which the
sampling dates were randomly reassigned to different strains. For each replication, we ran
the same BEAST2 analysis as for the original (observed) dataset (one run per replicate, 50
million generations, 10% burn-in). We used TipDatingBeast to parse the log files output
of BEAST2 and compare the clock rate estimates for the observed data and the random-
ized replications. The estimates of the molecular clock rate did not overlap between the
observed and the randomized dataset, indicating that there is a clear temporal signal and
that we could proceed with further analysis (Figure B.2).
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Model selection
To identify the clock model that best fits the data, we estimated the marginal likelihood
of three different clock models: UCED and UCLD (Drummond et al., 2006), assum-
ing a coalescent constant population size tree prior and the HKY model of nucleotide
substitution. We used the Model selection package of BEAST2 to run a path sampling
analysis (Lartillot et al., 2006) following the recommendations of the BEAST2 developers
(http://www.beast2.org/path-sampling/). We used the following settings: 100 steps,
4 million generations per step, alpha = 0.3, pre-burn-in=1million generations, burn-in
for each step=40% (*PS.xml). For these analyses, we used proper priors as suggested by
(Baele et al., 2012).
UCLD analysis
Since the model selection analysis indicated that the UCLD clock was the best fitting
model, we repeated the analysis using the UCLD and the same settings used in the path
sampling analysis, sampling every 10,000 generations. We ran three independent runs
(800 million generations in total), we used Tracer 1.7 (Rambaut et al., 2018) to identify
the burn-in (10 million generations), to assess that the different runs converged and to
estimate the effective sample size (ESS) for all parameters, the posterior and the likelihood
(ESS >260 for all parameters) (UCLD_final.xml and Supplementary Table 3).
We checked the sensitivity to the priors by running one analysis of 250 million generation
sampling from the prior, and compared the parameter estimates with the analysis using
the data. We observed the posterior distribution and the prior distribution of all param-
eters are very distinct (Supplementary Table 4), indicating that the parameter estimates
are influenced by the data and not by the priors (Bromham et al., 2018). Additionally we
repeated the dating analysis with a coalescent exponential population growth tree prior
(UCLD + HKY + exponential growth) and with a GTR model of nucleotide substitution
(UCLD + GTR + constant size). All these analyses resulted in similar estimates of the
age of the introductions of L2 in Africa, thus showing that our results are not strongly in-
fluenced by the tree prior and the nucleotide substitution model (Table B.3). We repeated
the tip randomization test with the UCLD model as described above (20 replicates, one
run per replicate, 105 million generations per replicate or more, burn-in 10%), and again
we found a temporal signal (Figure B.3).
To summarize the results, we sampled the trees from the three runs (5% burn-in corre-
sponding to 10 million generations or more, sampling every 25,000 generation). We then
summarized the 31,758 sampled trees, created a maximum clade credibility tree using
the software TreeAnnotator fromthe BEAST2 package and used FigTree version 1.4.2
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(http://tree.bio.ed.ac.uk/software/ figtree) for visualization (Figure B.4).
6.4. Results
6.4.1. Phylogenetic Inference of L2 Strains
We analyzed a total of 781 L2 genomes originating from 14 geographical regions includ-
ing Eastern and Southern Africa (Figure B.1 and Supplementary Table 1). We focused
on seven geographical regions that had more than 20 genomes each, and assigned the
remainder to “Other,” including two genomes from Western Africa (Figure 6.1 A). The
resulting phylogeny of L2 was divided into two main sublineages: the L2–proto-Beijing
and L2– Beijing, supporting previous results (Luo et al., 2015; Shitikov et al., 2017).
The L2–proto-Beijing was the most basal L2 sublineage and was restricted to East- and
Southeast Asia. L2–Beijing, particularly the “modern” (also known as “typical”) sublin-
eage, was geographically widely distributed and included strains from Africa. We further
characterized L2–Beijing using the recently described unified classification scheme for L2
(Shitikov et al., 2017).
6.4.2. The Population Structure of L2–Beijing in Eastern and
Southern Africa
Our findings showed the population of African L2–Beijing to be heterogeneous (Figures 6.1
B, 6.2 and Table B.2). Most of the African L2–Beijing strains were classified into several
groups within the “modern” sublineage, which included primarily the “Asian- African”
sublineages (L2.2.4, L2.2.5 and L2.2.7), consistent with previous findings (Merker et al.,
2015). We also identified the “ancient” (atypical) strains among the African L2–Beijing.
Given that “ancient” L2–Beijing strains (L2.2.1—L2.2.3) are generally uncommon (Luo
et al., 2015), it is interesting to observe such strains in both African regions. In several
instances, African L2– Beijing strains did not fall into any of the previously defined groups
(Figure 6.2). Of the two African regions studied here, East Africa had higher proportion of
previously uncharacterized L2–Beijing strains (43/92, 46.7%). In summary, our findings
show that African regions harbored distinct L2–Beijing populations. This is unlike Eastern
Europe and Central Asia, where L2–Beijing is dominated by a few highly similar strains
(Casali et al., 2014; Eldholm et al., 2016). Of note, L2–Beijing strains typical Eastern
Europe and Central Asia were completely absent from the African populations (Figure
6.2).
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6.4.3. Genetic Diversity of L2–Beijing Strains Across Geographic
Regions
The spatial distribution of L2–Beijing sublineages and the prevalence of “ancient” L2–Beijing
strains observed in this study and previously (Luo et al., 2015; Merker et al., 2015),
suggest that L2–Beijing has expanded worldwide from Asia. This view can further be
supported by the measures of genetic diversity of L2–Beijing in the different geographical
regions (Figure 6.3). As expected, East- and Southeast Asia contained the most geneti-
cally diverse L2 populations, which is consistent with previous results (Luo et al., 2015).
Conversely, L2 populations in other geographies were less genetically diverse, suggest-
ing recent dissemination of L2 to these regions. Within Africa, Southern Africa showed
a higher diversity in L2–Beijing populations compared to Eastern Africa. The genetic
diversity within the African L2–Beijing populations not only reflects the number and va-
riety of source populations but also local patterns of diversification that occurred after
their introduction. Therefore, the higher genetic diversity of the L2–Beijing populations
in Southern Africa compared to Eastern Africa likely reflects both aspects.
6.4.4. Multiple Introductions of L2–Beijing From Asia Into
Africa
Based on our reconstructed phylogeny, African L2–Beijing strains clustered into several
unrelated clades indicating multiple introductions into Africa (Figure 6.1 B). We next
investigated the most likely geographical origins of those introductions. As anticipated,
our ancestral reconstruction using RASP estimated East Asia as the most likely origin
of all L2 (posterior probability of 96.1%) and L2–Beijing (posterior probability 92.5%)
(Figure B.5). Our data further indicate that L2–Beijing was introduced into Africa from
East- and Southeast Asia on multiple occasions independently. Furthermore, we observed
both direct introductions from Asia into Africa as well as subsequent dispersal within
the continent (Figures B.6, B.7). Using stochastic mapping, we estimated a total of 13
introductions or migration events (M1–M13) into Africa (Figure 6.4). Eight of the African
L2–Beijing introductions originated from East Asia and five from Southeast Asia. Out
of the 13 introductions, three (M3, M10, and M13) were present in both African regions
analyzed here, suggesting initial introductions from Asia followed by subsequent spread
within Africa. Overall, our analysis inferred more independent introductions into Southern
Africa (n = 7, M1, M4, M7-9, M11 and M12, all of them with extant strains sampled in
South Africa) than Eastern Africa (n = 3, M2 sampled in Malawi and Tanzania; M5 and
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M6 sampled in Kenya and in Malawi, respectively). Taken together, our data suggest
that multiple migration events have shaped the populations of L2–Beijing in Africa.
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Figure 6.2.: Frequency in proportions of Lineage 2 sub-lineages across seven geographical regions.
6.4.5. Bayesian Molecular Dating
Different hypotheses have been formulated on the possible timing of the introduction of
L2–Beijing into Africa (Helden et al., 2002). Here we used tip-calibration to date the phy-
logenetic tree of L2 and estimate the age of its introduction to Africa. For these analyses,
we identified 308 strains among the 781 for which the sampling year was known. These
strains were sampled during a period of 19 years; 1995–2014 (Figure B.8), were evenly
distributed on the complete phylogenetic tree (Figure B.9) and included 40% members of
the African L2–Beijing strains (Figure B.10). Eleven of the 13 African introductions were
represented in this dataset (M1-M3 and M6-M13).
We performed a Date Randomization Test with a strict clock and with a relaxed clock.
With both models we detected no overlap in the 95% credibility interval of the clock
rate estimates of observed and randomized datasets indicating that there was sufficient
temporal signal in the dataset to perform inference (see methods, Figures B.2, B.3).
Further, we found that the UCLD clock had the highest marginal likelihood and a Bayes
Factor of 27 with the second best fitting model, the strict clock (Table 6.1), indicating
strong evidence in favor of the UCLD clock (Kass et al., 1995).
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Figure 6.3.: Genetic diversity of L2 strains within geographical regions. (A) Nucleotide diversity
(p) per site of L2 strains by geography. Error bars are the 95% confidence intervals
obtained by bootstrapping. (B) Pairwise genetic SNP distance of L2 by geography
(p-values were obtained from Wilcoxon rank-sum tests). Each box represents the
25% and 75% quartiles and the line denotes the median.
We performed a phylogenetic analysis with BEAST2 using the UCLD clock. Under the
UCLD model, the coefficient of variation (COV), which is a summary of the branch rates
distribution (standard deviation divided by the mean), gives an indication on the clock-
likeness of the data (Drummond et al., 2006). A coefficient of variation of zero indicates
that the data fit a strict clock, whilst a greater COV indicates a higher heterogeneity of
rates through the phylogeny. We obtained a mean COV of 0.22 (95% credibility interval=
0.1732, 0.2732), indicating a moderate level of rate variation across different branches
and thus supporting the results of the path sampling analysis that favored the UCLD
model.
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Table 6.1.: Model selection based on path sampling Log-Marginal Likelihood.




6.4.6. Recent Origins of the African L2–Beijing Clades
We used the UCLD clock model to infer the clock rate and divergent times of the 308
L2 strains with known sampling dates and estimated a mean substitution rate of 1.34 ×
107 [95%Highest Posterior Density (HPD), 9.2867×1081.7719× 107]. These estimates are
in agreement with previously reported rates from epidemiological studies (Walker et al.,
2013; Eldholm et al., 2016). However, the estimated rate by (Eldholm et al., 2016) is
relatively higher compared to our estimates, which likely reflects the fact that our dataset
included the entire Lineage 2 as opposed to a only a single particular clade in the case of
(Eldholm et al., 2016).
We estimated the most recent common ancestor (MRCA) of the extant L2–Beijing of the
308 strains to the year 1225 [95% HPD, 9001519] (Figure B.4). This estimate was slightly
younger than the previous estimate for the whole of Lineage 2 by the study of Bos et al.,
2014, likely reflecting the difference in methodology. The latter study used ancient M.
pinipeddii DNA recovered from pre-Columbian human remains to calibrate the phylogeny
as opposed to tip-dating based on contemporary sampling dates. For each African clade,
we estimated the year of introduction using the 0.975 quantile of the HPD of the age
of the MRCA as the upper limit (most recent possible year) and the 0.025 quantile of
the HPD of the divergence time between the closest non-African L2–Beijing strain (the
closest outgroup) and the African clade of interest as lowest limit (most ancient possi-
ble year). This approach produced conservative estimates, while relying only on the age
of the MRCA of the African clades would systematically underestimate the age of the
introductions. Our estimates placed the earliest introductions of the African L2–Beijing
(M1, M3, M7, and M12) in the eighteenth and nineteenth century (Figure 6.5) and Ta-
ble A.6). Four additional migration events (M6, M9, M10, and M11) were estimated to
have occurred between the beginning of the nineteenth century and the first half of the
twentieth century. Finally, the three most recent introductions to Africa happened in
the second half of the twentieth century (M2, M8, and M13). Diversity patterns of the
African clades exclusive to Eastern and Southern Africa could further provide support
for the recent introductions of African L2–Beijing. We thus calculated the pairwise SNP
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distances within the individual introductions to explore the local patterns of diversifica-
tion associated with regional epidemics after the introductions. Although strains within
Southern African introductions were relatively more distantly related, L2–Beijing strains
from both African regions were on average 20 to 40 SNPs apart (Figures B.11, B.12,
B.13). The latter thresholds were proposed to correspond to strains involved in transmis-
sion clusters of estimated 50 to 100 years (Meehan et al., 2018), supporting the relatively
recent introductions of L2–Beijing into the African continent.
Overall, these results indicate that the different introductions of L2–Beijing to Africa
occurred over a period of 300 years.While the earliest introduction is unlikely to have
happened after 1732– 1874, the most recent is unlikely to have occurred before 1946–
1980. However, our 95% HPDs show a wide range of uncertainty, which likely resulted
from extrapolating several centuries back in time based on a comparably short calibration
interval spanning only 19 years.
6.4.7. Introductions of L2–Beijing Into Africa Unrelated to Drug
Resistance
Because of the repeated association of L2–Beijing with antibiotic resistance (Borrell and
Gagneux, 2009), the emergence and dissemination of L2–Beijing strains has often been
attributed to drug resistance. However, our estimated timing of these introductions sug-
gest that African L2–Beijing strains were introduced prior the discovery of TB antibiotics,
and thus must have involved drug-susceptible strains (Figure 6.5). To explore this ques-
tion further, we assessed the drug resistance profiles of L2–Beijing strains linked to the
various introduction events into the two African regions. We found that all the Eastern
African populations contained only drug-susceptible strains and that approximately three-
quarters of L2–Beijing strains in the Southern African populations were drug-susceptible,
with the remaining being either mono–, multi–, or extensively drugresistant (Figure 6.6
and Figure B.14). Taken together, these results suggest that the emergence of L2–Beijing
in Africa, particularly in Eastern Africa, was not driven by drug resistance. Moreover,
our data indicate independent acquisition of drug resistance for the resistant strains de-
tected in the Southern African L2– Beijing population (Figure 6.6), which might partly
contribute to the subsequent spread of L2–Beijing in Southern Africa but not in Eastern
Africa.
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Figure 6.5.: Estimated time in median ages for the introductions of African L2–Beijing (M1-
M3 and M6-M13). Introductions to Eastern Africa are colored in red and those to
Southern Africa in blue. Migration M10 contained L2–Beijing from both Southern
and Eastern Africa. Dotted line marks the year of first anti-TB drug discovery
(1943). The error bars correspond to the 95% HPD.
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Figure 6.6.: Proportions of drug resistance profiles for L2 strains in seven geographical regions.
6.5. Discussion
This study investigated the most likely geographical origin of the L2–Beijing in Africa.
In line with previous findings (Luo et al., 2015; Merker et al., 2015), we identified East
Asia as the most likely place of origin of L2 and L2–Beijing. Our findings further re-
vealed multiple independent introductions of L2–Beijing into Africa linked to separate
populations originating from both East and Southeast Asia. Some of these introductions
were followed by further onward spread of L2–Beijing within African regions. Finally, we
demonstrate that most introductions of L2–Beijing on the continent occurred before the
age of antibiotics.
L2–Beijing has received much attention given its hypervirulence in infection models (Manca
et al., 2001; Ribeiro et al., 2014), faster progression to disease and higher transmission
potential in humans (de Jong et al., 2008; Holt et al., 2018), frequent association with
drug resistance, and recent emergence in different regions of the world (Bifani et al., 2002;
Borrell and Gagneux, 2009; Fenner et al., 2013). Several studies indicate L2–Beijing orig-
inated in Asia and spread from there to the rest of the world (Luo et al., 2015; Merker
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et al., 2015). Our results support this notion by identifying “Asia” as themost likely ge-
ographical origin of both L2 and L2–Beijing based on our ancestral reconstructions and
the fact the L2–Beijing populations in Asia are much more diverse than in other regions.
In addition, our findings show that L2–Beijing was introduced into Africa multiple times
from both East- and Southeast Asia. The presence of L2–Beijing in South Africa has pre-
viously been proposed to be due to the importation of slaves from Southeastern Asia by
Europeans in the seventeenth and eighteenth centuries followed by the import of Chinese
labor-forces in the early 1900s (Helden et al., 2002)(van Helden et al., 2002; Mokrousov
et al., 2005). Our Bayesian dating estimates predicted the earliest introductions of L2–
Beijing into Africa to have occurred in the eighteenth and nineteenth centuries, concurring
with these proposed time periods. However, our findings also point to later introductions
of L2–Beijing into the continent in the nineteenth and early twentieth centuries. The tim-
ings of the latest three introductions in the second half of the twentieth century coincide
with the decolonization and post-colonial period in Africa when investments into infras-
tructure and other projects by Chinese enterprises substantially increased (Yuan, 2006;
Rice, 2011). These activities also brought many Chinese workers to Africa during a time
when TB was still very prevalent in China (Murray, 2018). Hence, many of these workers
were likely latently infected with L2–Beijing and might have later reactivated (Pescarini
et al., 2017). Overall, our findings suggest that L2–Beijing has emerged in Africa over the
last 300 years and that these introductions have occurred sporadically ever since. The
repeated association of L2–Beijing with drug resistance (Borrell and Gagneux, 2009) has
led some to propose that drug resistance is another reason why this sublineage might suc-
cessfully compete against and eventually replace other M. tuberculosis genotypes (Parwati
et al., 2010). However, the underlying reason for the association of L2–Beijing with drug
resistance remains unclear (Borrell and Trauner, 2017), and it is also far from univer-
sal, with several reports from e.g., China and other regions finding no such association
(Hanekom et al., 2007; Yang et al., 2012). Our results show that most introduction events
of L2–Beijing into Africa pre-date the antibiotic era, and because of that, these introduc-
tions were most likely caused by drug-susceptible strains. The notion that the initial
emergence of L2–Beijing in Africa was not driven by drug resistance is further supported
by our findings that none of L2–Beijing strains from Eastern Africa strains analyzed here
were drug-resistant. Of note, our observations suggest that drug resistance in South Africa
was acquired via independent events post initial introductions from Asia. This is in sharp
contrast to the situation in Eastern Europe and Central Asia, where L2–Beijing is highly
prevalent but dominated by few recently expanded drug-resistant clones, which account
for up to 60% of the L2–Beijing populations in some of these countries (Casali et al., 2014;
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Eldholm et al., 2016). The association of L2–Beijing with drug resistance in these regions
were likely favored by the economic and public health crises that followed the collapse of
Soviet Union (Luo et al., 2015; Merker et al., 2015).
Based on our finding that the original introductions of L2– Beijing into Africa involved
drug-susceptible strains and that the prevalence of drug-resistant L2–Beijing in Africa
overall is comparably low (WHO, 2017), we propose that some of the other characteris-
tics of this sub-lineage, in particular its high virulence, high transmissibility and rapid
progression from infection to disease, were responsible for the initial competitive success
of L2–Beijing in Africa. Until recently, Africa was considered a Virgin Soil for TB and
that TB was only introduced following European contact (Comas et al., 2015). However,
this notion is incompatible with the current evidence supporting an African origin for the
MTBC overall (Hershberg et al., 2008; Wirth et al., 2008; Comas et al., 2013). Indeed,
Africa is the only continent to harbor all seven known human-adapted MTBC lineages,
three of which are almost exclusively observed there (Gagneux, 2018), as well as several
animal-adapted MTBC ecotypes, which affect several wild African mammals (Brites et
al., 2018). Moreover, one study showed that TB epidemics on the continent were caused
by many different “native” genotypes prior to foreign contacts (Comas et al., 2015), sug-
gesting that TB existed in Africa before the initial European contact. Perhaps the clinical
and epidemiological picture of TB in Africa was different at the time, characterized by
a low virulent and slow progressing disease, which would have escaped the attention of
European colonial officials reporting the absence of TB in Africa, at a time when the TB
epidemic was raging in the cities of Europe and North America, killing up to 20% of the
adult population (Comas and Gagneux, 2011). We hypothesized previously that rapid
co-expansion of MTBC L2, L3, and L4 with their respective human host populations in
China, India and Europe might have selected for higher virulence and shorter latency in
these “modern” lineages (Hershberg et al., 2008). The emergence and expansion of these
“foreign” genotypes including L2–Beijing into Africa as reported here, and as reported ear-
lier for L4 (Stucki et al., 2016; Brynildsrud et al., 2018), demonstrate the ability of these
lineages to successfully compete against the existing genotypes on the continent, likely as
a result of their high transmissibility and rapid progression to disease. Following their ini-
tial establishment, poor TB treatment programs subsequently selected for drug resistance
in L2–Beijing but also in other MTBC lineages including L4, which might have facilitated
their further spread in countries such as South Africa (Müller et al., 2013).
Finally, the estimates of the TMRCA for L2 reported here are largely consistent with
recent reports using similar tipdating analyses based on isolation dates (Eldholm et al.,
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2016), and support the notion that the MTBC overall is younger than what has been
proposed in earlier studies, based on a hypothesized co-divergence of the human-adapted
MTBC and modern humans since theirmigration out of Africa (Comas et al., 2013; Luo
et al., 2015).
This study is limited by the fact that we analyzed a globally diverse collection of L2
genomes available in public repositories. Hence, these strains might not be fully rep-
resentative of the respective geographical regions. Moreover, our African L2– Beijing
dataset came from convenient sampling and comprised L2–Beijing mainly from Eastern
and Southern Africa, as whole genome data of L2–Beijing from the other African re-
gions were unavailable at the time of the study. However, the representation of African
L2–Beijing in our sample reflects the overall prevalence of this sub-lineage as recently
reported for the continent (Mbugi et al., 2015; Chihota et al., 2018). Moreover, although
regions outside of Eastern- and Southern Africa were underrepresented, this is unlikely
to invalidate our findings regarding the multiple independents of L2– Beijing into Africa,
except by underestimating the number of true introductions.
In conclusion, this is the first study to address the geographical origins of L2–Beijing in
Africa using whole genome sequencing data. Our findings indicate multiple independent
introductions of L2–Beijing epidemics into Africa from East- and Southeast Asia during
the last 300 years that were unrelated to drug resistance. The TB epidemics in Africa
have remained fairly stable over the last few decades (WHO, 2017). However, Africa’s
population growth and increasing urbanization (driven by booming economies) are likely
to have an impact on the future of TB in this continent, whether directly by e.g., fa-
cilitating transmission or indirectly by promoting new risk factors such as diabetes that
increase TB susceptibility (Dye et al., 2010). It is therefore crucial to follow the TB
epidemics in the continent very closely, especially those related to hypervirulent strains
such as L2–Beijing, as these might take particular advantage of this expanding ecological
niche (Cowley et al., 2008).
6.6. Data Availability
The xml files used for this study can be found here https://github.com/SwissTPH/
TBRU_L2Africa
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7. General Discussion
It was only a few decades ago that Mtb complex was considered a “clone” (Sreevatsan et
al., 1997; Musser et al., 2000). Despite the high sequence identity among the Mtb strains,
substantial genetic variation exists (Hershberg et al., 2008; Comas et al., 2010). Over the
years, we have witnessed the advancements in different molecular markers and genotyping
techniques (Embden et al., 1993; Kamerbeek et al., 1997; Hershberg et al., 2008; Supply et
al., 2000; Stucki et al., 2012) and lately whole genome sequencing technologies (Comas et
al., 2010; Roetzer et al., 2013; Walker et al., 2013). Without a doubt, these developments
have given us invaluable insights into the micro- and macroevolution of Mtb, the basis of
its disease pathogenesis and fundamentally, the phenotypic consequences of Mtb variation
in TB infection and disease.
In this PhD thesis, we first aimed to gain insights into the national and local diversity of
Mtb in Tanzania using a combination of SNP-typing and WGS techniques and to assess
for the associated clinical phenotypes. Secondly, we aimed to study the evolutionary
history of the prevalent Lineages 1 and 3, and the recently emerged Lineage 2-Beijing in
Africa. We show that TB epidemic in Tanzania is caused by four of the seven human-
adapted Mtb lineages and identified associated clinical phenotypes related to enhanced
transmission and unusual higher female-to-male ratio in TB patients. Using the most
comprehensive whole genome datasets to date, we were able to reveal that prevalence of
Lineage 1 and 3 in Eastern Africa and the recent emergence of Lineage 2 on the African
continent reflect multiple introductions back-to-Africa from Asia.
In this chapter, we summarize the key findings of the research conducted in this PhD
thesis and the implications of molecular epidemiology and evolutionary history studies of
Mtb in high TB endemic settings of sub-Sahara Africa.
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7.1. Mtb lineages in Africa
Africa is the only continent where all the seven human-adapted Mtb lineages are found
(Gagneux, 2018). Remarkably, the Mtb lineages show a geographical distribution within
the continent with the “specialist” Lineage 5 and 6 confined to Western and Lineage 7
to the Horn of Africa. The globally distributed “generalist” Lineage 4 occurs in high fre-
quencies throughout the continent (Stucki et al., 2016) whilst Lineage 2 has only recently
emerged and is found at low frequencies in most regions (Affolabi et al., 2009; Gehre et
al., 2016; Chihota et al., 2018; Rutaihwa et al., 2019a) except Southern Africa (Chihota
et al., 2018; Cowley et al., 2008; Spuy et al., 2009). On the other hand, the “intermediate”
Lineage 1 and 3 are prevalent in the Eastern and Northern Africa (Comas et al., 2015;
O’Neill et al., 2019; Rutaihwa et al., 2019b) and less frequent elsewhere in the continent
(Chihota et al., 2018).
Reconstruction of the evolutionary history of Mtb revealed the African origin prior its
dispersal particularly of the evolutionary “ancient” Lineage 1 out of the continent (Comas
et al., 2013). Mtb was also brought back-to-Africa as evidenced by the presence of the
evolutionary “modern” Lineage 2–4 that emerged outside of Africa (Hershberg et al.,
2008; Stucki et al., 2016; O’Neill et al., 2019). Our study on the phylogeography of the
“intermediate” lineages (described in Chapter 5 of this thesis) revealed the re-introduction
and introductions of heterogeneous populations of Lineage 1 and Lineage 3, respectively,
into Africa from Southern Asia. Moreover, in Chapter 6 we showed recent introductions of
Lineage 2–Beijing into Africa related to heterogeneous bacterial populations from Eastern-
and Southeastern Asia. These introductions were followed by subsequent spread within
the continent.
The phylogeography of human-adapted Mtb lineages like that of other geographically
structured human-pathogens (Falush et al., 2003; Monot et al., 2005) reflects human de-
mographic history and propose local adaptation of the Mtb lineages to particular human
populations (Reed et al., 2009), suggesting long–standing host-pathogen relationships
(Woolhouse et al., 2002). This is further demonstrated by Mtb lineage–human popula-
tion combinations, for instance in metropolitan settings where different Mtb and human
populations co-exist, sympatric associations are favored over allopatric ones (Hirsh et al.,
2004; Gagneux et al., 2006). In Africa, typical sympatric host-pathogen associations are
reflected by “specialist” lineages such as Lineage 5 in Ewe ethnicity (Asante-Poku et al.,
2015; Asante-Poku et al., 2016) and Lineage 7 in Ethiopia (Firdessa et al., 2013) as
well as by “specialist” sublineages such as Lineage 4–Uganda and Lineage 4–Cameroon in
Uganda and Cameroon, respectively (Stucki et al., 2016). However, a large proportion of
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TB epidemic in Africa is caused by other genotypes of Lineage 4 and 3 variants like we
observed in Tanzania (in Chapter 3 and 4 in this thesis). This could suggest that sym-
patric/allopatric relationships are not as clear-cut, particularly in the African settings. On
the one hand, perhaps the TB/HIV co-infections could disrupt such relationships (Fenner
et al., 2013), but the prevalence of HIV-coinfection is only about 30% in TB patients.
On the other hand, the frequency of “foreign” genotypes in Africa demonstrates their suc-
cessful establishment and expansion in the presence of “local” genotypes (Comas et al.,
2015). The fact that these genotypes co-exist show their ability to transmit within African
populations, some better than others. Indeed, we show from our preliminary molecular
clustering analysis in Chapter 4 that on-going transmission in urban Tanzania is dispro-
portionally contributed by modern lineages, Lineage 2–4. Hence, the current TB epidemic
in Africa could be largely shaped by “virulent” strains of modern lineages in combination
with factors related to demographic changes such as overcrowding due to increased host
density and urbanization across the African continent (Dye et al., 2010).
Prior the two studies conducted at local and national level in Tanzania (Chapter 3 and 4
in this thesis), no such study in the country had addressed the Mtb diversity to that extent
using the complementary SNP-typing and WGS technologies and only a few studies have
been conducted elsewhere in Africa (Guerra-Assunção et al., 2015b; Guerra-Assunção et
al., 2015a). This calls for the opportunity to employ such tools to investigate the complex
interactions of the TB infection and disease determinants in high-endemic settings.
7.2. Molecular epidemiology of Mtb in high TB burden
settings
It is now widely accepted that genetic variation in Mtb plays role in determining the
fate of TB infection and disease (Coscolla, 2017). This is relevant especially when genetic
variation translates into relevant phenotypes. Of particular interest would be Mtb clinical
phenotypes related to transmission, taking into account the undesirable magnitude of Mtb
transmission in high-endemic TB settings at present (Yates et al., 2016). Understanding
transmission is among the research priorities in TB where the focus lies on its interrup-
tion in order to reduce TB incidence. Social and environmental aspects contributing to
transmission are often evaluated and particularly in the urban and rural settings studied
in Chapter 4. A few studies have assessed health seeking behavior in order to determine
pathways to care taken by TB patients (Said et al., 2017; Sikalengo et al., 2018), so as
to minimize delays in diagnosis and treatment which contribute to on-going transmission
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by extending the duration of infectiousness (Golub et al., 2006). Another study looked at
potential transmission hot-spots using indoor carbon dioxide measures that would suggest
ways to minimize Mtb exposure through contaminated air (Hella et al., 2017).
Given the high transmission levels and the co-existence of Mtb lineages, it would appear
that transmission occurs independently of Mtb background. Our findings based on the
age of TB patients at the national level in Tanzania (Chapter 3 ) would suggest that to
be case. Even though findings from the urban setting in Tanzania (Chapter 4 ) suggest
otherwise as Lineage 2 was more frequent in patients’ of young age, Lineage 2 is found in
low frequencies. One obvious reason could be due to the recent introductions of Lineage
2 into the African regions as established in Chapter 6 of this thesis. Indeed, in another
African setting, the Gambia, Mtb lineages showed similar transmission rates but the rates
of progression to disease were higher in contacts exposed to Lineage 2–Beijing (Jong et
al., 2008). What this portrays is that the faster “progressors” would end up contributing
much sooner into the transmission cycle. Yet still other “local” Mtb genotypes persist
e.g. Lineage 6 in the Gambia and Lineage 1 in Tanzania. The two lineages constitute
the evolutionary “ancient” lineages which emerged in Africa and therefore have co-existed
with their respective hosts for much longer creating stable host-pathogen relations. These
lineages are hypothesized to have adapted to low human population densities characterized
by slow progression to active disease. Certainly, contacts exposed to Lineage 6 were less
likely to progress to disease (Jong et al., 2008) and Lineage 1 has been found to be frequent
in patients of older ages, which is proxy for reactivation of long term latent infection (Holt
et al., 2018).
Knowledge on circulating Mtb genotypes in a clinical setting gives us insights into trans-
mission patterns and helps identify transmission chains. Although our study conducted in
urban Tanzania (Chapter 4 ) was not population-based, we could still detect some level of
Mtb genetic clustering suggesting on-going transmission, the magnitude of which was how-
ever likely underestimated. In a perfect scenario, following the detection of clustered Mtb
strains, such strains could be tracked by screening the new incoming TB cases, and better
yet, contact tracing in households and communities. WGS provides the opportunity to
identify highly transmissible strains in communities in “real-time”, which in theory could
guide contact tracing approaches and thus interrupt transmission. The reality however is
different as discussed below in section 7.5 of this chapter.
Apart from transmission, other epidemiological features correlated with Mtb lineage in-
clude disease severity, although when considering parameters such as cavitation and bacte-
rial load, severity can be extrapolated to transmission. We pooled 12 parameters to score
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disease severity of TB patients in the urban setting (Chapter 4 ) with the aim to assess for
clinical phenotypes related to TB disease severity. While, no evidence was found for such
an association, a recent study showed the influence of severity on treatment duration and
outcome of TB patients (Imperial et al., 2018). Hence, it remains necessary to investigate
severity of disease among patients and to determine the pathogen influence.
7.3. Sex bias in TB and the role of pathogen
TB affects generally more males than females (WHO, 2018; Guerra-Silveira et al., 2013).
The higher male-to-female ratio has almost universally been reported in high burden
settings with few exceptions like Afghanistan (WHO, 2018). We observed a similar trend
in both nationwide and local settings of Tanzania (Chapter 3 and 4 ). One could speculate
the observed differences to be influenced by biased notification, diagnosis or health seeking
behavior, however evidence shows those factors not to be confounding (Rhines, 2013).
The consistent global trends toward male bias in TB have been explained by gender-
related social and physiological differences (Nhamoyebonde et al., 2014). Social factors
tied to risk behavior such as substance abuse e.g. alcoholism, smoking and drug use
and those related to risk occupations e.g. mining are frequent in males thus placing
them at a much higher risk for TB. Aside from social determinants, biological differences
involving sex hormones and genetic makeup have been implicated to influence sex-specific
TB susceptibility (Nhamoyebonde et al., 2014). Epidemiological and experimental studies
suggest female sex hormones to be protective, an observation which might explain the
apparent male-female bias in adult TB patients. What is striking is that, the sex bias is
maintained even though the most important risk factor for TB, HIV, is more frequent in
females (Hegdahl et al., 2016). We (in Chapter 3 ) and a few others previously (Holt et al.,
2018; Malla et al., 2012) reveal a higher trend in female-male-ratio in TB patients infected
with Lineage 2. These observations could suggest a possible pathogen role in Lineage 2
“naïve” populations where female “resistance” to TB is overcome. However, we could not
replicate these findings at the local level (Chapter 4 ), which could be due to differential
sampling in the national and local settings. In addition, gender factors influenced by
health seeking behavior could also contribute to this inconsistence. For instance, a recent
study in our setting revealed that men sought more formal care than women (Said et al.,
2017). Future studies should further investigate bacterial related factors that influence
this bias and taking the potential confounders into account.
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7.4. WGS application and challenges
In recent years, high-throughput sequencing technologies have significantly advanced in
terms of sequence amount and quality, costs and turnaround time (Loman et al., 2012).
These developments have led us to the era of genomic epidemiology including in the field
of TB, where we can tackle transmission questions at finer scales compared to conven-
tional molecular typing techniques (Comas, 2017). So far, application of WGS for clinical
microbiology practices has been primarily in low-endemic settings, with only a handful of
examples existing in high-endemic settings.
Most of genomic epidemiology studies in TB have been conducted retrospectively (Roetzer
et al., 2013; Walker et al., 2013; Stucki et al., 2015). In cases where WGS is applied
prospectively, the nature of TB outbreaks is unusual, given the complex infection outcome
in TB (Koul et al., 2011), where patients in the same transmission links can be identified
over a period of many years (Stucki et al., 2015). This fact raises concerns whether WGS
is an ideal “real-time” epidemiological tool and whether it would have an impact on TB
infection control, which is crucial in high-endemic settings (Comas, 2017). However, with
the integration of social links, WGS can disentangle transmission events that are inclined
to last over years in a given setting (Gardy et al., 2011). This could ultimately inform
control strategies and guide intervention approaches such as targeted contact tracing in
order to interrupt transmission. In addition, WGS has been successfully applied in high-
endemic setting such that it was possible to assess transmissibility within Mtb lineages
and distinguish disease recurrence vs., recent transmissions in population-based approach
(Guerra-Assunção et al., 2015b).
Although challenges concerning ease on the generation of sequencing data might be well
in-check, including “onsite” in high-endemic settings, analytical and technical challenges
remain. For starters, WGS requires high quality DNA as template, which involves cul-
turing of Mtb isolates. While culturing capacity might be feasible in a research setting,
it is not the case for health care facilities which in fact attend to TB patients. Even if
culturing facilities were widely available, the turnaround time for culture is much longer.
One way to circumvent such limitation is to invest on culture-independent methods for
instance, sequencing directly from sputum samples. Other challenges involve the rapid
and large amounts of data generated by the technology, creating considerable concerns
on data management and storage infrastructure, lack of skilled and trained personnel to
utilize such data in a meaningful way.
Despite the challenges that come with WGS technologies, it is still worth to discover
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its full potential in high-endemic settings. Beyond sequencing of clinical isolates, high-
throughput sequencing provide the opportunity to study complex microbial communi-
ties related to human health and disease via approaches such as metagenomics and se-
quence profiling (Qin et al., 2010; Hess et al., 2011). Overall, high-throughput sequencing
could become an invaluable epidemiological tool in high-endemic settings as well, pro-
vided the willingness to tackle the challenges and limitations that tag along with the
technology.
7.5. Conclusions
Sub-Saharan African countries are highly burdened with TB. The recent advances in
genotyping techniques and gradually WGS provide the opportunity to study the molecular
epidemiology of TB in such settings. From one arm of this thesis, we provided insights into
nationwide and local diversity of Mtb lineages in Tanzania using cost-effective SNP-typing
complemented with WGS. This allowed us to further investigate epidemiological features
associated with Mtb lineages using patients’ sociodemographic and clinical information
and explored molecular clustering of Mtb strains in urban Tanzania. We revealed four of
seven human-adapted lineages showing similar epidemiological features in the rural and
urban setting. By contrast, Lineage 2 was more frequent in patients of young age in the
urban setting. Our analysis of Mtb genomes isolated from urban TB patients showed a
transmission bias towards strains of the modern lineages, Lineage 2–4.
From the other arm of the thesis, we demonstrate the value of using large whole genome
datasets to study the phylogeography and evolutionary histories of Mtb lineages. We
revisited the global phylogenies and geographical distributions of Lineage 1 and 3 where
we showed substantial substructures within these two lineages, which have most likely
been partially shaped by back-to-Africa migrations from South Asia. Secondly, we show
that Lineage 2–Beijing has only recently emerged in Africa via multiple introductions
from Eastern- and Southeastern Asia. Further, the estimated timing indicated most of
these Lineage 2–Beijing introductions pre-date the antibiotic era, and therefore suggest
its success to be linked to higher virulence and enhanced transmission rather than to drug
resistance.
Overall, our findings highlight epidemiological features related to the pathogen in Tanza-
nia, at local and national levels, improving our knowledge on the molecular epidemiology
of TB in the country. Finally, our results reveal the origins of the recently emerged Lin-
eage 2–Beijing and the prevalent Lineage 1 and 3 across Africa, which were until now
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largely underexplored.
8. Bibliography
Achtman, M (2008) Evolution, population structure, and phylogeography of genetically
monomorphic bacterial pathogens. Annual review of microbiology , 62 53–70.
Affolabi, D, Faïhun, F, Sanoussi, N, Anyo, G, Shamputa, IC, Rigouts, L, Kestens, L,
Anagonou, S, Portaels, F (2009) Possible outbreak of streptomycin-resistant Mycobac-
terium tuberculosis Beijing in Benin. Emerging infectious diseases , 15(7): 1123–5.
Alexander, KA, Laver, PN, Michel, AL, Williams, M, Helden, PD van, Warren, RM,
Gey van Pittius, NC (2010) Novel Mycobacterium tuberculosis Complex Pathogen, M.
mungi. Emerging Infectious Diseases , 16(8): 1296–1299.
Asante-Poku, A, Otchere, ID, Osei-Wusu, S, Sarpong, E, Baddoo, A, Forson, A, Laryea,
C, Borrell, S, Bonsu, F, Hattendorf, J, Ahorlu, C, Koram, KA, Gagneux, S, Yeboah-
Manu, D (2016) Molecular epidemiology of Mycobacterium africanum in Ghana. BMC
infectious diseases , 16 385.
Asante-Poku, A, Yeboah-Manu, D, Otchere, ID, Aboagye, SY, Stucki, D, Hattendorf,
J, Borrell, S, Feldmann, J, Danso, E, Gagneux, S (2015) Mycobacterium africanum
is associated with patient ethnicity in Ghana. PLoS neglected tropical diseases , 9(1):
e3370.
Baele, G, Li, WLS, Drummond, AJ, Suchard, MA, Lemey, P (2012) Accurate Model
Selection of Relaxed Molecular Clocks in Bayesian Phylogenetics. Molecular Biology
and Evolution, 30(2): 239–243.
Bhanu, NV, Soolingen, D van, Embden, JDA van, Dar, L, Pandey, RM, Seth, P (2002)
Predominace of a novel Mycobacterium tuberculosis genotype in the Delhi region of
India. Tuberculosis , 82(2-3): 105–12.
Bifani, PJ, Mathema, B, Kurepina, NE, Kreiswirth, BN (2002) Global dissemination
of the Mycobacterium tuberculosis W-Beijing family strains. Trends in Microbiology ,
10(1): 45–52.
Bolger, AM, Lohse, M, Usadel, B (2014) Trimmomatic: a flexible trimmer for Illumina
sequence data. Bioinformatics , 30(15): 2114–20.
118 8. Bibliography
Bollback, JP (2006) SIMMAP: stochastic character mapping of discrete traits on phylo-
genies. BMC bioinformatics , 7 88.
Boonaiam, S, Chaiprasert, A, Prammananan, T, Leechawengwongs, M (2010) Genotypic
analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB
isolates from Thailand. Clinical microbiology and infection, 16(4): 396–9.
Borgdorff, MW, Soolingen, D van (2013) The re-emergence of tuberculosis: what have
we learnt from molecular epidemiology? Clinical microbiology and infection, 19(10):
889–901.
Borrell, S, Gagneux, S (2009) Infectiousness, reproductive fitness and evolution of drug-
resistant Mycobacterium tuberculosis. The international journal of tuberculosis and lung
disease, 13(12): 1456–66.
Bos, KI, Harkins, KM, Herbig, A, Coscolla, M, Weber, N, Comas, I, Forrest, SA, Bryant,
JM, Harris, SR, Schuenemann, VJ, Campbell, TJ, Majander, K, Wilbur, AK, Guichon,
RA, Wolfe Steadman, DL, Cook, DC, Niemann, S, Behr, MA, Zumarraga, M, Bastida,
R, Huson, D, Nieselt, K, Young, D, Parkhill, J, Buikstra, JE, Gagneux, S, Stone, AC,
Krause, J (2014) Pre-Columbian mycobacterial genomes reveal seals as a source of New
World human tuberculosis. Nature, 514(7523): 494–497.
Bouckaert, R, Heled, J, Kühnert, D, Vaughan, T, Wu, CH, Xie, D, Suchard, MA, Ram-
baut, A, Drummond, AJ (2014) BEAST 2: A Software Platform for Bayesian Evolu-
tionary Analysis. PLoS Computational Biology , 10(4): e1003537.
Bromham, L, Duchêne, S, Hua, X, Ritchie, AM, Duchêne, DA, Ho, SYW (2018) Bayesian
molecular dating: opening up the black box. Biological Reviews , 93(2): 1165–1191.
Brosch, R, Gordon, SV, Marmiesse, M, Brodin, P, Buchrieser, C, Eiglmeier, K, Garnier, T,
Gutierrez, C, Hewinson, G, Kremer, K, Parsons, LM, Pym, AS, Samper, S, Soolingen,
D van, Cole, ST (2002) A new evolutionary scenario for the Mycobacterium tuberculo-
sis complex. Proceedings of the National Academy of Sciences of the United States of
America, 99(6): 3684–9.
Brossier, F, Veziris, N, Truffot-Pernot, C, Jarlier, V, Sougakoff, W (2011) Molecular in-
vestigation of resistance to the antituberculous drug ethionamide in multidrug-resistant
clinical isolates of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy ,
55(1): 355–60.
Brudey, K, Driscoll, JR, Rigouts, L, Prodinger, WM, Gori, A, Al-Hajoj, SA, Allix, C,
Aristimuño, L, Arora, J, Baumanis, V, Binder, L, Cafrune, P, Cataldi, A, Cheong, S,
Diel, R, Ellermeier, C, Evans, JT, Fauville-Dufaux, M, Ferdinand, S, Garcia de Viedma,
D, Garzelli, C, Gazzola, L, Gomes, HM, Guttierez, MC, Hawkey, PM, Helden, PD van,
Kadival, GV, Kreiswirth, BN, Kremer, K, Kubin, M, Kulkarni, SP, Liens, B, Lillebaek,
8. Bibliography 119
T, Ho, ML, Martin, C, Martin, C, Mokrousov, I, Narvskaïa, O, Ngeow, YF, Naumann,
L, Niemann, S, Parwati, I, Rahim, Z, Rasolofo-Razanamparany, V, Rasolonavalona, T,
Rossetti, ML, Rüsch-Gerdes, S, Sajduda, A, Samper, S, Shemyakin, IG, Singh, UB,
Somoskovi, A, Skuce, RA, Soolingen, D van, Streicher, EM, Suffys, PN, Tortoli, E,
Tracevska, T, Vincent, V, Victor, TC, Warren, RM, Yap, SF, Zaman, K, Portaels,
F, Rastogi, N, Sola, C (2006) Mycobacterium tuberculosis complex genetic diversity:
mining the fourth international spoligotyping database (SpolDB4) for classification,
population genetics and epidemiology. BMC microbiology , 6 23.
Brynildsrud, OB, Pepperell, CS, Suffys, P, Grandjean, L, Monteserin, J, Debech, N,
Bohlin, J, Alfsnes, K, Pettersson, JOH, Kirkeleite, I, Fandinho, F, Silva, MA da, Perdi-
gao, J, Portugal, I, Viveiros, M, Clark, T, Caws, M, Dunstan, S, Thai, PVK, Lopez, B,
Ritacco, V, Kitchen, A, Brown, TS, Soolingen, D van, O’Neill, MB, Holt, KE, Feil, EJ,
Mathema, B, Balloux, F, Eldholm, V (2018) Global expansion of Mycobacterium tuber-
culosis lineage 4 shaped by colonial migration and local adaptation. Science advances ,
4(10): eaat5869.
Buu, TN, Huyen, MN, Lan, NTN, Quy, HT, Hen, NV, Zignol, M, Borgdorff, MW, Co-
belens, FGJ, Soolingen, D van (2009) The Beijing genotype is associated with young
age and multidrug-resistant tuberculosis in rural Vietnam. The international journal of
tuberculosis and lung disease, 13(7): 900–6.
Buu, TN, Soolingen, D van, Huyen, MNT, Lan, NTN, Quy, HT, Tiemersma, EW, Kre-
mer, K, Borgdorff, MW, Cobelens, FGJ (2012) Increased transmission of Mycobac-
terium tuberculosis Beijing genotype strains associated with resistance to streptomycin:
a population-based study. PloS one, 7(8): e42323.
Casali, N, Nikolayevskyy, V, Balabanova, Y, Harris, SR, Ignatyeva, O, Kontsevaya, I,
Corander, J, Bryant, J, Parkhill, J, Nejentsev, S, Horstmann, RD, Brown, T, Drob-
niewski, F (2014) Evolution and transmission of drug-resistant tuberculosis in a Russian
population. Nature genetics , 46(3): 279–86.
Casali, N, Nikolayevskyy, V, Balabanova, Y, Ignatyeva, O, Kontsevaya, I, Harris, SR,
Bentley, SD, Parkhill, J, Nejentsev, S, Hoffner, SE, Horstmann, RD, Brown, T, Drob-
niewski, F (2012) Microevolution of extensively drug-resistant tuberculosis in Russia.
Genome Research, 22(4): 735–745.
Casanova, JL, Abel, L (2002) Genetic dissection of immunity to mycobacteria: the human
model. Annual review of immunology , 20(1): 581–620.
Chihota, VN, Niehaus, A, Streicher, EM, Wang, X, Sampson, SL, Mason, P, Källenius, G,
Mfinanga, SG, Pillay, M, Klopper, M, Kasongo, W, Behr, MA, Gey van Pittius, NC,
120 8. Bibliography
Helden, PD van, Couvin, D, Rastogi, N, Warren, RM (2018) Geospatial distribution of
Mycobacterium tuberculosis genotypes in Africa. PloS one, 13(8): e0200632.
Cirillo, DM, Miotto, P, Tortoli, E (2017) Evolution of Phenotypic and Molecular Drug
Susceptibility Testing. In: Gagneux S. (eds) Strain Variation in the Mycobacterium
tuberculosis Complex: Its Role in Biology, Epidemiology and Control. Advances in Ex-
perimental Medicine and Biology , 1019 221–246.
Colditz, GA, Berkey, CS, Mosteller, F, Brewer, TF, Wilson, ME, Burdick, E, Fineberg,
HV (1995) The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants
in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics ,
96 29–35.
Coll, F, McNerney, R, Guerra-Assunção, JA, Glynn, JR, Perdigão, J, Viveiros, M, Por-
tugal, I, Pain, A, Martin, N, Clark, TG (2014) A robust SNP barcode for typing My-
cobacterium tuberculosis complex strains. Nature communications , 5(1): 4812.
Coll, F, McNerney, R, Preston, MD, Guerra-Assunção, JA, Warry, A, Hill-Cawthorne, G,
Mallard, K, Nair, M, Miranda, A, Alves, A, Perdigão, J, Viveiros, M, Portugal, I, Hasan,
Z, Hasan, R, Glynn, JR, Martin, N, Pain, A, Clark, TG (2015) Rapid determination
of anti-tuberculosis drug resistance from whole-genome sequences. Genome Medicine,
7(1): 51.
Comas, I (2017) Genomic Epidemiology of Tuberculosis. In: Gagneux S. (eds) Strain
Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology
and Control. Advances in Experimental Medicine and Biology , 1019 79–93.
Comas, I, Chakravartti, J, Small, PM, Galagan, J, Niemann, S, Kremer, K, Ernst, JD,
Gagneux, S (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolution-
arily hyperconserved. Nature genetics , 42(6): 498–503.
Comas, I, Coscolla, M, Luo, T, Borrell, S, Holt, KE, Kato-Maeda, M, Parkhill, J, Malla,
B, Berg, S, Thwaites, G, Yeboah-Manu, D, Bothamley, G, Mei, J, Wei, L, Bentley,
S, Harris, SR, Niemann, S, Diel, R, Aseffa, A, Gao, Q, Young, D, Gagneux, S (2013)
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with
modern humans. Nature genetics , 45(10): 1176–82.
Comas, I, Gagneux, S (2009) The past and future of tuberculosis research. PLoS pathogens ,
5(10): e1000600.
Comas, I, Hailu, E, Kiros, T, Bekele, S, Mekonnen, W, Gumi, B, Tschopp, R, Ameni, G,
Hewinson, RG, Robertson, BD, Goig, GA, Stucki, D, Gagneux, S, Aseffa, A, Young, D,
Berg, S (2015) Population Genomics of Mycobacterium tuberculosis in Ethiopia Con-
tradicts the Virgin Soil Hypothesis for Human Tuberculosis in Sub-Saharan Africa.
Current biology : CB , 25(24): 3260–6.
8. Bibliography 121
Corbett, EL, Charalambous, S, Moloi, VM, Fielding, K, Grant, AD, Dye, C, De Cock, KM,
Hayes, RJ, Williams, BG, Churchyard, GJ (2004) Human Immunodeficiency Virus and
the Prevalence of Undiagnosed Tuberculosis in African Gold Miners. American Journal
of Respiratory and Critical Care Medicine, 170(6): 673–679.
Coscolla, M (2017) Biological and Epidemiological Consequences of MTBC Diversity. In:
Gagneux S. (eds) Strain Variation in the Mycobacterium tuberculosis Complex: Its Role
in Biology, Epidemiology and Control. Advances in Experimental Medicine and Biology ,
1019 95–116.
Coscolla, M, Gagneux, S (2014) Consequences of genomic diversity in Mycobacterium
tuberculosis. Seminars in immunology , 26(6): 431–44.
Coscolla, M, Lewin, A, Metzger, S, Maetz-Rennsing, K, Calvignac-Spencer, S, Nitsche, A,
Dabrowski, PW, Radonic, A, Niemann, S, Parkhill, J, Couacy-Hymann, E, Feldman, J,
Comas, I, Boesch, C, Gagneux, S, Leendertz, FH (2013) Novel Mycobacterium tuber-
culosis complex isolate from a wild chimpanzee. Emerging infectious diseases , 19(6):
969–76.
Cousins, DV, Peet, RL, Gaynor, WT, Williams, SN, Gow, BL (1994) Tuberculosis in
imported hyrax (Procavia capensis) caused by an unusual variant belonging to the
Mycobacterium tuberculosis complex. eng. Veterinary microbiology , 42(2-3): 135–45.
Cowley, D, Govender, D, February, B, Wolfe, M, Steyn, L, Evans, J, Wilkinson, RJ,
Nicol, MP (2008) Recent and rapid emergence of W-Beijing strains of Mycobacterium
tuberculosis in Cape Town, South Africa. Clinical infectious diseases , 47(10): 1252–9.
Daniel, TM (2006) The history of tuberculosis. Respiratory medicine, 100(11): 1862–70.
Demay, C, Liens, B, Burguière, T, Hill, V, Couvin, D, Millet, J, Mokrousov, I, Sola,
C, Zozio, T, Rastogi, N (2012) SITVITWEB–a publicly available international multi-
marker database for studying Mycobacterium tuberculosis genetic diversity and molec-
ular epidemiology. Infection, genetics and evolution, 12(4): 755–66.
Douglas, JT, Qian, L, Montoya, JC, Musser, JM, Van Embden, JDA, Van Soolingen, D,
Kremer, K (2003) Characterization of the Manila Family ofMycobacterium tuberculosis.
Journal of Clinical Microbiology , 41(6): 2723–2726.
Drummond, AJ, Ho, SYW, Phillips, MJ, Rambaut, A (2006) Relaxed Phylogenetics and
Dating with Confidence. PLoS Biology , 4(5): e88.
Dye, C, Williams, BG (2010) The population dynamics and control of tuberculosis. Sci-
ence, 328(5980): 856–61.
Egwaga, SM, Cobelens, FG, Muwinge, H, Verhage, C, Kalisvaart, N, Borgdorff, MW
(2006) The impact of the HIV epidemic on tuberculosis transmission in Tanzania. AIDS ,
20(6): 915–21.
122 8. Bibliography
Eldholm, V, Matee, M, Mfinanga, SGM, Heun, M, Dahle, UR (2006) A first insight into
the genetic diversity ofMycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed
by spoligotyping. BMC microbiology , 6(1): 76.
Eldholm, V, Pettersson, JHO, Brynildsrud, OB, Kitchen, A, Rasmussen, EM, Lillebaek,
T, Rønning, JO, Crudu, V, Mengshoel, AT, Debech, N, Alfsnes, K, Bohlin, J, Pep-
perell, CS, Balloux, F (2016) Armed conflict and population displacement as drivers of
the evolution and dispersal of Mycobacterium tuberculosis. Proceedings of the National
Academy of Sciences , 113(48): 13881–13886.
Embden, JD van, Cave, MD, Crawford, JT, Dale, JW, Eisenach, KD, Gicquel, B, Her-
mans, P, Martin, C, McAdam, R, Shinnick, TM (1993) Strain identification of My-
cobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized
methodology. Journal of clinical microbiology , 31(2): 406–9.
Falush, D, Wirth, T, Linz, B, Pritchard, JK, Stephens, M, Kidd, M, Blaser, MJ, Graham,
DY, Vacher, S, Perez-Perez, GI, Yamaoka, Y, Mégraud, F, Otto, K, Reichard, U, Kat-
zowitsch, E, Wang, X, Achtman, M, Suerbaum, S (2003) Traces of human migrations
in Helicobacter pylori populations. Science, 299(5612): 1582–5.
Fenner, L, Egger, M, Bodmer, T, Furrer, H, Ballif, M, Battegay, M, Helbling, P, Fehr,
J, Gsponer, T, Rieder, HL, Zwahlen, M, Hoffmann, M, Bernasconi, E, Cavassini, M,
Calmy, A, Dolina, M, Frei, R, Janssens, JP, Borrell, S, Stucki, D, Schrenzel, J, Böttger,
EC, Gagneux, S, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study
Groups (2013) HIV infection disrupts the sympatric host-pathogen relationship in hu-
man tuberculosis. PLoS genetics , 9(3): e1003318.
Fenner, L, Malla, B, Ninet, B, Dubuis, O, Stucki, D, Borrell, S, Huna, T, Bodmer, T,
Egger, M, Gagneux, S (2011) "Pseudo-Beijing": evidence for convergent evolution in
the direct repeat region of Mycobacterium tuberculosis. PloS one, 6(9): e24737.
Fine, PE (1995) Variation in protection by BCG: implications of and for heterologous
immunity. Lancet , 346(8986): 1339–45.
Firdessa, R, Berg, S, Hailu, E, Schelling, E, Gumi, B, Erenso, G, Gadisa, E, Kiros, T,
Habtamu, M, Hussein, J, Zinsstag, J, Robertson, BD, Ameni, G, Lohan, AJ, Loftus,
B, Comas, I, Gagneux, S, Tschopp, R, Yamuah, L, Hewinson, G, Gordon, SV, Young,
DB, Aseffa, A (2013) Mycobacterial lineages causing pulmonary and extrapulmonary
tuberculosis, Ethiopia. Emerging infectious diseases , 19(3): 460–3.
Gagneux, S (2012) Host-pathogen coevolution in human tuberculosis. Philosophical trans-
actions of the Royal Society of London, 367(1590): 850–9.
Gagneux, S (2018) Ecology and evolution of Mycobacterium tuberculosis. Nature reviews.
Microbiology , 16(4): 202–213.
8. Bibliography 123
Gagneux, S, DeRiemer, K, Van, T, Kato-Maeda, M, Jong, BC de, Narayanan, S, Nicol,
M, Niemann, S, Kremer, K, Gutierrez, MC, Hilty, M, Hopewell, PC, Small, PM (2006)
Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proceedings of the
National Academy of Sciences , 103(8): 2869–2873.
Gardy, JL, Johnston, JC, Ho Sui, SJ, Cook, VJ, Shah, L, Brodkin, E, Rempel, S, Moore,
R, Zhao, Y, Holt, R, Varhol, R, Birol, I, Lem, M, Sharma, MK, Elwood, K, Jones, SJM,
Brinkman, FSL, Brunham, RC, Tang, P (2011) Whole-genome sequencing and social-
network analysis of a tuberculosis outbreak. The New England journal of medicine,
364(8): 730–9.
Gehre, F, Kumar, S, Kendall, L, Ejo, M, Secka, O, Ofori-Anyinam, B, Abatih, E, Antonio,
M, Berkvens, D, Jong, BC de (2016) A Mycobacterial Perspective on Tuberculosis in
West Africa: Significant Geographical Variation of M. africanum and Other M. tuber-
culosis Complex Lineages. PLoS neglected tropical diseases , 10(3): e0004408.
Getahun, H, Gunneberg, C, Granich, R, Nunn, P (2010) HIV infection-associated tuber-
culosis: the epidemiology and the response. Clinical infectious diseases , 50(s3): S201–
7.
Gilbert, E (2002) Coastal East Africa and the Western Indian Ocean: Long-Distance
Trade, Empire, Migration, and Regional Unity, 1750-1970. The History Teacher , 36(1):
7.
Githui, WA, Jordaan, AM, Juma, ES, Kinyanjui, P, Karimi, FG, Kimwomi, J, Meme, H,
Mumbi, P, Streicher, EM, Warren, R, Helden, PD van, Victor, TC (2004) Identification
of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi,
Kenya. The international journal of tuberculosis and lung disease, 8(3): 352–60.
Glynn, JR, Alghamdi, S, Mallard, K, McNerney, R, Ndlovu, R, Munthali, L, Houben, RM,
Fine, PEM, French, N, Crampin, AC (2010) Changes in Mycobacterium tuberculosis
Genotype Families Over 20 Years in a Population Based Study in Northern Malawi.
PLoS ONE , 5(8): e12259.
Golub, JE, Bur, S, Cronin, WA, Gange, S, Baruch, N, Comstock, GW, Chaisson, RE
(2006) Delayed tuberculosis diagnosis and tuberculosis transmission. The international
journal of tuberculosis and lung disease, 10(1): 24–30.
Gonzalo-Asensio, J, Malaga, W, Pawlik, A, Astarie-Dequeker, C, Passemar, C, Moreau,
F, Laval, F, Daffé, M, Martin, C, Brosch, R, Guilhot, C (2014) Evolutionary history
of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. Pro-
ceedings of the National Academy of Sciences of the United States of America, 111(31):
11491–6.
124 8. Bibliography
Guerra-Assunção, JA, Crampin, AC, Houben, RMGJ, Mzembe, T, Mallard, K, Coll, F,
Khan, P, Banda, L, Chiwaya, A, Pereira, RPA, McNerney, R, Fine, PEM, Parkhill, J,
Clark, TG, Glynn, JR (2015a) Large-scale whole genome sequencing of M. tuberculosis
provides insights into transmission in a high prevalence area. eLife, 4
Guerra-Assunção, JA, Houben, RMGJ, Crampin, AC, Mzembe, T, Mallard, K, Coll, F,
Khan, P, Banda, L, Chiwaya, A, Pereira, RPA, McNerney, R, Harris, D, Parkhill, J,
Clark, TG, Glynn, JR (2015b) Recurrence due to relapse or reinfection with Mycobac-
terium tuberculosis : a whole-genome sequencing approach in a large, population-based
cohort with a high HIV infection prevalence and active follow-up. The Journal of in-
fectious diseases , 211(7): 1154–63.
Guerra-Silveira, F, Abad-Franch, F (2013) Sex bias in infectious disease epidemiology:
patterns and processes. PloS one, 8(4): e62390.
Gutierrez, MC, Brisse, S, Brosch, R, Fabre, M, Omaïs, B, Marmiesse, M, Supply, P, Vin-
cent, V (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium
tuberculosis. PLoS pathogens , 1(1): e5.
Hanekom, M, Spuy, GD van der, Streicher, E, Ndabambi, SL, McEvoy, CRE, Kidd, M,
Beyers, N, Victor, TC, Helden, PD van, Warren, RM (2007) A recently evolved sub-
lineage of the Mycobacterium tuberculosis Beijing strain family is associated with an
increased ability to spread and cause disease. Journal of clinical microbiology , 45(5):
1483–90.
Hasegawa, M, Kishino, H, Yano, T (1985) Dating of the human-ape splitting by a molec-
ular clock of mitochondrial DNA. Journal of molecular evolution, 22(2): 160–74.
Hegdahl, HK, Fylkesnes, KM, Sandøy, IF (2016) Sex Differences in HIV Prevalence Per-
sist over Time: Evidence from 18 Countries in Sub-Saharan Africa. PloS one, 11(2):
e0148502.
Helden, PD van, Warren, RM, Victor, TC, Spuy, G van der, Richardson, M, Hoal-van
Helden, E (2002) Strain families of Mycobacterium tuberculosis. Trends in microbiology ,
10(4): 167–8.
Hella, J, Morrow, C, Mhimbira, F, Ginsberg, S, Chitnis, N, Gagneux, S, Mutayoba, B,
Wood, R, Fenner, L (2017) Tuberculosis transmission in public locations in Tanzania:
A novel approach to studying airborne disease transmission. The Journal of infection,
75(3): 191–197.
Hershberg, R, Lipatov, M, Small, PM, Sheffer, H, Niemann, S, Homolka, S, Roach, JC,
Kremer, K, Petrov, DA, Feldman, MW, Gagneux, S (2008) High functional diversity
in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS
biology , 6(12): e311.
8. Bibliography 125
Hess, M, Sczyrba, A, Egan, R, Kim, TW, Chokhawala, H, Schroth, G, Luo, S, Clark,
DS, Chen, F, Zhang, T, Mackie, RI, Pennacchio, LA, Tringe, SG, Visel, A, Woyke, T,
Wang, Z, Rubin, EM (2011) Metagenomic discovery of biomass-degrading genes and
genomes from cow rumen. Science, 331(6016): 463–7.
Heyckendorf, J, Andres, S, Köser, CU, Olaru, ID, Schön, T, Sturegård, E, Beckert, P,
Schleusener, V, Kohl, TA, Hillemann, D, Moradigaravand, D, Parkhill, J, Peacock, SJ,
Niemann, S, Lange, C, Merker, M (2017) What Is Resistance? Impact of Phenotypic
versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-
Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy , 62(2): 1550–1567.
Hirsh, AE, Tsolaki, AG, DeRiemer, K, Feldman, MW, Small, PM (2004) Stable association
between strains of Mycobacterium tuberculosis and their human host populations. Pro-
ceedings of the National Academy of Sciences of the United States of America, 101(14):
4871–6.
Hiza, H, Doulla, B, Sasamalo, M, Hella, J, Kamwela, L, Mhimbira, F, Reither, K, Gag-
neux, S, Jugheli, L, Fenner, L (2017) Preservation of sputum samples with cetylpyri-
dinium chloride (CPC) for tuberculosis cultures and Xpert MTB/RIF in a low-income
country. BMC infectious diseases , 17(1): 542.
Holt, KE, McAdam, P, Thai, PVK, Thuong, NTT, Ha, DTM, Lan, NN, Lan, NH, Nhu,
NTQ, Hai, HT, Ha, VTN, Thwaites, G, Edwards, DJ, Nath, AP, Pham, K, Ascher,
DB, Farrar, J, Khor, CC, Teo, YY, Inouye, M, Caws, M, Dunstan, SJ (2018) Frequent
transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection
for the EsxW Beijing variant in Vietnam. Nature genetics , 50(6): 849–856.
Houben, RMGJ, Dodd, PJ (2016) The Global Burden of Latent Tuberculosis Infection:
A Re-estimation Using Mathematical Modelling. PLoS medicine, 13(10): e1002152.
Imperial, MZ, Nahid, P, Phillips, PPJ, Davies, GR, Fielding, K, Hanna, D, Hermann, D,
Wallis, RS, Johnson, JL, Lienhardt, C, Savic, RM (2018) A patient-level pooled analysis
of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nature
medicine, 24(11): 1708–1715.
Ingen, J van, Rahim, Z, Mulder, A, Boeree, MJ, Simeone, R, Brosch, R, Soolingen, D van
(2012) Characterization ofMycobacterium orygis asM. tuberculosis complex subspecies.
Emerging infectious diseases , 18(4): 653–5.
Jong, BC de, Hill, PC, Aiken, A, Awine, T, Antonio, M, Adetifa, IM, Jackson-Sillah, DJ,
Fox, A, Deriemer, K, Gagneux, S, Borgdorff, MW, McAdam, KPWJ, Corrah, T, Small,
PM, Adegbola, RA (2008) Progression to active tuberculosis, but not transmission,
varies by Mycobacterium tuberculosis lineage in The Gambia. The Journal of infectious
diseases , 198(7): 1037–43.
126 8. Bibliography
Kamerbeek, J, Schouls, L, Kolk, A, Agterveld, M van, Soolingen, D van, Kuijper, S,
Bunschoten, A, Molhuizen, H, Shaw, R, Goyal, M, Embden, J van (1997) Simultaneous
detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and
epidemiology. Journal of clinical microbiology , 35(4): 907–14.
Kass, RE, Raftery, AE (1995) Bayes Factors. Journal of the American Statistical Associ-
ation, 90(430): 773–795.
Kato-Maeda, M, Metcalfe, JZ, Flores, L (2011) Genotyping ofMycobacterium tuberculosis :
application in epidemiologic studies. Future microbiology , 6(2): 203–16.
Kato-Maeda, M, Shanley, CA, Ackart, D, Jarlsberg, LG, Shang, S, Obregon-Henao, A,
Harton, M, Basaraba, RJ, Henao-Tamayo, M, Barrozo, JC, Rose, J, Kawamura, LM,
Coscolla, M, Fofanov, VY, Koshinsky, H, Gagneux, S, Hopewell, PC, Ordway, DJ, Orme,
IM (2012) Beijing Sublineages of Mycobacterium tuberculosis Differ in Pathogenicity in
the Guinea Pig. Clinical and Vaccine Immunology , 19(8): 1227–1237.
Kibiki, GS, Mulder, B, Dolmans, WMV, Beer, JL de, Boeree, M, Sam, N, Soolingen, D
van, Sola, C, Zanden, AGM van der (2007) M. tuberculosis genotypic diversity and
drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern
Tanzania. BMC microbiology , 7(1): 51.
Klopper, M, Warren, RM, Hayes, C, Pittius, NCG van, Streicher, EM, M??ller, B, Sirgel,
FA, Chabula-Nxiweni, M, Hoosain, E, Coetzee, G, Helden, PD van, Victor, TC, Trollip,
AP (2013) Emergence and spread of extensively and totally drug-resistant tuberculosis,
South Africa. Emerging Infectious Diseases , 19(3): 449–455.
Ko, AMS, Chen, CY, Fu, Q, Delfin, F, Li, M, Chiu, HL, Stoneking, M, Ko, YC (2014)
Early Austronesians: into and out of Taiwan. American journal of human genetics ,
94(3): 426–36.
Koboldt, DC, Zhang, Q, Larson, DE, Shen, D, McLellan, MD, Lin, L, Miller, CA, Mardis,
ER, Ding, L, Wilson, RK (2012) VarScan 2: somatic mutation and copy number alter-
ation discovery in cancer by exome sequencing. Genome research, 22(3): 568–76.
Koch, AS, Brites, D, Stucki, D, Evans, JC, Seldon, R, Heekes, A, Mulder, N, Nicol, M,
Oni, T, Mizrahi, V, Warner, DF, Parkhill, J, Gagneux, S, Martin, DP, Wilkinson, RJ
(2017) The Influence of HIV on the Evolution of Mycobacterium tuberculosis. Molecular
Biology and Evolution, 34(7): 1654–1668.
Koul, A, Arnoult, E, Lounis, N, Guillemont, J, Andries, K (2011) The challenge of new
drug discovery for tuberculosis. Nature, 469(7331): 483–490.
Kwan, CK, Ernst, JD (2011) HIV and tuberculosis: a deadly human syndemic. Clinical
microbiology reviews , 24(2): 351–76.
8. Bibliography 127
Lalor, MK, Anderson, LF, Hamblion, EL, Burkitt, A, Davidson, JA, Maguire, H, Abubakar,
I, Thomas, HL (2017) Recent household transmission of tuberculosis in England, 2010-
2012: retrospective national cohort study combining epidemiological and molecular
strain typing data. BMC medicine, 15(1): 105.
Lartillot, N, Philippe, H (2006) Computing Bayes Factors Using Thermodynamic Inte-
gration. Systematic Biology , 55(2): 195–207.
Li, H (2011) A statistical framework for SNP calling, mutation discovery, association
mapping and population genetical parameter estimation from sequencing data. Bioin-
formatics , 27(21): 2987–93.
Li, H, Durbin, R (2009) Fast and accurate short read alignment with Burrows-Wheeler
transform. Bioinformatics , 25(14): 1754–60.
Loman, NJ, Constantinidou, C, Chan, JZM, Halachev, M, Sergeant, M, Penn, CW, Robin-
son, ER, Pallen, MJ (2012) High-throughput bacterial genome sequencing: an embar-
rassment of choice, a world of opportunity. Nature reviews. Microbiology , 10(9): 599–
606.
Luo, T, Comas, I, Luo, D, Lu, B, Wu, J, Wei, L, Yang, C, Liu, Q, Gan, M, Sun, G, Shen,
X, Liu, F, Gagneux, S, Mei, J, Lan, R, Wan, K, Gao, Q (2015) Southern East Asian
origin and coexpansion of Mycobacterium tuberculosis Beijing family with Han Chi-
nese. Proceedings of the National Academy of Sciences of the United States of America,
112(26): 8136–41.
Main, P, Attenborough, R, Chelvanayagam, G, Bhatia, K, Gao, X (2001) The peopling
of New Guinea: evidence from class I human leukocyte antigen. Human biology , 73(3):
365–83.
Malla, B, Stucki, D, Borrell, S, Feldmann, J, Maharjan, B, Shrestha, B, Fenner, L, Gag-
neux, S (2012) First insights into the phylogenetic diversity of Mycobacterium tubercu-
losis in Nepal. PloS one, 7(12): e52297.
Manson, AL, Cohen, KA, Abeel, T, Desjardins, CA, Armstrong, DT, Barry Iii, CE,
Brand, J, TBResist Global Genome Consortium, Chapman, SB, Cho, SN, Gabrielian,
A, Gomez, J, Jodals, AM, Joloba, M, Jureen, P, Lee, JS, Malinga, L, Maiga, M, Norden-
berg, D, Noroc, E, Romancenco, E, Salazar, A, Ssengooba, W, Velayati, AA, Winglee,
K, Zalutskaya, A, Via, LE, Cassell, GH, Dorman, SE, Ellner, J, Farnia, P, Galagan,
JE, Rosenthal, A, Crudu, V, Homorodean, D, Hsueh, PR, Narayanan, S, Pym, AS,
Skrahina, A, Swaminathan, S, Walt, M der, Alland, D, Bishai, WR, Cohen, T, Hoffner,
S, Birren, BW, Earl, AM (2017) Genomic analysis of globally diverse Mycobacterium
tuberculosis strains provides insights into the emergence and spread of multidrug resis-
tance. Nature genetics , 49 395–402.
128 8. Bibliography
Mbugi, EV, Katale, BZ, Streicher, EM, Keyyu, JD, Kendall, SL, Dockrell, HM, Michel,
AL, Rweyemamu, MM, Warren, RM, Matee, MI, Helden, PD van, Couvin, D, Rastogi,
N (2016) Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles
in Tanzania and Other African Countries. PloS one, 11(5): e0154571.
Mbugi, EV, Katale, BZ, Siame, KK, Keyyu, JD, Kendall, SL, Dockrell, HM, Streicher,
EM, Michel, AL, Rweyemamu, MM, Warren, RM, Matee, MI, Helden, PD van (2015)
Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in
the Serengeti ecosystem in Tanzania. Tuberculosis , 95(2): 170–8.
McEvoy, CRE, Falmer, AA, Gey van Pittius, NC, Victor, TC, Helden, PD van, Warren,
RM (2007) The role of IS6110 in the evolution of Mycobacterium tuberculosis. Tubercu-
losis , 87(5): 393–404.
Merker, M, Blin, C, Mona, S, Duforet-Frebourg, N, Lecher, S, Willery, E, Blum, MGB,
Rüsch-Gerdes, S, Mokrousov, I, Aleksic, E, Allix-Béguec, C, Antierens, A, Augustynowicz-
Kopeć, E, Ballif, M, Barletta, F, Beck, HP, Barry, CE, Bonnet, M, Borroni, E, Campos-
Herrero, I, Cirillo, D, Cox, H, Crowe, S, Crudu, V, Diel, R, Drobniewski, F, Fauville-
Dufaux, M, Gagneux, S, Ghebremichael, S, Hanekom, M, Hoffner, S, Jiao, Ww, Kalon,
S, Kohl, TA, Kontsevaya, I, Lillebæk, T, Maeda, S, Nikolayevskyy, V, Rasmussen, M,
Rastogi, N, Samper, S, Sanchez-Padilla, E, Savic, B, Shamputa, IC, Shen, A, Sng,
LH, Stakenas, P, Toit, K, Varaine, F, Vukovic, D, Wahl, C, Warren, R, Supply, P, Nie-
mann, S, Wirth, T (2015) Evolutionary history and global spread of the Mycobacterium
tuberculosis Beijing lineage. Nature genetics , 47(3): 242–9.
Mfinanga, SGM, Warren, RM, Kazwala, R, Kahwa, A, Kazimoto, T, Kimaro, G, Mfaume,
S, Chonde, T, Ngadaya, E, Egwaga, S, Streicher, EM, Van Pittius, GNC, Morkve Odd,
M, Cleaveland, S (2014) Genetic profile of Mycobacterium tuberculosis and treatment
outcomes in human pulmonary tuberculosis in Tanzania. en. Tanzania journal of health
research, 16(2): 58–69.
Mhimbira, F, Hella, J, Said, K, Kamwela, L, Sasamalo, M, Maroa, T, Chiryamkubi, M,
Mhalu, G, Schindler, C, Reither, K, Knopp, S, Utzinger, J, Gagneux, S, Fenner, L
(2017) Prevalence and clinical relevance of helminth co-infections among tuberculosis
patients in urban Tanzania. PLoS neglected tropical diseases , 11(2): e0005342.
Migliori, GB, De Iaco, G, Besozzi, G, Centis, R, Cirillo, DM (2007) First tuberculosis cases
in Italy resistant to all tested drugs. eng. Euro surveillance : European communicable
disease bulletin, 12(5): E070517.1.
Miotto, P, Cabibbe, AM, Borroni, E, Degano, M, Cirillo, DM (2018) Role of Disputed
Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture
8. Bibliography 129
Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis. Journal of
Clinical Microbiology , 56(5): e01599–17.
MoHSW (2013) First tuberculosis prevalence survey in the United Republic of Tanzania.
Monot, M, Honoré, N, Garnier, T, Araoz, R, Coppée, JY, Lacroix, C, Sow, S, Spencer,
JS, Truman, RW, Williams, DL, Gelber, R, Virmond, M, Flageul, B, Cho, SN, Ji, B,
Paniz-Mondolfi, A, Convit, J, Young, S, Fine, PE, Rasolofo, V, Brennan, PJ, Cole, ST
(2005) On the origin of leprosy. Science, 308(5724): 1040–2.
Musser, JM, Amin, A, Ramaswamy, S (2000) Negligible genetic diversity ofMycobacterium
tuberculosis host immune system protein targets: evidence of limited selective pressure.
Genetics , 155(1): 7–16.
Nagu, TJ, Aboud, S, Mwiru, R, Matee, M, Fawzi, W, Mugusi, F (2015) Multi drug
and other forms of drug resistant tuberculosis are uncommon among treatment naïve
tuberculosis patients in Tanzania. PloS one, 10(4): e0118601.
Nathanson, E, Lambregts-van Weezenbeek, C, Rich, ML, Gupta, R, Bayona, J, Blöndal,
K, Caminero, JA, Cegielski, JP, Danilovits, M, Espinal, MA, Hollo, V, Jaramillo, E,
Leimane, V, Mitnick, CD, Mukherjee, JS, Nunn, P, Pasechnikov, A, Tupasi, T, Wells,
C, Raviglione, MC (2006) Multidrug-resistant tuberculosis management in resource-
limited settings. Emerging infectious diseases , 12(9): 1389–97.
Nava-Aguilera, E, López-Vidal, Y, Harris, E, Morales-Pérez, A, Mitchell, S, Flores-Moreno,
M, Villegas-Arrizón, A, Legorreta-Soberanis, J, Ledogar, R, Andersson, N (2011) Clus-
tering of Mycobacterium tuberculosis cases in Acapulco: Spoligotyping and risk factors.
Clinical & developmental immunology , 2011 408375.
Nhamoyebonde, S, Leslie, A (2014) Biological differences between the sexes and suscep-
tibility to tuberculosis. The Journal of infectious diseases , 209(3): S100–S106.
NTLP (2013) Annual Report 2013, 1689–1699.
NTLP (2016) Annual Report 2016, 1–48.
O’Neill, MB, Shockey, A, Zarley, A, Aylward, W, Eldholm, V, Kitchen, A, Pepperell, CS
(2019) Lineage specific histories of Mycobacterium tuberculosis dispersal in Africa and
Eurasia. Molecular ecology , 28(13): 3241–3256.
Paradis, E, Claude, J, Strimmer, K (2004) APE: Analyses of Phylogenetics and Evolution
in R language. Bioinformatics , 20(2): 289–290.
Parsons, SDC, Drewe, JA, Gey van Pittius, NC, Warren, RM, Helden, PD van (2013)
Novel cause of tuberculosis in meerkats, South Africa. Emerging infectious diseases ,
19(12): 2004–7.
Phelan, J, Coll, F, McNerney, R, Ascher, DB, Pires, DEV, Furnham, N, Coeck, N, Hill-
Cawthorne, GA, Nair, MB, Mallard, K, Ramsay, A, Campino, S, Hibberd, ML, Pain,
130 8. Bibliography
A, Rigouts, L, Clark, TG (2016) Mycobacterium tuberculosis whole genome sequencing
and protein structure modelling provides insights into anti-tuberculosis drug resistance.
BMC Medicine, 14(1): 31.
Portevin, D, Gagneux, S, Comas, I, Young, D (2011) Human macrophage responses to
clinical isolates from the Mycobacterium tuberculosis complex discriminate between an-
cient and modern lineages. PLoS pathogens , 7(3): e1001307.
Portevin, D, Sukumar, S, Coscolla, M, Shui, G, Li, B, Guan, XL, Bendt, AK, Young, D,
Gagneux, S, Wenk, MR (2014) Lipidomics and genomics of Mycobacterium tuberculosis
reveal lineage-specific trends in mycolic acid biosynthesis. MicrobiologyOpen, 3(6): 823–
35.
Qin, J, Li, R, Raes, J, Arumugam, M, Burgdorf, KS, Manichanh, C, Nielsen, T, Pons, N,
Levenez, F, Yamada, T, Mende, DR, Li, J, Xu, J, Li, S, Li, D, Cao, J, Wang, B, Liang,
H, Zheng, H, Xie, Y, Tap, J, Lepage, P, Bertalan, M, Batto, JM, Hansen, T, Le Paslier,
D, Linneberg, A, Nielsen, HB, Pelletier, E, Renault, P, Sicheritz-Ponten, T, Turner, K,
Zhu, H, Yu, C, Li, S, Jian, M, Zhou, Y, Li, Y, Zhang, X, Li, S, Qin, N, Yang, H, Wang, J,
Brunak, S, Doré, J, Guarner, F, Kristiansen, K, Pedersen, O, Parkhill, J, Weissenbach,
J, MetaHIT Consortium, Bork, P, Ehrlich, SD, Wang, J (2010) A human gut microbial
gene catalogue established by metagenomic sequencing. Nature, 464(7285): 59–65.
R Core Team (2018) R: A Language and Environment for Statistical Computing. R Foun-
dation for Statistical Computing, Vienna.
Rambaut, A, Drummond, AJ, Xie, D, Baele, G, Suchard, MA (2018) Posterior Summa-
rization in Bayesian Phylogenetics Using Tracer 1.7. Systematic Biology , 67(5): 901–
904.
Ramsden, C, Melo, FL, Figueiredo, LM, Holmes, EC, Zanotto, PM (2008) High Rates of
Molecular Evolution in Hantaviruses. Molecular Biology and Evolution, 25(7): 1488–
1492.
Reed, MB, Domenech, P, Manca, C, Su, H, Barczak, AK, Kreiswirth, BN, Kaplan, G,
Barry, CE (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the
innate immune response. Nature, 431(7004): 84–7.
Reed, MB, Gagneux, S, Deriemer, K, Small, PM, Barry, CE (2007) The W-Beijing lineage
of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy
regulon constitutively upregulated. Journal of bacteriology , 189(7): 2583–9.
Reed, MB, Pichler, VK, McIntosh, F, Mattia, A, Fallow, A, Masala, S, Domenech, P,
Zwerling, A, Thibert, L, Menzies, D, Schwartzman, K, Behr, MA (2009) Major My-
cobacterium tuberculosis lineages associate with patient country of origin. Journal of
clinical microbiology , 47(4): 1119–28.
8. Bibliography 131
Reich, D, Patterson, N, Kircher, M, Delfin, F, Nandineni, MR, Pugach, I, Ko, AMS, Ko,
YC, Jinam, TA, Phipps, ME, Saitou, N, Wollstein, A, Kayser, M, Pääbo, S, Stoneking,
M (2011) Denisova admixture and the first modern human dispersals into Southeast
Asia and Oceania. American journal of human genetics , 89(4): 516–28.
Revell, LJ (2012) phytools: an R package for phylogenetic comparative biology (and other
things). Methods in Ecology and Evolution, 3(2): 217–223.
Rhines, AS (2013) The role of sex differences in the prevalence and transmission of tu-
berculosis. Tuberculosis , 93(1): 104–7.
Rieder, HL (1999) Epidemiologic Basis of Tuberculosis Control First edition 1999. Tech.
rep.
Rieux, A, Balloux, F (2016) Inferences from tip-calibrated phylogenies: a review and a
practical guide. Molecular Ecology , 25(9): 1911–1924.
Rieux, A, Khatchikian, CE (2017) TIPDATINGBEAST: an R package to assist the imple-
mentation of phylogenetic tip-dating tests using BEAST. Molecular Ecology Resources ,
17(4): 608–613.
Roetzer, A, Diel, R, Kohl, TA, Rückert, C, Nübel, U, Blom, J, Wirth, T, Jaenicke, S,
Schuback, S, Rüsch-Gerdes, S, Supply, P, Kalinowski, J, Niemann, S (2013) Whole
genome sequencing versus traditional genotyping for investigation of a Mycobacterium
tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS medicine,
10(2): e1001387.
Rose, G, Cortes, T, Comas, I, Coscolla, M, Gagneux, S, Young, DB (2013) Mapping of
genotype-phenotype diversity among clinical isolates of Mycobacterium tuberculosis by
sequence-based transcriptional profiling. Genome biology and evolution, 5(10): 1849–62.
Rueda, J, Realpe, T, Mejia, GI, Zapata, E, Rozo, JC, Ferro, BE, Robledo, J (2015) Geno-
typic Analysis of Genes Associated with Independent Resistance and Cross-Resistance
to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. Antimi-
crobial agents and chemotherapy , 59(12): 7805–10.
Rutaihwa, LK, Menardo, F, Stucki, D, Gygli, SM, Ley, SD, Malla, B, Feldmann, J, Borrell,
S, Beisel, C, Middelkoop, K, Carter, EJ, Diero, L, Ballif, M, Jugheli, L, Reither, K,
Fenner, L, Brites, D, Gagneux, S (2019a) Multiple Introductions of Mycobacterium
tuberculosis Lineage 2–Beijing Into Africa Over Centuries. Frontiers in Ecology and
Evolution, 7 112.
Rutaihwa, LK, Sasamalo, M, Jaleco, A, Hella, J, Kingazi, A, Kamwela, L, Kingalu, A,
Malewo, B, Shirima, R, Doetsch, A, Feldmann, J, Reinhard, M, Borrell, S, Brites, D,
Reither, K, Doulla, B, Fenner, L, Gagneux, S (2019b) Insights into the genetic diversity
of Mycobacterium tuberculosis in Tanzania. PloS one, 14(4): e0206334.
132 8. Bibliography
Said, K, Hella, J, Mhalu, G, Chiryankubi, M, Masika, E, Maroa, T, Mhimbira, F, Ka-
palata, N, Fenner, L (2017) Diagnostic delay and associated factors among patients with
pulmonary tuberculosis in Dar es Salaam, Tanzania. Infectious diseases of poverty , 6(1):
64.
Shitikov, E, Kolchenko, S, Mokrousov, I, Bespyatykh, J, Ischenko, D, Ilina, E, Govorun,
V (2017) Evolutionary pathway analysis and unified classification of East Asian lineage
of Mycobacterium tuberculosis. Scientific Reports , 7(1): 9227.
Sikalengo, G, Hella, J, Mhimbira, F, Rutaihwa, LK, Bani, F, Ndege, R, Sasamalo, M,
Kamwela, L, Said, K, Mhalu, G, Mlacha, Y, Hatz, C, Knopp, S, Gagneux, S, Reither,
K, Utzinger, J, Tanner, M, Letang, E, Weisser, M, Fenner, L (2018) Distinct clinical
characteristics and helminth co-infections in adult tuberculosis patients from urban
compared to rural Tanzania. Infectious diseases of poverty , 7(1): 24.
Singh, UB, Suresh, N, Bhanu, NV, Arora, J, Pant, H, Sinha, S, Aggarwal, RC, Singh, S,
Pande, JN, Sola, C, Rastogi, N, Seth, P (2004) Predominant tuberculosis spoligotypes,
Delhi, India. Emerging infectious diseases , 10(6): 1138–42.
Soolingen, D van, Hoogenboezem, T, Haas, PE de, Hermans, PW, Koedam, MA, Teppema,
KS, Brennan, PJ, Besra, GS, Portaels, F, Top, J, Schouls, LM, Embden, JD van (1997)
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: charac-
terization of an exceptional isolate from Africa. eng. International journal of systematic
bacteriology , 47(4): 1236–45.
Spuy, GD van der, Kremer, K, Ndabambi, SL, Beyers, N, Dunbar, R, Marais, BJ, Helden,
PD van, Warren, RM (2009) Changing Mycobacterium tuberculosis population high-
lights clade-specific pathogenic characteristics. Tuberculosis , 89(2): 120–5.
Spuy, GD van der, Warren, RM, Richardson, M, Beyers, N, Behr, MA, Helden, PD van
(2003) Use of genetic distance as a measure of ongoing transmission of Mycobacterium
tuberculosis. Journal of clinical microbiology , 41(12): 5640–4.
Sreevatsan, S, Pan, X, Stockbauer, KE, Connell, ND, Kreiswirth, BN, Whittam, TS,
Musser, JM (1997) Restricted structural gene polymorphism in the Mycobacterium
tuberculosis complex indicates evolutionarily recent global dissemination. Proceedings
of the National Academy of Sciences of the United States of America, 94(18): 9869–74.
Staden, R (1996) The Staden sequence analysis package. Molecular biotechnology , 5(3):
233–41.
Stamatakis, A (2006) RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses
with thousands of taxa and mixed models. Bioinformatics , 22(21): 2688–90.
Stavrum, R, PrayGod, G, Range, N, Faurholt-Jepsen, D, Jeremiah, K, Faurholt-Jepsen,
M, Krarup, H, Aabye, MG, Changalucha, J, Friis, H, Andersen, AB, Grewal, HMS
8. Bibliography 133
(2014) Increased level of acute phase reactants in patients infected with modern My-
cobacterium tuberculosis genotypes in Mwanza, Tanzania. BMC infectious diseases ,
14(1): 309.
Steiner, A, Hella, J, Grüninger, S, Mhalu, G, Mhimbira, F, Cercamondi, CI, Doulla, B,
Maire, N, Fenner, L (2016) Managing research and surveillance projects in real-time
with a novel open-source eManagement tool designed for under-resourced countries.
Journal of the American Medical Informatics Association : JAMIA, 23(5): 916–23.
Steiner, A, Stucki, D, Coscolla, M, Borrell, S, Gagneux, S (2014) KvarQ: targeted and
direct variant calling from fastq reads of bacterial genomes. BMC Genomics , 15(1):
881.
Stucki, D, Ballif, M, Bodmer, T, Coscolla, M, Maurer, AM, Droz, S, Butz, C, Bor-
rell, S, Längle, C, Feldmann, J, Furrer, H, Mordasini, C, Helbling, P, Rieder, HL,
Egger, M, Gagneux, S, Fenner, L (2015) Tracking a Tuberculosis Outbreak Over 21
Years: Strain-Specific Single-Nucleotide Polymorphism Typing Combined With Tar-
geted Whole-Genome Sequencing. The Journal of Infectious Diseases , 211(8): 1306–
1316.
Stucki, D, Brites, D, Jeljeli, L, Coscolla, M, Liu, Q, Trauner, A, Fenner, L, Rutaihwa, L,
Borrell, S, Luo, T, Gao, Q, Kato-Maeda, M, Ballif, M, Egger, M, Macedo, R, Mar-
dassi, H, Moreno, M, Tudo Vilanova, G, Fyfe, J, Globan, M, Thomas, J, Jamieson, F,
Guthrie, JL, Asante-Poku, A, Yeboah-Manu, D, Wampande, E, Ssengooba, W, Joloba,
M, Henry Boom, W, Basu, I, Bower, J, Saraiva, M, Vaconcellos, SEG, Suffys, P, Koch,
A, Wilkinson, R, Gail-Bekker, L, Malla, B, Ley, SD, Beck, HP, Jong, BC de, Toit, K,
Sanchez-Padilla, E, Bonnet, M, Gil-Brusola, A, Frank, M, Penlap Beng, VN, Eisenach,
K, Alani, I, Wangui Ndung’u, P, Revathi, G, Gehre, F, Akter, S, Ntoumi, F, Stewart-
Isherwood, L, Ntinginya, NE, Rachow, A, Hoelscher, M, Cirillo, DM, Skenders, G,
Hoffner, S, Bakonyte, D, Stakenas, P, Diel, R, Crudu, V, Moldovan, O, Al-Hajoj, S,
Otero, L, Barletta, F, Jane Carter, E, Diero, L, Supply, P, Comas, I, Niemann, S, Gag-
neux, S (2016) Mycobacterium tuberculosis lineage 4 comprises globally distributed and
geographically restricted sublineages. Nature genetics , 48(12): 1535–1543.
Stucki, D, Malla, B, Hostettler, S, Huna, T, Feldmann, J, Yeboah-Manu, D, Borrell,
S, Fenner, L, Comas, I, Coscollà, M, Gagneux, S (2012) Two new rapid SNP-typing
methods for classifying Mycobacterium tuberculosis complex into the main phylogenetic
lineages. PloS one, 7(7): e41253.
Supply, P, Marceau, M, Mangenot, S, Roche, D, Rouanet, C, Khanna, V, Majlessi, L,
Criscuolo, A, Tap, J, Pawlik, A, Fiette, L, Orgeur, M, Fabre, M, Parmentier, C, Frigui,
W, Simeone, R, Boritsch, EC, Debrie, AS, Willery, E, Walker, D, Quail, MA, Ma, L,
134 8. Bibliography
Bouchier, C, Salvignol, G, Sayes, F, Cascioferro, A, Seemann, T, Barbe, V, Locht, C,
Gutierrez, MC, Leclerc, C, Bentley, SD, Stinear, TP, Brisse, S, Médigue, C, Parkhill, J,
Cruveiller, S, Brosch, R (2013) Genomic analysis of smooth tubercle bacilli provides
insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nature ge-
netics , 45(2): 172–9.
Supply, P, Mazars, E, Lesjean, S, Vincent, V, Gicquel, B, Locht, C (2000) Variable human
minisatellite-like regions in the Mycobacterium tuberculosis genome. Molecular micro-
biology , 36(3): 762–71.
Suzuki, R, Shimodaira, H (2006) Pvclust: an R package for assessing the uncertainty in
hierarchical clustering. Bioinformatics , 22(12): 1540–1542.
Trunz, BB, Fine, P, Dye, C (2006) Effect of BCG vaccination on childhood tuberculous
meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-
effectiveness. Lancet , 367(9517): 1173–80.
UNESCO (1992) General history of Africa-V Africa from the Sixteenth to the Eighteenth
Century. Tech. rep.
Vos, J (2012) From Africa to Brazil: Culture, Identity, and an Atlantic Slave Trade, 1600-
1830. By Walter Hawthorne (New York: Cambridge University Press, 2010. xxi plus
259 pp. $25.99). Journal of Social History , 46(1): 261–264.
Walker, TM, Ip, CLC, Harrell, RH, Evans, JT, Kapatai, G, Dedicoat, MJ, Eyre, DW,
Wilson, DJ, Hawkey, PM, Crook, DW, Parkhill, J, Harris, D, Walker, AS, Bowden,
R, Monk, P, Smith, EG, Peto, TEA (2013) Whole-genome sequencing to delineate
Mycobacterium tuberculosis outbreaks: a retrospective observational study. The Lancet
Infectious diseases , 13(2): 137–46.
Walker, TM, Kohl, TA, Omar, SV, Hedge, J, Del Ojo Elias, C, Bradley, P, Iqbal, Z,
Feuerriegel, S, Niehaus, KE, Wilson, DJ, Clifton, DA, Kapatai, G, Ip, CLC, Bowden,
R, Drobniewski, FA, Allix-Béguec, C, Gaudin, C, Parkhill, J, Diel, R, Supply, P, Crook,
DW, Smith, EG, Walker, AS, Ismail, N, Niemann, S, Peto, TEA (2015) Whole-genome
sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resis-
tance: a retrospective cohort study. The Lancet Infectious Diseases , 15(10): 1193–1202.
Wampande, EM, Mupere, E, Debanne, SM, Asiimwe, BB, Nsereko, M, Mayanja, H, Eise-
nach, K, Kaplan, G, Boom, HW, Gagneux, S, Joloba, ML (2013) Long-term dominance
of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not as-
sociated with cavitary disease. BMC infectious diseases , 13(1): 484.
Wejse, C, Gustafson, P, Nielsen, J, Gomes, VF, Aaby, P, Andersen, PL, Sodemann,
M (2008) TBscore: Signs and symptoms from tuberculosis patients in a low-resource
8. Bibliography 135
setting have predictive value and may be used to assess clinical course. Scandinavian
journal of infectious diseases , 40(2): 111–20.
Weyer, K, Carai, S, Nunn, P (2011) Viewpoint TB diagnostics: what does the world really
need? The Journal of infectious diseases , 204(4): S1196–202.
WHO (2017) Global tuberculosis report. Geneva: World Health Organization.
WHO (2018) Global tuberculosis report. Geneva: World Health Organization.
Wirth, T, Hildebrand, F, Allix-Béguec, C, Wölbeling, F, Kubica, T, Kremer, K, Soolin-
gen, D van, Rüsch-Gerdes, S, Locht, C, Brisse, S, Meyer, A, Supply, P, Niemann, S
(2008) Origin, spread and demography of the Mycobacterium tuberculosis complex.
PLoS pathogens , 4(9): e1000160.
Woolhouse, MEJ, Webster, JP, Domingo, E, Charlesworth, B, Levin, BR (2002) Biological
and biomedical implications of the co-evolution of pathogens and their hosts. Nature
genetics , 32(4): 569–77.
Yang, C, Luo, T, Sun, G, Qiao, K, Sun, G, DeRiemer, K, Mei, J, Gao, Q (2012) Mycobac-
terium tuberculosis Beijing strains favor transmission but not drug resistance in China.
Clinical infectious diseases , 55(9): 1179–87.
Yates, TA, Abubakar, I, Tanser, F (2015) HIV infection and the transmission of tubercu-
losis. The Journal of infectious diseases , 211(9): 1510.
Yates, TA, Khan, PY, Knight, GM, Taylor, JG, McHugh, TD, Lipman, M, White, RG,
Cohen, T, Cobelens, FG, Wood, R, Moore, DAJ, Abubakar, I (2016) The transmission
of Mycobacterium tuberculosis in high burden settings. The Lancet. Infectious diseases ,
16(2): 227–38.
Yen, S, Bower, JE, Freeman, JT, Basu, I, O’Toole, RF (2013) Phylogenetic lineages of
tuberculosis isolates in New Zealand and their association with patient demographics.
The international journal of tuberculosis and lung disease, 17(7): 892–7.
Young, DB, Perkins, MD, Duncan, K, Barry, CE (2008) Confronting the scientific ob-
stacles to global control of tuberculosis. The Journal of clinical investigation, 118(4):
1255–65.
Yu, Y, Harris, A, Blair, C, He, X (2015) RASP (Reconstruct Ancestral State in Phylo-
genies): A tool for historical biogeography. Molecular Phylogenetics and Evolution, 87
46–49.
Zhang, H, Li, D, Zhao, L, Fleming, J, Lin, N, Wang, T, Liu, Z, Li, C, Galwey, N, Deng, J,
Zhou, Y, Zhu, Y, Gao, Y, Wang, T, Wang, S, Huang, Y, Wang, M, Zhong, Q, Zhou, L,
Chen, T, Zhou, J, Yang, R, Zhu, G, Hang, H, Zhang, J, Li, F, Wan, K, Wang, J, Zhang,
XE, Bi, L (2013) Genome sequencing of 161 Mycobacterium tuberculosis isolates from
136 8. Bibliography
China identifies genes and intergenic regions associated with drug resistance. Nature
genetics , 45(10): 1255–1260.
List of Figures
1.1. Estimated TB incidence rates in 2017 by WHO . . . . . . . . . . . . . . . . 2
1.2. Countries in the three high burden lists for TB, TB/HIV and MDR-TB . . 3
1.3. Global phylogeny and distribution of the human-adapted Mtb complex . . 5
3.1. MTBC lineages in Tanzania . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
4.1. Regional tuberculosis (TB) notification rates in Tanzania . . . . . . . . . . . 32
4.2. Study population flow chart for Temeke . . . . . . . . . . . . . . . . . . . . . 34
4.3. Study population flow chart for Ifakara . . . . . . . . . . . . . . . . . . . . . 35
4.4. Study population compared to total patients recruited in Temeke . . . . . . 36
4.5. Study population compared to total patients recruited in Ifakara . . . . . . 37
4.6. Samples genotyped among study and total patients recruited at Temeke . . 39
4.7. Samples genotyped among study and total patients recruited at Ifakara . . 40
4.8. Risk factors among TB patients in Temeke . . . . . . . . . . . . . . . . . . . 44
4.9. Spatial distribution of TB patients in Temeke . . . . . . . . . . . . . . . . . . 45
4.10. Frequency distribution of Mtb lineages in Temeke . . . . . . . . . . . . . . . 46
4.11. Frequency distribution of Mtb lineages across recruitment years . . . . . . . 47
4.12. Age distribution of TB patients by infecting Mtb lineage in Temeke . . . . 49
4.13. Mean severity TB scores for each score parameter across Mtb lineages . . . 50
4.14. Spatial distribution of TB patients by infecting Mtb lineage and HIV status 51
4.16. Maximum likelihood phylogeny of 515 Mtb strains in Temeke . . . . . . . . 53
4.17. Transmission clusters based on a 5-SNP threshold . . . . . . . . . . . . . . . 57
4.18. Maximum likelihood phylogeny of Mtb strains illustrating clustering . . . . 58
4.19. Risk factors among TB patients in Ifakara . . . . . . . . . . . . . . . . . . . . 60
4.20. Frequency distribution of Mtb lineages in Ifakara . . . . . . . . . . . . . . . 61
5.1. Geographical distribution of Lineage 1 and 3 . . . . . . . . . . . . . . . . . . 72
5.2. Lineage 1 substructure based on 50 WGS Mtb strains . . . . . . . . . . . . . 73
5.3. Lineage 3 substructure based on 42 WGS Mtb strains . . . . . . . . . . . . . 74
5.4. Whole-genome phylogenetic tree of 1,667 Lineage 1 strains . . . . . . . . . . 79
138 List of Figures
5.5. Whole-genome phylogenetic tree of 2,104 Lineage 3 strains . . . . . . . . . . 80
6.1. Global phylogeny and geographical distribution of Lineage 2 strains . . . . 97
6.2. Frequency of Lineage 2 sub-lineages across seven geographical regions . . . 98
6.3. Genetic diversity of Lineage 2 strains within geographical regions . . . . . . 99
6.4. Introductions of Lineage 2 strains to Africa . . . . . . . . . . . . . . . . . . . 100
6.5. Estimated time in median ages for the introductions of African L2–Beijing 103
6.6. Drug resistance profiles for Lineage 2 strains in seven geographical regions 104
A.1. Flowchart illustrating estimated notified TB cases in 2012 and 2013 . . . . 142
A.2. Patients’ data available for the study . . . . . . . . . . . . . . . . . . . . . . . 143
A.3. MTBC lineage proportions in Tanzania . . . . . . . . . . . . . . . . . . . . . 144
A.4. Flowchart of genotyped strains for rpoB mutations . . . . . . . . . . . . . . 145
A.5. Patients’ age distribution across MTBC lineages . . . . . . . . . . . . . . . . 146
A.6. Spoligotype patterns of a subset of MTBC clinical strains in Tanzania. . . 147
B.1. Flow chart for WGS Lineage 2 dataset selection . . . . . . . . . . . . . . . . 153
B.2. Tip randomization test on clock rate . . . . . . . . . . . . . . . . . . . . . . . 154
B.3. Tip randomization test on rate mean . . . . . . . . . . . . . . . . . . . . . . . 155
B.4. Dated phylogeny of 308 Lineage 2–Beijing strains . . . . . . . . . . . . . . . 156
B.5. Ancestral reconstruction of 422 Lineage 2–Beijing strains . . . . . . . . . . . 157
B.6. Estimated most likely origins of Lineage 2-Beijing in Eastern Africa . . . . 158
B.7. Estimated most likely origins of Lineage 2-Beijing in Southern Africa . . . 159
B.8. Temporal distribution of 308 Lineage 2 samples with isolation dates . . . . 160
B.9. Phylogenetic tree of 781 Lineage 2 samples and isolation date information 161
B.10.Lineage 2 sample proportion with information on isolation dates . . . . . . 162
B.11.Pairwise SNP distance of Lineage 2 strains linked to introductions into
Eastern Africa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
B.12.Pairwise SNP distance of Lineage 2 strains linked to introductions to and
dispersal in Africa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
B.13.Pairwise SNP distance of Lineage 2 strains linked to introductions into
Southern Africa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
B.14.Phylogeny of the 781 Lineage 2 strains indicating drug resistance status . . 166
List of Tables
3.1. Clinical and demographic characteristics of the TB cases . . . . . . . . . . . 18
3.2. MTBC lineage distribution across regions in Tanzania . . . . . . . . . . . . 19
3.3. Frequency distribution of MTBC lineages across patients’ characteristics . 21
3.4. Associations of patients’ characteristics with MTBC lineages . . . . . . . . 22
3.5. Non-synonymous mutations on the rpoB gene among retreatment cases . . 24
4.1. Socio-demographic and clinical characteristics of TB patients in Temeke . . 42
4.2. Patients’ characteristics by infecting Mtb lineage in Temeke . . . . . . . . . 48
4.3. Frequency of (any) drug resistance mutation across Mtb lineages . . . . . . 55
4.4. Drug resistance mutations among Mtb strains . . . . . . . . . . . . . . . . . 55
4.5. Proportion of clustered and non-clustered Mtb strains in Temeke . . . . . . 56
4.6. Socio-demographic and clinical characteristics of TB patients in Ifakara . . 59
4.7. Patients’ characteristics by infecting Mtb lineage in Ifakara . . . . . . . . . 63
6.1. Model selection based on path sampling Log-Marginal Likelihood . . . . . . 101
A.1. Sex distribution across the age groups . . . . . . . . . . . . . . . . . . . . . . 143
A.2. Mutations detected in the rpoB gene . . . . . . . . . . . . . . . . . . . . . . . 146
A.3. Distribution of rpoB mutations across the four Mtb lineages . . . . . . . . . 148
B.1. Drug resistance status of Lineage 2 samples across the seven geographical
regions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
B.2. Lineage 2 sublineage proportions across seven geographical regions. . . . . 167
B.3. Estimates for time to the MRCA of the African Lineage 2-Beijing . . . . . 167
140 List of Tables

142 A. Supplementary Chapter 3
A. Supplementary Chapter 3
 
Notified TB cases 2012-2013 
n = 129,624 
Retreatment cases 
n = 5, 546 
New cases 
n = 124,078 
Sputum received at 
CTRL 
n = 11,023 
Sputum processed 
for culture 
n = 9, 475 
  Culture negative 
n = 4, 252 
 Culture positive 
n = 4, 929 
  Contaminated culture 




n = 1, 548 
 Culture retrieved 
n = 2,080 
Unique Study 
Population 
n = 2,039 
Figure A.1.: Flowchart illustrating estimated notified TB cases in 2012 and 2013 (dashed lines)
and the study population (solid line)
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Figure A.2.: Patients’ data included in the study. Proportion of observed and missing data for
the variables included in the study.
Table A.1.: Sex distribution across the age groups
Age group Sex Total
F M
Child age (<15) 82 (42.5) 111 (57.5) 193
Young age (15 - 24) 208 (35.9) 372 (64.1) 580
Early adult (25 - 44) 290 (30.9) 647 (69.1) 937
Late adult (45 – 64) 46 (23.5) 150 (76.5) 196
Old age (>65) 13 (27.1) 35 (72.9) 48
Total 639 (32.7) 1315 (67.3) 1954
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Figure A.3.: MTBC lineage proportions. Distribution of MTBC lineages across different regions
of Tanzania. Size of the circle is proportional to the number of isolates analyzed
from the regions. MTBC lineage proportions.
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rpoB PCR 
n = 144
  No mutation 




n = 17 
Retreatment Cases 







Figure A.4.: Flowchart of genotyped strains for rpoB mutations. A subset of MTBC strains from
retreatment cases included for rpoB drug resistance genotyping.
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Figure A.5.: Patients’ age distribution across MTBC lineages. The age distributions of TB pa-
tients grouped by infecting MTBC lineage
Table A.2.: Mutations detected in the rpoB gene.
Patient Lineage rpoB mutation Amino acid change
315 L2 A1198G;C1349T T400A;S450L
446 L3 C1386T No change
470 L4 G1683A No change
620 L4 A1334T H445L
626 L4 G1333C H445D
718 L2 C1333T H445Y
719 L4 G1683A No change
720 L2 C1349T S450L
1649 L3 T1289C L430P
1816 L2 C1349T S450L
1822 L3 C1333T H445Y
1834 L2 C1349T S450L
1843 L3 C1349T S450L
1927 L4 C1294G;A1442G;G1683A Q432E;E481A; No change
1949 L4 C1333T H445Y
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Lineage Spoligotype pattern (spacer 1-43) SIT Spoligoytpe name
1 2 ■■■■■■■■■■■□□□□□□□□□□□□□■■■■□□□□■□■■□■■■■■■ 924 EAI5 
1 10 ■□□□□□□□□□□□□■■■■■■■■■■■■■■■□□□□■□■■■■■■■■■ 8 EAI5 
1 1 ■□□■■■■■■■■■■■■■■■■■■■■■■■■■□□□□■□■■■■■□□□□ Orphan Unknown 
1 1 ■□□□□□□□□□□□□■■■■■■■■■■■■■■■□□□□■□■■■■■■■□■ 2593 Unknown 
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1 1 ■□□■■■■■■■■□□□□■■■■■■■■■■■■■□□□□■□■■■■■■■■■ Orphan Unknown 
1 1 ■■■■■■■■■■■■■■□■■■■■■■□□■■□□□□■■□□■■■■■■■■■ Orphan Unknown 
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Figure A.6.: Spoligotype patterns of a subset of MTBC clinical strains.
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Table A.3.: Distribution of rpoB mutations across the four M. tuberculosis lineages
lineage rpoB mutation Total
no yes
L1 7 (100) 0 (0) 7
L2 17 (77.3) 5 (22.7) 22
L3 51 (94.4) 3 (5.6) 54
L4 39 (90.7) 4 (9.3) 43
Total 114 12 126
B. Supplementary Chapter 6
Multiple Introductions of Mycobacterium tuberculosis Lineage 2–Beijing into
Africa over centuries
Supplementary Figures 1-14
Supplementary Tables 2, 5 and 6. Table 1, 3 and 4 are available online https://www.
frontiersin.org/articles/10.3389/fevo.2019.00112/full#supplementary-material
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Supplementary Figure B.1
Flowchart showing selection of whole genome sequence dataset included in this study.
Supplementary Figure B.2
Tip randomization test on clock rate with strict molecular clock model.
Supplementary Figure B.3
Tip randomization test on rate mean with the UCLD model.
Supplementary Figure B.4
Dated phylogeny of the 308 L2–Beijing strains.
Supplementary Figure B.5
Results of the ancestral reconstruction of 422 L2–Beijing strains using RASP.
Supplementary Figure B.6
Screen shots of the RASP reconstruction to show examples of estimated most likely geo-
graphic origins of Lineage 2-Beijing in Eastern Africa.
Supplementary Figure B.7
Screen shots of the RASP reconstruction to show examples of estimated most likely geo-
graphic origins of Lineage 2-Beijing in Southern Africa.
Supplementary Figure B.8
Temporal distribution of the 308 samples with information on isolation dates.
Supplementary Figure B.9
Phylogenetic tree showing the distribution of samples with isolation dates.
Supplementary Figure B.10
Proportion of samples with information on isolation dates across the seven geographical
regions.
Supplementary Figure B.11
Pairwise SNP distance of Lineage 2 strains linked to introduction events to Eastern Africa
(M5 and M6).
Supplementary Figure B.12
Pairwise SNP distance of Lineage 2 strains linked to introduction events to Africa followed
by dispersal within the region (M3, M10 and M13).
Supplementary Figure B.13
Pairwise SNP distance of Lineage 2 strains linked to introduction events to Southern
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Africa (M1, M8, M9 and M11).
Supplementary Figure B.14
Phylogeny of the 781 Lineage 2 strains mapped with strains’ drug resistance status.
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Supplementary Table 1 – Provided as a separate file online
List of 781 Lineage 2 strains used in this study with the associated metadata.
Supplementary Table B.1
Drug resistance status of Lineage 2 samples across the seven geographical regions.
Supplementary Table 3 – Provided as a separate file online
Parameter estimates obtained from the UCLD clock model.
Supplementary Table 4 – Provided as a separate file online
Comparison of the prior and posterior distribution for all parameter estimates.
Supplementary Table B.2
Lineage 2 sublineage proportions across the seven geographical regions.
Supplementary Table B.3
Estimate for time to the MRCA of the African Lineage 2-Beijing clades using different
nucleotide substitution and demographic models.
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834       
Public and in-house genomes 
Dataset used for phylogenetic 
reconstruction (RAxML) and 
stochastic character mapping 
53  
Bad quality genomes 
781       
Worldwide distributed genomes 
422       
Reconstruction of geographic 
range (RASP) 
359  
Filtered out genomes 
308 
Dataset with isolation 
dates used for dating  
Figure B.1.: Flow chart showing the selection of whole genome sequence dataset from previous
studies and current study.



































































































No Overlapping: DRT SUCCESSFULLY PASSED !!!
Figure B.2.: Tip randomization test on clock rate with strict molecular clock model. Error bars
are the 95% HPD.



















































































No Overlapping: DRT SUCCESSFULLY PASSED !!!
Figure B.3.: Tip randomization test on rate mean with the UCLD model. Error bars are the
95% HPD.



























































































































































































































































































































































































































































































































































Figure B.5.: Ancestral reconstruction of 422 L2–Beijing strains using RASP software.
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A) B) 
Figure B.6.: Screen shots of the RASP reconstruction to show examples of estimated most likely
geographic origins of Lineage 2-Beijing in Eastern Africa A) Direct introduction and
(B) dispersal within African region. Pie-charts indicate the reconstructed ancestral
geographical range at the nodes. Color codes are the same as described in Figure
6.1.
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A) B)   
Figure B.7.: Screen shots of the RASP reconstruction to show examples of estimated most likely
geographic origins of Lineage 2-Beijing in Southern Africa. Direct introductions from
A) Southeastern Asia and (B) Eastern Asia. Pie-charts indicate the reconstructed
ancestral geographical range at the nodes. Color codes are the same as described in
Figure 6.1.
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Figure B.8.: Temporal distribution of the 308 samples with information on isolation dates.
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Figure B.9.: Phylogenetic tree of the 781 Lineage 2 showing the distribution of samples with
isolation dates. Taxa labeled red are samples with isolation date information and
those in grey are samples with missing date information.
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Figure B.10.: Sample proportion with information on isolation dates across the seven geograph-
ical regions.
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M5 M6
N = 18 N = 24
Figure B.11.: Pairwise SNP distance of Lineage 2 strains linked to Eastern Africa introductions
(M5 and M6).




N = 11N = 20
Figure B.12.: Pairwise SNP distance of Lineage 2 strains linked to introductions and dispersal
in Africa (M3, M10 and M13).
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M1 M8
M9 M11
N = 12 N = 37
N = 46 N = 13
Figure B.13.: Pairwise SNP distance of Lineage 2 strains linked to Southern Africa introductions
(M1, M8, M9 and M11).
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Table B.1.: Drug resistance status of Lineage 2 samples across the seven geographical regions.
Drug resistance profile E. Africa S. Africa E. Asia S.E Asia S. Asia C. Asia E. Europe
FQ_monoresistant 0 0 5 0 0 0 0
INH_monoresistant 0 7 5 7 3 8 14
mdr 0 28 40 0 6 22 32
polyresistant 0 0 6 0 0 0 2
RIF_monoresistant 0 12 7 0 1 0 0
susceptible 92 107 170 45 38 4 16
xdr 0 10 27 1 1 1 11
TOTAL 92 164 260 53 49 35 75
Table B.2.: Lineage 2 sublineage proportions across the seven geographical regions.
Sublineage Eastern Africa Southern Africa Eastern Asia S.eastern Asia Southern Asia Central Asia Eastern Europe
L2.1 (Proto-beijing) 0 0 20 4 0 0 0
L2.2.1 (Asia Ancestral 1) 0 12 23 4 0 2 0
L2.2.2 (Asia Ancestral 2) 0 0 5 1 1 0 2
L2.2.3 (Asia Ancestral 3) 5 2 34 5 3 0 0
L2.2.4 (Asian African 1) 18 6 2 2 0 0 0
L2.2.5 (Asian African 3) 23 0 7 6 0 0 0
L2.2.6 (Pacific RD150) 0 38 19 15 1 0 1
L2.2.7 (Asian African 2) 3 69 40 5 4 0 1
L2.2.8 (Asian African 2/RD142) 0 0 4 2 0 0 0
L2.2.9 (B0/W148) 0 0 0 0 0 3 24
L2.2.10 (Central Asia) 0 0 1 0 2 29 44
Other 43 37 105 9 38 1 3
TOTAL 92 164 260 53 49 35 75
Table B.3.: Estimates for time to the MRCA of the African Lineage 2-Beijing clades using different
nucleotide substitution and demographic models.
Migration TMRCA 95% HPD
UCLD GTR Exp UCLD GTR Exp
M1 1809 1779 1786 1732-1874 1683-1863 1694-1863
M2 1964 1958 1956 1946-1980 1936-1978 1934-1976
M3 1831 1804 1806 1768-1886 1723-1874 1727-1872
M6 1876 1856 1857 1828-1920 1796-1910 1798-1909
M7 1820 1791 1793 1752-1876 1712-1869 1715-1867
M8 1929 1917 1915 1899-1955 1880-1951 1879-1948
M9 1906 1891 1889 1865-1942 1839-1936 1840-1933
M10 1862 1840 1842 1809-1909 1777-1902 1778-1898
M11 1863 1840 1842 1809-1910 1775-1901 1777-1900
M12 1855 1832 1833 1801-1903 1765-1896 1766-1890
M13 1962 1955 1954 1942-1979 1931-1978 1929-1976
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